
<html lang="en"     class="pb-page"  data-request-id="ac0cb4e8-a678-4f4f-926c-598f1b2dc3e5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2016.59.issue-23;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.6b01022"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300" /></meta><meta name="dc.Creator" content="Terry D.  Crawford" /></meta><meta name="dc.Creator" content="F. Anthony  Romero" /></meta><meta name="dc.Creator" content="Kwong Wah  Lai" /></meta><meta name="dc.Creator" content="Vickie  Tsui" /></meta><meta name="dc.Creator" content="Alexander M.  Taylor" /></meta><meta name="dc.Creator" content="Gladys  de Leon Boenig" /></meta><meta name="dc.Creator" content="Cameron L.  Noland" /></meta><meta name="dc.Creator" content="Jeremy  Murray" /></meta><meta name="dc.Creator" content="Justin  Ly" /></meta><meta name="dc.Creator" content="Edna F.  Choo" /></meta><meta name="dc.Creator" content="Thomas L.  Hunsaker" /></meta><meta name="dc.Creator" content="Emily W.  Chan" /></meta><meta name="dc.Creator" content="Mark  Merchant" /></meta><meta name="dc.Creator" content="Samir  Kharbanda" /></meta><meta name="dc.Creator" content="Karen E.  Gascoigne" /></meta><meta name="dc.Creator" content="Susan  Kaufman" /></meta><meta name="dc.Creator" content="Maureen H.  Beresini" /></meta><meta name="dc.Creator" content="Jiangpeng  Liao" /></meta><meta name="dc.Creator" content="Wenfeng  Liu" /></meta><meta name="dc.Creator" content="Kevin X.  Chen" /></meta><meta name="dc.Creator" content="Zhongguo  Chen" /></meta><meta name="dc.Creator" content="Andrew R.  Conery" /></meta><meta name="dc.Creator" content="Alexandre  Côté" /></meta><meta name="dc.Creator" content="Hariharan  Jayaram" /></meta><meta name="dc.Creator" content="Ying  Jiang" /></meta><meta name="dc.Creator" content="James R.  Kiefer" /></meta><meta name="dc.Creator" content="Tracy  Kleinheinz" /></meta><meta name="dc.Creator" content="Yingjie  Li" /></meta><meta name="dc.Creator" content="Jonathan  Maher" /></meta><meta name="dc.Creator" content="Eneida  Pardo" /></meta><meta name="dc.Creator" content="Florence  Poy" /></meta><meta name="dc.Creator" content="Kerry L.  Spillane" /></meta><meta name="dc.Creator" content="Fei  Wang" /></meta><meta name="dc.Creator" content="Jian  Wang" /></meta><meta name="dc.Creator" content="Xiaocang  Wei" /></meta><meta name="dc.Creator" content="Zhaowu  Xu" /></meta><meta name="dc.Creator" content="Zhongya  Xu" /></meta><meta name="dc.Creator" content="Ivana  Yen" /></meta><meta name="dc.Creator" content="Laura  Zawadzke" /></meta><meta name="dc.Creator" content="Xiaoyu  Zhu" /></meta><meta name="dc.Creator" content="Steven  Bellon" /></meta><meta name="dc.Creator" content="Richard  Cummings" /></meta><meta name="dc.Creator" content="Andrea G.  Cochran" /></meta><meta name="dc.Creator" content="Brian K.  Albrecht" /></meta><meta name="dc.Creator" content="Steven  Magnuson" /></meta><meta name="dc.Description" content="The single bromodomain of the closely related transcriptional regulators CBP/EP300 is a target of much recent interest in cancer and immune system regulation. A co-crystal structure of a ligand-eff..." /></meta><meta name="Description" content="The single bromodomain of the closely related transcriptional regulators CBP/EP300 is a target of much recent interest in cancer and immune system regulation. A co-crystal structure of a ligand-eff..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 28, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01022" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01022" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01022" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01022" /></link>
        
    
    

<title>Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01022" /></meta><meta property="og:title" content="Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0027.jpeg" /></meta><meta property="og:description" content="The single bromodomain of the closely related transcriptional regulators CBP/EP300 is a target of much recent interest in cancer and immune system regulation. A co-crystal structure of a ligand-efficient screening hit and the CBP bromodomain guided initial design targeting the LPF shelf, ZA loop, and acetylated lysine binding regions. Structure–activity relationship studies allowed us to identify a more potent analogue. Optimization of permeability and microsomal stability and subsequent improvement of mouse hepatocyte stability afforded 59 (GNE-272, TR-FRET IC50 = 0.02 μM, BRET IC50 = 0.41 μM, BRD4(1) IC50 = 13 μM) that retained the best balance of cell potency, selectivity, and in vivo PK. Compound 59 showed a marked antiproliferative effect in hematologic cancer cell lines and modulates MYC expression in vivo that corresponds with antitumor activity in an AML tumor model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01022"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01022">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01022&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01022&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01022&amp;href=/doi/10.1021/acs.jmedchem.6b01022" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 10549-10563</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00998" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01068" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Terry+D.++Crawford">Terry D. Crawford</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=F.+Anthony++Romero">F. Anthony Romero</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kwong+Wah++Lai">Kwong Wah Lai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vickie++Tsui">Vickie Tsui</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander+M.++Taylor">Alexander M. Taylor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gladys++de+Leon+Boenig">Gladys de Leon Boenig</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cameron+L.++Noland">Cameron L. Noland</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeremy++Murray">Jeremy Murray</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Justin++Ly">Justin Ly</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edna+F.++Choo">Edna F. Choo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+L.++Hunsaker">Thomas L. Hunsaker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Emily+W.++Chan">Emily W. Chan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Merchant">Mark Merchant</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Samir++Kharbanda">Samir Kharbanda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karen+E.++Gascoigne">Karen E. Gascoigne</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan++Kaufman">Susan Kaufman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maureen+H.++Beresini">Maureen H. Beresini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiangpeng++Liao">Jiangpeng Liao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenfeng++Liu">Wenfeng Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+X.++Chen">Kevin X. Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhongguo++Chen">Zhongguo Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+R.++Conery">Andrew R. Conery</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexandre++C%C3%B4t%C3%A9">Alexandre Côté</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hariharan++Jayaram">Hariharan Jayaram</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ying++Jiang">Ying Jiang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+R.++Kiefer">James R. Kiefer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tracy++Kleinheinz">Tracy Kleinheinz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yingjie++Li">Yingjie Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan++Maher">Jonathan Maher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eneida++Pardo">Eneida Pardo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Florence++Poy">Florence Poy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kerry+L.++Spillane">Kerry L. Spillane</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fei++Wang">Fei Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Wang">Jian Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaocang++Wei">Xiaocang Wei</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhaowu++Xu">Zhaowu Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhongya++Xu">Zhongya Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ivana++Yen">Ivana Yen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Zawadzke">Laura Zawadzke</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoyu++Zhu">Xiaoyu Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Bellon">Steven Bellon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Cummings">Richard Cummings</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea+G.++Cochran">Andrea G. Cochran</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+K.++Albrecht">Brian K. Albrecht</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Magnuson">Steven Magnuson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Genentech, Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Wuxi Apptec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s Republic of China</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Constellation Pharmaceuticals, Inc. 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +1-650-467-6384. E-mail: <a href="/cdn-cgi/l/email-protection#42302d2f27302d6c2430232c290225272c276c212d2f"><span class="__cf_email__" data-cfemail="55273a3830273a7b3327343b3e1532303b307b363a38">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01022&amp;href=/doi/10.1021%2Facs.jmedchem.6b01022" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 10549–10563</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 22, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 July 2016</li><li><span class="item_label"><b>Published</b> online</span>28 September 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 December 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01022" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01022</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10549%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTerry%2BD.%2BCrawford%252C%2BF.%2BAnthony%2BRomero%252C%2BKwong%2BWah%2BLai%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D23%26contentID%3Dacs.jmedchem.6b01022%26title%3DDiscovery%2Bof%2Ba%2BPotent%2Band%2BSelective%2Bin%2BVivo%2BProbe%2B%2528GNE-272%2529%2Bfor%2Bthe%2BBromodomains%2Bof%2BCBP%252FEP300%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10563%26publicationDate%3DDecember%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01022"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4108</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">46</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01022" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Terry&quot;,&quot;last_name&quot;:&quot;D. Crawford&quot;},{&quot;first_name&quot;:&quot;F.&quot;,&quot;last_name&quot;:&quot;Anthony Romero&quot;},{&quot;first_name&quot;:&quot;Kwong&quot;,&quot;last_name&quot;:&quot;Wah Lai&quot;},{&quot;first_name&quot;:&quot;Vickie&quot;,&quot;last_name&quot;:&quot;Tsui&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;M. Taylor&quot;},{&quot;first_name&quot;:&quot;Gladys&quot;,&quot;last_name&quot;:&quot;de Leon Boenig&quot;},{&quot;first_name&quot;:&quot;Cameron&quot;,&quot;last_name&quot;:&quot;L. Noland&quot;},{&quot;first_name&quot;:&quot;Jeremy&quot;,&quot;last_name&quot;:&quot;Murray&quot;},{&quot;first_name&quot;:&quot;Justin&quot;,&quot;last_name&quot;:&quot;Ly&quot;},{&quot;first_name&quot;:&quot;Edna&quot;,&quot;last_name&quot;:&quot;F. Choo&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;L. Hunsaker&quot;},{&quot;first_name&quot;:&quot;Emily&quot;,&quot;last_name&quot;:&quot;W. Chan&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Merchant&quot;},{&quot;first_name&quot;:&quot;Samir&quot;,&quot;last_name&quot;:&quot;Kharbanda&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;E. Gascoigne&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;Kaufman&quot;},{&quot;first_name&quot;:&quot;Maureen&quot;,&quot;last_name&quot;:&quot;H. Beresini&quot;},{&quot;first_name&quot;:&quot;Jiangpeng&quot;,&quot;last_name&quot;:&quot;Liao&quot;},{&quot;first_name&quot;:&quot;Wenfeng&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;X. Chen&quot;},{&quot;first_name&quot;:&quot;Zhongguo&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;R. Conery&quot;},{&quot;first_name&quot;:&quot;Alexandre&quot;,&quot;last_name&quot;:&quot;Côté&quot;},{&quot;first_name&quot;:&quot;Hariharan&quot;,&quot;last_name&quot;:&quot;Jayaram&quot;},{&quot;first_name&quot;:&quot;Ying&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;R. Kiefer&quot;},{&quot;first_name&quot;:&quot;Tracy&quot;,&quot;last_name&quot;:&quot;Kleinheinz&quot;},{&quot;first_name&quot;:&quot;Yingjie&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;Maher&quot;},{&quot;first_name&quot;:&quot;Eneida&quot;,&quot;last_name&quot;:&quot;Pardo&quot;},{&quot;first_name&quot;:&quot;Florence&quot;,&quot;last_name&quot;:&quot;Poy&quot;},{&quot;first_name&quot;:&quot;Kerry&quot;,&quot;last_name&quot;:&quot;L. Spillane&quot;},{&quot;first_name&quot;:&quot;Fei&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Xiaocang&quot;,&quot;last_name&quot;:&quot;Wei&quot;},{&quot;first_name&quot;:&quot;Zhaowu&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Zhongya&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Ivana&quot;,&quot;last_name&quot;:&quot;Yen&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Zawadzke&quot;},{&quot;first_name&quot;:&quot;Xiaoyu&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Bellon&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Cummings&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;G. Cochran&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;K. Albrecht&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Magnuson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;10549-10563&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01022&quot;},&quot;abstract&quot;:&quot;The single bromodomain of the closely related transcriptional regulators CBP/EP300 is a target of much recent interest in cancer and immune system regulation. A co-crystal structure of a ligand-efficient screening hit and the CBP bromodomain guided initial design targeting the LPF shelf, ZA loop, and acetylated lysine binding regions. Structure–activity relationship studies allowed us to identify a more potent analogue. Optimization of permeability and microsomal stability and subsequent improvement of mouse hepatocyte stability afforded 59 (GNE-272, TR-FRET IC50 = 0.02 μM, BRET IC50 = 0.41 μM, BRD4(1) IC50 = 13 μM) that retained the best balance of cell potency, selectivity, and in vivo PK. Compound 59 showed a marked antiproliferative effect in hematologic cancer cell lines and modulates MYC expression in vivo that corresponds with antitumor activity in an AML tumor model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01022&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01022" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01022&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01022" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01022&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01022" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01022&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01022&amp;href=/doi/10.1021/acs.jmedchem.6b01022" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01022" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01022" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01022%26sid%3Dliteratum%253Aachs%26pmid%3D27682507%26genre%3Darticle%26aulast%3DCrawford%26date%3D2016%26atitle%3DDiscovery%2Bof%2Ba%2BPotent%2Band%2BSelective%2Bin%2BVivo%2BProbe%2B%2528GNE-272%2529%2Bfor%2Bthe%2BBromodomains%2Bof%2BCBP%252FEP300%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D23%26spage%3D10549%26epage%3D10563%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291445" title="Chemical structure">Chemical structure</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/jmcmar.2016.59.issue-23/20161208/jmcmar.2016.59.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0027.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The single bromodomain of the closely related transcriptional regulators CBP/EP300 is a target of much recent interest in cancer and immune system regulation. A co-crystal structure of a ligand-efficient screening hit and the CBP bromodomain guided initial design targeting the LPF shelf, ZA loop, and acetylated lysine binding regions. Structure–activity relationship studies allowed us to identify a more potent analogue. Optimization of permeability and microsomal stability and subsequent improvement of mouse hepatocyte stability afforded <b>59</b> (GNE-272, TR-FRET IC<sub>50</sub> = 0.02 μM, BRET IC<sub>50</sub> = 0.41 μM, BRD4(1) IC<sub>50</sub> = 13 μM) that retained the best balance of cell potency, selectivity, and in vivo PK. Compound <b>59</b> showed a marked antiproliferative effect in hematologic cancer cell lines and modulates <i>MYC</i> expression in vivo that corresponds with antitumor activity in an AML tumor model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60801" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60801" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There has been significant progress recently in the development of non-BET (bromodomain and extra terminal domain family) bromodomain probes that will facilitate the understanding of the physiological function of the targeted bromodomain and its relevance in cellular models of disease states.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> As part of a discovery program aimed at identifying potent and selective non-BET bromodomain inhibitors<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> we were interested in discovering such an inhibitor for the bromodomain of cyclic-AMP response element binding protein (CBP or CREBBP). CBP and a highly similar paralogue, adenoviral E1A binding protein (EP300 or p300), are large, multidomain proteins<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> that each contain a single bromodomain shown to recognize acetylated p53 at K382 following DNA damage.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> CBP and EP300 have been implicated as potential oncology targets.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> We have reported that the bromodomain of CBP/EP300 (going forward in the paper “CBP” will be used as a surrogate for CBP/EP300) regulates <i>MYC</i>,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> a transcription factor and oncogene widely expressed in human cancer, which suggests a potential therapeutic strategy for targeting multiple myeloma and other lymphoid malignancies. In addition, we have described the ability of CBP bromodomain inhibitors to impair <i>T</i><sub>reg</sub> differentiation and suppressive function, and this activity could constitute a novel small molecule approach for cancer immunotherapy.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> CBP has also been implicated in neurological disorders where a CBP bromodomain inhibitor has been shown to reduce expression of a regulator of G-protein signaling (RGS4).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Given these combined activities, the CBP/EP300 bromodomain has emerged as an especially interesting new therapeutic target.</div><div class="NLM_p">Because of the potential therapeutic relevance, there has been increasing interest in drug discovery targeting the bromodomain of CBP.<a onclick="showRef(event, 'ref3 ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref3 ref13 ref14 ref15 ref16 ref17 ref18">(3, 13-18)</a><a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> shows selected CBP bromodomain inhibitors (<b>1</b>,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a><b>2</b>,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a><b>3</b>,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a><b>4</b>,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a><b>5</b>,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and <b>6</b><a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a>) reported in the literature. A key issue has been to identify CBP inhibitors that are not only potent and selective with excellent cellular activity but that are also devoid of BET activity. Inhibition of the BET family bromodomains produces profound phenotypes that are, in some cases, related to effects produced by CBP bromodomain inhibitors, and there is little shift in cellular potency from the measured biochemical IC<sub>50</sub>s against bromodomain-containing protein 4 (BRD4; representative BET bromodomain).<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> It is therefore imperative to use compounds with a high degree of selectivity over BET in studies to understand CBP and that in vitro and in vivo studies that are performed do not significantly use concentrations above the BRD4 biochemical/cellular potency. We have recently reported on the fragment-based lead discovery of <b>6</b> (CPI-637), a highly selective in vitro probe with good cellular potency (CBP BRET IC<sub>50</sub> = 0.29 μM, <i>MYC</i> EC<sub>50</sub> = 0.13 μM).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Unfortunately, an in vivo probe remained elusive from further modification of <b>6</b> and we hoped a new chemical series may prove more suitable for the development of an in vivo tool compound. While we and others have made significant progress in identifying selective in vitro probes, there remains the challenge of identifying a probe suitable for in vivo studies. Here we describe the structure-based design of <b>59</b> (GNE-272), a potent and selective CBP inhibitor that is active in a MOLM-16 pharmacokinetic/pharmacodynamic (PK/PD) model measuring <i>MYC</i> expression and is efficacious in a MOLM-16 acute myeloid leukemia (AML) xenograft model.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. CBP and the first bromodomain of the bromodomain-containing protein 4 [BRD4(1)] time-resolved fluorescence resonance energy transfer (TR-FRET) biochemical IC<sub>50</sub>s, CBP bioluminescence resonance energy transfer (BRET), cellular IC<sub>50</sub>s, and MYC cellular EC<sub>50</sub>s for selected CBP bromodomain inhibitors reported in the literature. Data shown in this figure were determined using assay protocols reported in this paper. All values are reported as means of values from at least two determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74832" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74832" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Screening of CBP against a lead-like property-restricted diversity set<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> in a thermal shift assay resulted in the identification of several ligand-efficient hits. Compounds that increased the CBP bromodomain melting temperature by at least one degree Celsius were further characterized by dose response in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. In addition to ligand efficiency, selectivity against the first bromodomain of BRD4 [BRD4(1)] (our surrogate for BET bromodomains) as well as other bromodomains was of central importance in choosing a starting point. Compound <b>7</b> (Δ<i>T</i><sub>m</sub> = 2.3, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A) emerged as a submicromolar CBP inhibitor that met our criteria (LE = 0.47; see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01022/suppl_file/jm6b01022_si_001.pdf" class="ext-link">Supporting Information</a> for selected for more extensive bromodomain selectivity data). Importantly, this hit was selective against BRD4(1), displaying approximately 100-fold greater affinity for CBP. We obtained a co-crystal structure of <b>7</b> with the bromodomain of CBP (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B) and found that the amide of <b>7</b> binds in the KAc (acetylated lysine) binding site, with the amide carbonyl making a canonical hydrogen bond to Asn1168 and additional water-mediated hydrogen bond interactions to Pro1110 and Tyr1125. The pyrazolopiperidine core is sandwiched between the gatekeeper (Val1174) and Leu1120, while the phenyl ring makes van der Waals interactions with the LPF shelf (Leu1109, Pro1110, Phe1111). To understand the lower affinity of <b>7</b> for BRD4(1), we examined several published structures. Modeling of <b>7</b> into BRD4(1) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MXF">3MXF</a>) shows BRD4 Trp81 clashing with <b>7</b> (this conformation of Trp81 is representative of that seen in the majority of published BRD4(1) structures). To further probe the preferred binding mode, we carried out ab initio torsion scans (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01022/suppl_file/jm6b01022_si_001.pdf" class="ext-link">Supporting Information</a>) of the pyrazolopiperidine core with respect to the aniline. The results illustrate that the out-of-plane conformation of <b>7</b>, as it is bound to CBP, is a low-energy conformation, whereas forcing the aniline to be planar with respect to the pyrazolopiperidine to avoid steric clash with BRD4 Trp81 would raise the conformational energy of the ligand and help to explain the selectivity of <b>7</b> for CBP over BRD4(1).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) CBP-selective screening hit <b>7</b>. (B) Co-crystal structure of <b>7</b> and the CBP bromodomain (1.38 Å resolution; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTU">5KTU</a>). Residues engaging in important contacts between the ligand and receptor are shown in stick representation. Water molecules are shown as small red spheres. (C) Compound <b>7</b> placed into the BRD4(1) binding site by overlay of the BRD4(1) complex structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MXF">3MXF</a>) and the complex structure shown in B. Only ligand <b>7</b> and the BRD4(1) protein are shown. BRD4 Trp81 is shown in stick representation (bottom right). (D) The solvent accessible surface of the CBP bromodomain colored to highlight hydrophobicity and charge where hydrocarbon groups without polar substitutions are yellow, negatively charged oxygens of glutamate and aspartate are red, nitrogens of positively charged functional groups of lysine and arginine are blue, and all remaining atoms including the polar backbone is white. Bound ligand <b>7</b> is shown in stick representation (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">From the co-crystal structure of <b>7</b>, there were several areas in the binding site for which we could explore to improve potency. We initially examined three different areas in parallel for SAR optimization: interactions with the LPF shelf, the ZA loop, and the KAc binding regions.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> A series of benzene derivatives bearing small electron-withdrawing substituents and lipophilic substituents at the 2-, 3-, or 4-positions was designed to explore the LPF region (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) to observe the effect on van der Waals interactions with Pro1110 and Val1109. Substitution at the 2-position reduced inhibitory potency relative to the unsubstituted <b>7</b>, whereas substitution at the 3- or 4-positions enhanced inhibitory potency (up to 7-fold for <b>18</b>). Our hypothesis for the loss of potency for substituents placed at the 2-position was that substituents at the 2-position provided a disfavorable interaction with Pro1110. Because this initial data with the limited number of substituents at the 2-position was not productive, we chose to focus on substituents at the 3- and 4-positions. Generally, substitution at the 3- or 4-positions increased inhibitory potency with substitution at the 3-position being marginally (up to 2-fold for <b>12</b> compared to <b>13</b>) more potent. Building on compound <b>9</b>, we looked at a small set of substituents at the 3-position. Extension of the methyl substituent of <b>9</b> to an ethyl (<b>14</b>) resulted in a ∼2-fold increase in potency. Most likely, the increase in potency is due to the increased van der Waals interaction of the ethyl substituent with Pro1110 and Val1109. Further examination of various substituents (methyl ester <b>16</b>, trifluoromethyl <b>18</b>, methoxy <b>19</b>, and difluoromethoxy <b>20</b>) revealed that all were tolerated matching or exceeding the potency of <b>9</b>. Although we were unable to obtain any co-crystal structures for this small set of compounds, we hypothesized that substitution at the 3-position created a better interaction with Arg1173 (e.g., dipolar interactions, hydrogen bond interactions, van der Waals interactions with the carbon side chain of Arg1173) with the methyl ester of <b>16</b> and trifluoromethyl group of <b>18</b>, exhibiting a ∼7-fold increase in potency from compound <b>7</b>. Consistent with previous reports,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> substituents in this same area improve potency. Importantly, the compounds shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> failed to bind significantly to BRD4(1). However, we continued to monitor BRD4(1) potency to ensure that we were not affecting selectivity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of Substitution on the Benzene Ring of <b>7</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0016.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.62</td><td class="colsep0 rowsep0" align="char" char=".">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">2-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">3-CH3</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="char" char=".">0.43</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char=".">0.91</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">3-CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.19</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">4-CH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">3-CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">4-CO<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">3-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.34</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">3-OCF<sub>2</sub>H</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">All IC<sub>50</sub> values are reported as means of values from at least two determinations. TR-FRET assay with the isolated CBP or BRD4(1) bromodomain.</p></div></div></div><div class="NLM_p">In the second area suggested by the co-crystal structure with <b>7</b>, effects of changes to the KAc-mimetic group were examined (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Extending the acyl chain length of <b>9</b> by one (<b>21</b>) or two (<b>22</b>) carbons dramatically decreased inhibitory potency. Replacing the terminal acetyl carbon with a cyclopropyl (<b>23</b>) or trifluoromethyl (<b>24</b>) substituent was also not productive. Lastly, replacing the acetyl with an alternative Asn binder, methyl sulfone (<b>25</b>), was not tolerated. The strong sensitivity to the length of the acetyl moiety is consistent with previous work,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> where we have found in another series that while certain alkyl chains are accommodated in the conserved water region of BRD9 and TAF1(2), they are not tolerated by CBP. Taken together, these findings suggest that the conserved water molecules in CBP may be especially difficult to displace. Alternatively, neither the pyrazolopiperidine of <b>9</b> nor the pyrrolopyridone scaffold<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> may present the optimal vector to grow toward the analogous pockets of CBP. On the basis of results from our small SAR study (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), we chose the acetyl group as the preferred KAc binding region moiety for future analogues.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effect of Substitution in the KAc Binding Region</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0017.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0018.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">All IC<sub>50</sub> values are reported as means of values from at least two determinations. TR-FRET assay with the isolated CBP or BRD4(1) bromodomain.</p></div></div><div></div></div><div class="NLM_p">The third area of the binding site that we explored is the ZA loop. In particular, we explored substitution on the <i>N</i><sup>1</sup> nitrogen of the pyrazole of <b>9</b> to improve contacts with this region of the protein. A solvent accessible surface mapped with a hydrophobic potential indicated that hydrophobic substituents might increase potency (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>D). Addition of alkyl substituents from methyl (<b>26</b>) to propyl (<b>28</b>) incrementally increased potency 5-fold over parent <b>9</b>. Further derivitization of <b>28</b> with polar functionality (<b>29</b>–<b>31</b>) resulted in decreased potency. Cyclopropyl derivatives (<b>32</b>–<b>34</b>) were prepared to increase hydrophobic interactions within the ZA loop region (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). While <b>32</b> and <b>34</b> lost ∼2.5-fold in potency compared to <b>28</b>, compound <b>33</b> had a marginal increase in potency compared to <b>28</b>. The subtle improvement in potency of <b>33</b> over the straight-chain alkyl analogues (<b>26</b>–<b>28</b>) indicated that larger groups may improve potency from van der Waals interactions and filling more volume between the ZA and BC loop regions. With this in mind, the cyclopropyl of <b>33</b> was replaced with a phenyl and various pyridine regioisomers. Unfortunately, all of these aryl replacements (<b>35</b>–<b>38</b>) lost inhibitory potency (only 2-fold in the case of pyridine derivative <b>37</b>) compared to <b>33</b> and this area of the active site may not be able to accommodate this larger substitution. At this point, we proceeded to continue with holding the cyclopropyl substituent constant because this modification appeared to be the most productive in this set of analogues in regards to potency, albeit marginal in some instances (ranging from 1.2- to 5.7-fold increase potency over parent <b>9</b>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Exploring the ZA Loop Region with Substitution on the Pyrazole of <b>9</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0019.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0020.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">All IC<sub>50</sub> values are reported as means of values from at least two determinations. TR-FRET assay with the isolated CBP or BRD4(1) bromodomain.</p></div></div><div></div></div><div class="NLM_p">Out of these explorations, one of the more productive substitutions on the phenyl ring of <b>7</b> was a methyl ester at the 3-position (<b>16</b>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). With this in mind, we explored the LPF shelf further with a small set of 3-amido derivatives (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) using <b>33</b> as the core. Methyl amide <b>39</b> matched the potency of <b>33</b>. At this point, we began monitoring MLM (mouse liver microsome) stability to make note of SAR that not only improved potency but metabolic stability as well. Compound <b>39</b> (MLM Cl<sub>hep</sub> = 45 mL/min/kg) showed encouraging MLM stability compared to <b>33</b> (MLM Cl<sub>hep</sub> = 78 mL/min/kg). We proceeded to explore other amides that might improve potency and MLM stability. Tertiary amide <b>40</b> was evaluated, however, this modification gave a 5-fold loss in potency compared to <b>39</b>. Extending the alkyl chain of <b>39</b> (ethyl amide <b>41</b> and propyl amide <b>42</b>) led to increased potency but no improvement of MLM stability. Ether <b>43</b> resulted in a dramatic loss in potency. To help increase van der Waals interactions in the LPF shelf, we explored branched analogue <b>44</b>. Compound <b>44</b> increased potency ∼3-fold over <b>39</b> and maintained moderate selectivity (123-fold) over BRD4(1). In addition, this compound displayed submicromolar potency in our bioluminescence resonance energy transfer (BRET) cellular assay and maintained moderate MLM stability. Compound <b>44</b> garnered our attention as it was potent and highly selective. In addition, we were encouraged by the molecule’s moderate MLM stability and, thus, evaluated <b>44</b> in mouse PK. Although <b>44</b> had moderate in vivo clearance (43 mL/min/kg) with a good in vitro/in vivo correlation, poor oral bioavailability (<i>F</i> = 5%) precluded use of this compound for in vivo studies. Examination of the in vitro permeability of <b>44</b> revealed relatively low permeability (<i>P</i><sub>app</sub> A to B = 2.4 × 10<sup>–6</sup> cm/s) and suggested this as a property to optimize. We obtained a co-crystal structure of <b>44</b> with CBP to understand the contributions of both the cyclopropyl methyl and isopropyl amide moieties (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The cyclopropyl group appears to make van der Waals contacts with Ile1122 in the ZA loop region. The isopropyl group makes van der Waals contacts with Leu1109 in the LPF shelf and with Pro1106. Arg1173 swings in to make a favorable hydrogen-bond contact with the amide carbonyl.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Amide Derivatives That Explore the LPF Shelf</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0021.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0022.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">All IC<sub>50</sub> values are reported as means of values from at least two determinations.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Mouse liver microsome-predicted hepatic clearance.</p></div></div><div></div></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. A co-crystal structure of <b>44</b> and the CBP bromodomain (1.09 Å resolution, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTW">5KTW</a>) displaying important contacts between the ligand and receptor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We surmised that the amide (h-bond donor) of <b>44</b> contributed to the low permeability of this compound. To eliminate the H-bond donor, we replaced the amide group of <b>44</b> with various isosteric aryl analogues (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). We initially explored phenyl analogue <b>45</b> and were pleased to observe a 2-fold increase in biochemical potency and, more importantly, improved permeability (∼7-fold increase). However, the addition of the phenyl ring also resulted in an increase in cLogP<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> potentially contributing to the observed decrease in MLM stability of this compound compared to <b>44</b>. With this in mind, we evaluated heterocycles that would have a desired lipophilic profile. Generally, the various heterocycles were only ∼2-fold less potent than parent <b>45</b> and most of the heterocycles evaluated imparted comparable permeability. At this point, we focused our attention on pyrazole <b>52</b>, which had good cellular potency and physical chemical properties. We acquired metabolite identification data (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01022/suppl_file/jm6b01022_si_001.pdf" class="ext-link">Supporting Information</a>) from liver microsomes, and the two major metabolites observed were oxidation on the phenyl ring and cleavage of the cyclopropylmethyl moiety. With this data in hand, we focused our strategy on addressing these metabolic soft spots as a way to improve MLM stability.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Examination of Aryl Groups and Their Effect on cLogP, MLM, and Permeability</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0023.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0024.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">All IC<sub>50</sub> values are reported as means of values from at least two determinations.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Mouse liver microsome-predicted hepatic clearance.</p></div><div class="footnote" id="t5fn3"><sup>Table c</sup><p class="last">MDCK cell line; apical-to-basolateral; units = × 10<sup>–6</sup> cm s<sup>–1</sup>.</p></div></div><div></div></div><div class="NLM_p">To address the oxidation of the phenyl ring, we moved the <i>N</i>-methyl pyrazole to the 4-position (<b>54</b>, <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>) to observe if blocking oxidation here would affect MLM. On the basis of the SAR discussed earlier (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), we expected that moving the pyrazole from the 3-position to the 4-position would result in only a slight decrease in inhibitory potency. However, we hoped that blocking the metabolic soft spot at the 4-position would improve microsomal stability and offset any potency loss. Indeed, pyrazole <b>54</b> had comparable potency to regioisomer <b>52</b>, and generally this trend was observed with other aryl rings as well. Gratifyingly, we observed a 2-fold improvement in MLM stability for <b>54</b> over <b>52</b>. We evaluated <b>54</b> in mouse PK experiments and observed high CL (118 mL/min/kg), which prompted us to turn our attention to the cyclopropylmethyl group of <b>54</b> to see if variations would lead to further improvement of MLM stability. Paring back the cyclopropylmethyl (<b>54</b>) to a methyl (<b>55</b>) resulted in a slight decrease in biochemical potency but a substantial increase in MLM stability. We designed cyclic ethers (<b>56</b>–<b>58</b>) that could fill the ZA loop region and provide superior physicochemical properties compared to the cyclopropylmethyl group of <b>54</b>. Previous SAR (compound <b>43</b>) suggested that the oxygen might not be tolerated, but modeling of the THF showed that there was a possibility of interacting with Arg1173. Experimentally, these compounds had increased MLM stability compared to <b>54</b> and we were pleased to observe that <b>57</b> retained potency. The flexible methoxy ethyl chain of <b>43</b> may reside in a different area in ZA loop region making unfavorable contacts compared to the rigidified THF of <b>54</b>. At this point, we obtained metabolite identification data for <b>54</b> in mouse hepatocytes and, interestingly, found that the sole metabolite was glucuronidation of the parent. This prompted us to collect mouse hepatocyte (MH) stability data for the analogues shown in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a> and not surprisingly revealed a disconnect between MLM stability and MH stability for these compounds as glucuronidation/phase II metabolism is likely the primary route of biotransformation for these compounds. Under the conditions used for mouse liver microsome incubations, only phase I metabolism is captured while hepatocyte incubations captures both phase I and II metabolism. We hypothesized that the aniline nitrogen was the likely culprit for glucuronidation and thus focused our efforts on modification of <b>57</b>. This tetrahydrofuran-containing analogue was equipotent to <b>54</b> but lacked the cyclopropyl methyl group that was a known metabolic liability. To decrease the propensity of <b>57</b> (calculated p<i>K</i><sub>a</sub> 2.34) to undergo glucoronidation, we attempted to reduce the p<i>K</i><sub>a</sub> of the aniline by placing a fluorine atom at the 2-position (<b>59</b>, calculated p<i>K</i><sub>a</sub> 2.1, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). This simple modification substantially improved MH stability while maintaining CBP potency. Previous SAR studies (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) suggested the addition of a fluorine atom to the 2-position would lead to a slight reduction in inhibitory potency, but we were surprised when we observed that the potency for <b>57</b> versus <b>59</b> was indistinguishable. We obtained a co-crystal structure of <b>59</b> and the CBP bromodomain (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). The compound binds as expected based on similar compounds in the series, with the pyrazolopiperidine core occupying the KAc binding site. The fluorine atom appears to provide little interaction with the binding site. The <i>N</i>-methylpyrazole packs along the surface defined by the LPF shelf, while the tetrahydrofuran sits under the ZA loop. The flexible side chain of Arg1173 points toward the oxygen of the tetrahydrofuran, making a hydrogen-bond contact. While we were unable to get a crystal structure for <b>11</b>, we were able to compare the CBP co-crystal structure of <b>7</b> with <b>59</b>. An overlay of these compounds (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01022/suppl_file/jm6b01022_si_001.pdf" class="ext-link">Supporting Information</a>) shows that the 2-fluorophenyl pyrazole arm of <b>59</b> shifts in the binding site relative to parent <b>7</b>. This suggests that the SAR on the simpler molecules in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> would not necessarily follow the SAR of <b>59</b> and provides an explanation why there is a disconnect in SAR going from <b>7</b> to <b>11</b> and <b>57</b> to <b>59</b>. The MH stability of <b>59</b> was improved while maintaining similar MLM clearance, thus supporting the hypothesis that phase 2 metabolism was at play. Furthermore, <b>59</b> demonstrated low clearance following a 1 mg/kg intravenous dose in a mouse PK experiment and good oral bioavailability when dosed at 100 mg/kg, reaching an unbound <i>C</i><sub>max</sub> of 26 μM. Examination of a subset of bromodomains revealed that this compound is exquisitely selective for CBP/EP300 (full bromodomain selectivity profile provided in <a href="/doi/suppl/10.1021/acs.jmedchem.6b01022/suppl_file/jm6b01022_si_001.pdf" class="ext-link">Supporting Information</a>) and remarkably selective (650-fold) over BRD4(1). When tested at 10 μM in an Invitrogen kinase panel (35 kinases; full list of kinases in <a href="/doi/suppl/10.1021/acs.jmedchem.6b01022/suppl_file/jm6b01022_si_001.pdf" class="ext-link">Supporting Information</a>) and Cerep off-target screening panel (42 receptors; full list of receptors in <a href="/doi/suppl/10.1021/acs.jmedchem.6b01022/suppl_file/jm6b01022_si_001.pdf" class="ext-link">Supporting Information</a>), <b>59</b> did not inhibit any target at >30%. In addition, <b>59</b> did not inhibit (>10 μM, top concentration) several cytochrome P450s (3A4, 1A2, 2C9, 2C19, 2D6). The compound had good potency in the BRET cellular assay. In an orthogonal measure of the target engagement, <b>59</b> was shown to inhibit the expression of <i>MYC</i><a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> (MV4–11 cell line) with an EC<sub>50</sub> of 0.91 μM and good correlation between the BRET and <i>MYC</i> cellular assays was observed. We also observed that the enantiomer of <b>59</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01022/suppl_file/jm6b01022_si_001.pdf" class="ext-link">Supporting Information</a>) is 2-fold less potent in the biochemical assay (CBP IC<sub>50</sub> = 0.4 μM) and <i>MYC</i> assay (EC<sub>50</sub> = 1.9 μM), providing an additional orthogonal measure of target engagement.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Analogues That Highlight the MLM/MH Disconnect</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0025.gif" alt="" id="fx10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0026.gif" alt="" id="fx11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">All IC<sub>50</sub> values are reported as means of values from at least two determinations.</p></div><div class="footnote" id="t6fn2"><sup>Table b</sup><p class="last">Mouse liver microsome-predicted hepatic clearance.</p></div><div class="footnote" id="t6fn3"><sup>Table c</sup><p class="last">Mouse hepatocyte-predicted hepatic clearance.</p></div></div><div></div></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Properties of <b>59</b>. <sup><i>a</i></sup>All IC<sub>50</sub> values are reported as means of values from at least two determinations. <sup><i>b</i></sup>MDCK cell line; apical-to-basolateral; units = × 10<sup>–6</sup> cm s<sup>–1</sup>. <sup><i>c</i></sup>Mouse plasma protein binding. <sup><i>d</i></sup>Mouse liver microsome-predicted hepatic clearance. <sup><i>e</i></sup>Mouse hepatocyte-predicted hepatic clearance. <sup><i>f</i></sup>Compounds were dosed iv (1 mg kg<sup>–1</sup>) as PEG400/H<sub>2</sub>O (35/65) solution and po (100 mg kg<sup>–1</sup>) as an aqueous suspension with 0.5% methylcellulose and 0.2% Tween 80.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0006.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) A co-crystal structure of <b>59</b> in the CBP bromodomain (1.23 Å resolution, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTX">5KTX</a>) displaying important contacts between the ligand and receptor. (B) A co-crystal structure of <b>59</b> in the BRD4(1) (1.14 Å resolution, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KU3">5KU3</a>) displaying important contacts between the ligand and receptor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further understand the selectivity for <b>59</b> over BRD4(1), we obtained a co-crystal structure of <b>59</b> with BRD4(1). As shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B, the bulky side chain of Trp81 from the WPF shelf of BRD4(1) causes the aniline and the 4-<i>N</i>-methylpyrazole to become almost coplanar to the pyrazolopiperidine core. This planar arrangement has a higher ligand energy as calculated by ab initio torsion scans (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01022/suppl_file/jm6b01022_si_001.pdf" class="ext-link">Supporting Information</a>) when compared to the <b>59</b>–CBP structure, as we had postulated from modeling the interaction of BRD4(1) with <b>7</b> from the <b>7</b>–CBP structure (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), and provides an explanation for the observed selectivity of <b>59</b> for CBP over BRD4(1). In addition, the <i>N</i>-methylpyrazole of <b>59</b> resides completely in bulk solvent when in complex with BRD4(1) rather than making the favorable van der Waals interactions it does with CBP.</div><div class="NLM_p">Given that compound <b>59</b> afforded a good balance of cell potency, selectivity, favorable in vivo PK, and good in vitro/in vivo correlation with MH, it was selected for additional profiling. We initially investigated the in vitro activity of <b>59</b> in a panel of hematologic cancer cell lines (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A). Compound <b>59</b>, dosed at 5 μM (which is below its BRD4 (1) and BRD4(2) IC<sub>50</sub> values), caused inhibition of <i>MYC</i> expression in a variety of genetic contexts. In a dose response study, using the AML MOLM-16 cell line, <b>59</b> repressed <i>MYC</i> expression at both the RNA (EC<sub>50</sub> = 69 nM) and protein level (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B). The impact of <b>59</b> treatment on expression of other oncogenes was also assessed by reverse transcription polymerase chain reaction (RT-PCR). After 4 h of treatment, significant repression of a number of key oncogenes was observed in MOLM-16 AML cells (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C). Consistent with the ability of <b>59</b> to inhibit oncogene expression, treatment of a broad panel of blood cancer cell lines caused a marked antiproliferative effect after 6 days (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>D).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0007.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vitro evaluation of <b>59</b>. (A) The indicated cell lines were treated for 4 h with 5 μM <b>59</b> or DMSO control. <i>MYC</i> expression was then determined by RT-PCR. Data represents mean ± standard deviation (SD). <i>N</i> = 4. (B) MOLM-16 AML cells were treated for 4 h with the indicated concentrations of <b>59</b> or DMSO control. <i>MYC</i> expression was then determined by RT-PCR and Western blot. (C) MOLM-16 AML cells were treated for 4 h with 5 μM <b>59</b> or DMSO control. Expression of the indicated oncogenes was then determined by RT-PCR. Data represent mean ± SD <i>N</i> = 4. (D) The indicated cell lines were treated with a dose range of <b>59</b>. After 6 days, cell viability was measured by CellTiter-Glo. Plot shows absolute IC<sub>50</sub> in μM. Data represent mean ± SD <i>N</i> = 3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">After demonstrating the ability of <b>59</b> to modulate <i>MYC</i> in vitro, we determined the effect of <b>59</b> in vivo in a PK/PD experiment in a MOLM-16 xenograft mouse model. Single doses of <b>59</b> were given at dose levels between 3 and 100 mg/kg in MOLM-16 tumor-bearing animals, and samples were collected at time points covering 2–24 h. Tumor RNA was generated and used to assess <i>MYC</i> transcript by quantitative RT-PCR relative to vehicle treated animals. Suppression of <i>MYC</i> was observed at doses as low as 10 mg/kg at 2–8 h with maximal suppression observed at 30 and 100 mg/kg at 2 h (78% and 86% inhibition, respectively) (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A). While the tumor-unbound drug levels at the 3 mg/kg dose were right at the <i>MYC</i> EC<sub>90</sub> for <b>59</b> (621 nM; calculated from the <i>MYC</i> EC<sub>50</sub> determined in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B), at the 10 mg/kg dose unbound drug levels were above <i>MYC</i> EC<sub>90</sub> at all time points save for the 24 h time point. It should be noted that suppression of <i>MYC</i> at the 10, 30, and 100 mg/kg doses was seen without reaching the BRD4(1) IC<sub>50</sub> (13 μM) of <b>59</b>. Inhibition of <i>MYC</i>-transcript was transient over the 24 h window, and an apparent rebound effect was observed at all doses, rising to about 150–200% of vehicle control. Increasing suppression of <i>MYC</i>-transcript level corresponded with increasing plasma and tumor drug levels (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0008.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In vivo evaluation of <b>59</b>. (A) Effect on <i>MYC</i> transcript levels with single doses of <b>59</b> in MOLM-16 tumor-bearing animals (<i>n</i> = 3/group; mean ± SEM plotted). Plasma and tumor levels were adjusted for PPB, and mean plasma and tumor unbound drug levels (±SD) are displayed. Displayed are the <i>MYC</i> EC<sub>90</sub> (green) and BRD4 IC<sub>50</sub> (red) for <b>59</b>. (B) Antitumor efficacy of <b>59</b> in a MOLM-16 AML xenograft study and effect on body weight (<i>n</i> = 8/group; mean ± SEM plotted).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To evaluate the in vivo antitumor efficacy of <b>59</b>, MOLM-16 AML xenografts were established in SCID beige mice. Upon tumor establishment, dosing of compound <b>59</b> was initiated with po doses of 12.5–50 mg/kg, twice daily (BID). Single-agent efficacy was observed at all doses, as evidenced by dose-dependent inhibition of MOLM-16 tumor growth (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B). Tumor growth inhibition (%TGI) was 46%, 65%, and 102% at 12.5, 25, and 50 mg/kg, respectively. At the highest dose, treatment resulted in one complete response out of eight mice tested. All doses of <b>59</b> were well tolerated over the 21-day dosing window, with a maximal body weight loss of −7.4%. Taken together, these results demonstrate that <b>59</b> is active in vivo to modulate CBP-dependent <i>MYC</i> transcription, which corresponds with antitumor activity in a MYC-dependent AML tumor model.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Chemistry</h3><div class="NLM_p">Compounds <b>8</b>–<b>20</b> were prepared according to <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Treatment of piperidinone <b>60</b> with various isothiocyanates followed by alkylation with methyl iodide yielded intermediate <b>61</b>. Cyclization of <b>61</b> with hydrazine afforded the corresponding pyrazolopiperidines <b>8</b>–<b>20</b>.</div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Substituted Aryl Analogues <b>8</b>–<b>20</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KO<i>t</i>Bu, THF, rt; (b) CH<sub>3</sub>I, 40 °C; (c) hydrazine monohydrate, EtOH, 85 °C, 5–44% from <b>60</b>.</p></p></figure><div class="NLM_p">The synthesis of <b>21</b>–<b>25</b> to explore the KAc site is outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Treatment of piperidinone <b>62</b> with 1-isothiocyanato-3-methylbenzene followed by alkylation with methyl iodide produced <b>63</b>. Cyclization of <b>63</b> with hydrazine afforded BOC protected pyrazolopiperidine <b>64</b>. Deprotection of the BOC group yielded intermediate <b>65</b> from which inhibitors <b>21</b>–<b>25</b> were produced. Amides <b>21</b>–<b>23</b> were formed from coupling of the appropriate carboxylic acid in the presence of HATU. Treatment of <b>65</b> with either methylsulfonyl chloride or trifluoroacetic anhydride yielded <b>24</b> and <b>25</b>, respectively.</div><figure id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Analogues <b>21</b>–<b>25</b> Exploring the KAc Binding Site</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-isothiocyanato-3-methylbenzene, KOtBu, THF, rt; (b) CH<sub>3</sub>I, 40 °C, 100%; (c) hydrazine monohydrate, EtOH, 80 °C, 91%; (d) HCl/EtOAc, rt, 83%; (e) propionic acid or butyric acid or cyclopropanecarboxylic acid, HATU, TEA, DMF, rt, 37–43%; (f) CH<sub>3</sub>SO<sub>2</sub>Cl or trifluoroacetic anhydride, TEA, DCM, rt, 38%.</p></p></figure><div class="NLM_p">Compound <b>9</b> was used as a key intermediate to explore the ZA loop region (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Alkylation of <b>9</b> with various alkyl or benzylic halides produced <b>26</b>–<b>30</b> and <b>33</b>–<b>38</b>. Both <i>N</i>1 and <i>N</i>2 alkylated regioisomers were obtained under these alkylation conditions and could be readily separated using reverse phase chromatography. Compound <b>31</b> was formed from a 1,4-conjugate addition with acrylonitrile. Cyclopropyl analogue <b>32</b> was formed from the treatment of <b>63</b> with cyclopropylhydrazine and TEA at elevated temperature to afford the cyclpropanated product <b>66</b>. Deprotection of the BOC group followed by acylation with acetic anhydride yielded <b>32</b>.</div><figure id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Analogues <b>26</b>–<b>38</b> Exploring the ZA Loop Region</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) alkyl halide, CsCO<sub>3</sub> or K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 11–37%; (b) acrylonitrile, DBU, MeCN, rt, 16%; (c) cyclopropylhydrazine, TEA, EtOH, 80 °C; (d) HCl/EtOAc, rt; (e) acetic anhydride, TEA, DMF, rt, 5% from <b>66</b>.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> shows the synthesis of compounds <b>39</b>–<b>44</b> that explored the LPF shelf. Compound <b>68</b> was used as the key intermediate from which all the amides were formed. Alkylation of <b>16</b> with (bromomethyl)cyclopropane afforded <b>67</b>. Saponification of <b>67</b> followed by amide coupling with various amines provided <b>39</b>–<b>44</b>.</div><figure id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Analogues Amides <b>39</b>–<b>44</b> That Explore the LPF Shelf</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (bromomethyl)cyclopropane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C; (b) KOH, MeOH/H<sub>2</sub>O, rt; (c) Amine, DIEA, HATU, DMF, 35 °C, 11–35% from <b>16</b>.</p></p></figure><div class="NLM_p">The synthesis of aryl analogues <b>45</b>–<b>54</b> is shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Compounds <b>69</b> and <b>70</b> were prepared similarly to the chemistry shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Alkylation of <b>69</b> and <b>70</b> with (bromomethyl)cyclopropane afforded the corresponding cyclopropylmethyl intermediates <b>71</b> and <b>72</b>, respectively. From these intermediates, <b>45</b>–<b>54</b> could be accessed readily either with Suzuki or Stille coupling of the appropriate boronic acid or stannane.</div><figure id="sch5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0013.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Aryl Analogues <b>45</b>–<b>54</b> Exploring the LPF Shelf</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (bromomethyl)cyclopropane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 47–49%; (b) Ar-B(OH)<sub>2</sub>, dioxane/water, Na<sub>2</sub>CO<sub>3</sub>, Pd(dppf)Cl<sub>2</sub>, 110 °C, 17–48%; (c) 2-(tributylstannyl)pyridine, Pd(PPh<sub>3</sub>)<sub>4</sub>, toluene, 120 °C, 31%.</p></p></figure><div class="NLM_p">The synthesis of analogues <b>55</b>–<b>58</b> that further probe the ZA loop region is shown in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. Suzuki coupling of 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole with <b>70</b> provided key intermediate <b>73</b>, from which compounds <b>55</b>–<b>58</b> were produced. Alkylation of <b>73</b> with the corresponding alkyl iodide or mesylate afforded candidate inhibitors <b>55</b>–<b>58</b>.</div><figure id="sch6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0014.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Analogues <b>55</b>–<b>58</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole, dioxane/water, Na<sub>2</sub>CO<sub>3</sub>, Pd(dppf)Cl<sub>2</sub>, 110 °C, 65%; (b) MeI, 3-iodooxetane, (<i>R</i>)-tetrahydrofuran-3-yl methanesulfonate or (<i>S</i>)-tetrahydrofuran-3-yl methanesulfonate CsCO<sub>3</sub>, DMF, 80 °C, 4–26%.</p></p></figure><div class="NLM_p">The synthesis of the in vivo probe compound <b>59</b> is shown in <a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>. Treatment of piperidinone <b>60</b> with 4-bromo-2-fluoro-1-isothiocyanato-benzene followed by alkylation with methyl iodide yielded <b>74</b>. Cyclization of <b>74</b> with hydrazine afforded the pyrazolopiperidine <b>75</b>. Subsequent Suzuki coupling with 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole followed by alkylation of the pyrazole with (<i>R</i>)-tetrahydrofuran-3-yl methanesulfonate yielded the in vivo probe compound <b>59</b>.</div><figure id="sch7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0015.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of in Vivo Probe <b>59</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-bromo-2-fluoro-1-isothiocyanato-benzene, KOtBu, THF, rt; (b) CH<sub>3</sub>I, 40 °C, 51%; (c) hydrazine monohydrate, EtOH, 85 °C, 96%; (d) 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole, dioxane/water, Na<sub>2</sub>CO<sub>3</sub>, Pd(dppf)Cl<sub>2</sub>, 100 °C, 63%; (e) (<i>R</i>)-tetrahydrofuran-3-yl methanesulfonate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 42%.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58118" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58118" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Herein we have outlined the identification of an inhibitor of the CBP/EP300 bromodomains that is potent biochemically and in cells and displays suitable metabolic stability for application as an in vivo probe. A ligand efficient screening hit, compound <b>7</b>, displayed submicromolar potency toward CBP while maintaining good selectivity toward a small panel of bromodomains. A co-crystal structure of <b>7</b> in CBP was obtained and guided initial design targeting the LPF shelf, ZA loop, and KAc binding regions. While modification of the acetyl moiety of <b>7</b> was not productive, structure–activity relationship studies in the ZA loop and LPF regions of the active site led to the identification of <b>44</b> (TR-FRET IC<sub>50</sub> = 0.03 μM, BRET IC<sub>50</sub> = 0.96 μM, BRD4(1) IC<sub>50</sub> = > 20 μM) as a viable in vitro probe, but the poor PK properties of this compound precluded further use in in vivo experiments. Further optimization to improve permeability and MLM stability led to the identification of <b>57</b> (CBP TR-FRET IC<sub>50</sub> = 0.02 μM, CBP BRET IC<sub>50</sub> = 0.73 μM, BRD4(1) IC<sub>50</sub> = 8.5 μM, but the poor MH stability (Cl<sub>hep</sub> = 59 mL/min/kg) of this compound again limited further evaluation. Addition of a fluorine <i>ortho</i> to the aniline of <b>57</b> to reduce the p<i>K</i><sub>a</sub> and thus glucoronidation of the aniline afforded <b>59</b> (CBP TR-FRET IC<sub>50</sub> = 0.02 μM, CBP BRET IC<sub>50</sub> = 0.41 μM, BRD4(1) IC<sub>50</sub> = 13 μM). Compound <b>59</b> afforded improved mouse hepatocyte stability (Cl<sub>hep</sub> = 6.2 mL/min/kg) while retaining the best balance of cell potency, selectivity, and favorable in vivo PK. Further evaluation of <b>59</b> in vitro showed a marked antiproliferative effect in hematologic cancer cell lines. In vivo, <b>59</b> is able to modulate CBP transcriptional dependent <i>MYC</i> expression that corresponds with antitumor activity in a <i>MYC</i>-dependent AML tumor model. Furthermore, the selectivity of this compound, particularly against BET bromodomains, underscores the use of <b>59</b> as a tool compound to further delineate phenotypes of CBP/EP300 bromodomains over that of BET bromodomains..</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28317" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28317" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Methods</h3><div class="NLM_p last">All solvents and reagents were used as obtained. NMR analysis performed in a deuterated solvent with a Varian Avance 300 MHz or Bruker Avance 400 or 500 MHz NMR spectrometers, referenced to trimethylsilane (TMS). Chemical shifts are expressed as δ units using TMS as the external standard (in NMR description, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, and br = broad peak). All coupling constants (<i>J</i>) are reported in hertz. Mass spectra were measured with a Finnigan SSQ710C spectrometer using an ESI source coupled to a Waters 600MS high performance liquid chromatography (HPLC) system operating in reverse-phase mode with an X-bridge phenyl column of dimensions 150 mm by 2.6 mm, with 5 μm sized particles. Preparatory-scale silica gel chromatography was performed using medium-pressure liquid chromatography (MPLC) on a CombiFlash Companion (Teledyne ISCO) with RediSep normal phase silica gel (35–60 μm) columns and UV detection at 254 nm. Reverse-phase (HPLC) was used to purify compounds as needed by elution from a Phenomenex Gemini-NX C18 column (20.2 mm × 50 mm, 5 μm) as stationary phase using mobile phase indicated, and operating at a 35 mL/min flow rate on a Waters 3100 mass-directed prep instrument. Chemical purities were >95% for all final compounds as assessed by LC/MS analysis. The following analytical method was used to determine chemical purity of final compounds: HPLC-Agilent 1200, water with 0.05% TFA, acetonitrile with 0.05% TFA (buffer B), Agilent SB-C18, 1.8 μM, 2.1 mm × 30 mm, 25 °C, 3–95% buffer B in 8.5 min, 95% in 2.5 min, 400 μL/min, 220 and 254 nm, equipped with Agilent quadrupole 6140, ESI positive, 90–1300 amu.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Synthesis and Characterization of (<i>S</i>)-1-(3-((2-Fluoro-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)amino)-1-(tetrahydrofuran-3-yl)-6,7-dihydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-5(4<i>H</i>)-yl)ethanone (<b>59</b>)</h3><div class="NLM_p">To a stirred solution of 1-acetylpiperidin-4-one (<b>60</b>, 6.08 g, 43.09 mmol) in THF (100 mL) was added <i>t</i>-BuOK (4.83 g, 43.09 mmol) in an ice bath. After being stirred at rt for 30 min, 4-bromo-2-fluoro-1-isothiocyanato-benzene (10 g, 43.09 mmol) was added. The mixture was stirred at rt for an additional 3 h before MeI (3.22 mL, 51.71 mmol) was added. The reaction mixture was heated to 40 °C for 1 h. The reaction was quenched with satd aq ammonium chloride (100 mL), and the mixture was extracted with EtOAc (100 mL × 2). The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude residue was purified by silica gel chromatography (petroleum ether/EtOAc = 1:1) to give (<i>Z</i>)-1-acetyl-3-(((4-bromo-2-fluorophenyl)amino) (methylthio)methylene)piperidin-4-one (<b>74</b>, 8.5 g, 51%) as a yellow oil.</div><div class="NLM_p">A mixture of (<i>Z</i>)-1-acetyl-3-(((4-bromo-2-fluorophenyl)amino) (methylthio)methylene)piperidin-4-one (<b>74</b>, 8.5 g, 21.95 mmol) and hydrazine monohydrate (1.88 mL, 32.92 mmol, 85%) in EtOH (85 mL) was heated to 60 °C for 2 h. The reaction mixture was concentrated in vacuo to give 1-(3-((4-bromo-2-fluorophenyl)amino)-6,7-dihydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-5(4<i>H</i>)-yl)ethanone (<b>75</b>, 7.5 g, 96%) as a white solid that required no further purification. LCMS <i>m</i>/<i>z</i> (M + H) 355.</div><div class="NLM_p">To a solution of 1-(3-((4-bromo-2-fluorophenyl)amino)-6,7-dihydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-5(4<i>H</i>)-yl)ethanone (<b>75</b>, 6 g, 16.99 mmol) in 1,4-dioxane (50 mL) and water (10 mL) was added 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole (4.24 g, 20.39 mmol), [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II) (1.24 g, 1.7 mmol), and Na<sub>2</sub>CO<sub>3</sub> (3.6 g, 33.98 mmol). The reaction mixture was heated to 100 °C for 12 h under a nitrogen atmosphere. After cooling to rt, the mixture was filtered and concentrated in vacuo. The residue was purified by silica gel chromatography (DCM/MeOH = 30:1) to give 1-(3-((2-fluoro-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)amino)-6,7-dihydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-5(4<i>H</i>)-yl)ethanone (<b>76</b>, 3.8 g, 63%) as a brown solid. LCMS <i>m</i>/<i>z</i> (M + H) 352.</div><div class="NLM_p">To a solution of (<i>R</i>)-tetrahydrofuran-3-ol (25 g, 253.7 mmol) in DCM (250 mL) at 0 °C was added triethylamine (117.8 mL, 851.2 mmol) and methanesulfonyl chloride (26.4 mL, 340.48 mmol) dropwise. The mixture was stirred at rt for 12 h. The reaction was quenched with water (100 mL) and extracted with DCM (100 mL × 2). The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to give (<i>R</i>)-tetrahydrofuran-3-yl methanesulfonate (47 g crude, 100%) as a brown oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.35–5.27 (m, 1H), 4.05–3.83 (m, 4H), 3.04 (s, 3 H), 2.28–2.20 (m, 2 H).</div><div class="NLM_p last">To a solution of 1-(3-((2-fluoro-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)amino)-6,7-dihydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-5(4<i>H</i>)-yl)ethanone (<b>76</b>, 20.0 g, 56.44 mmol) in DMF (100 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (55.16 g, 169.31 mmol) and (<i>R</i>)-tetrahydrofuran-3-yl methanesulfonate (11.26 g, 67.72 mmol). The mixture was heated to 90 °C for 16 h. After cooling to rt, the mixture was concentrated in vacuo. The crude residue was purified by silica gel chromatography (DCM/MeOH = 100:1) to give (<i>S</i>)-1-(3-((2-fluoro-4-(1-methyl-1<i>H</i>-pyrazol-4-yl)phenyl)amino)-1-(tetrahydrofuran-3-yl)-6,7-dihydro-1<i>H</i>-pyrazolo[4,3-<i>c</i>]pyridin-5(4<i>H</i>)-yl)ethanone (<b>59</b>, 10.0 g, 42%) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.76–7.72 (m, 1H), 7.68 (s, 1H), 7.53 (s, 1H), 7.20–7.12 (m, 2H), 5.86–5.77 (m, 1H), 4.79–4.69 (m, 1H), 4.47–4.29 (m, 2H), 4.25–4.08 (m, 2H), 4.06–3.72 (m, 4H), 3.99 (s, 3H), 2.76–2.65 (m, 2H), 2.49–2.28 (m, 2H), 2.25–2.12 (m, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 169.8, 169.4, 151.7 (d, <i>J</i> = 238.9 Hz), 145.5, 144.64, 137.83, 136.3, 135.9, 126.4, 121.4, 116.4 (d, <i>J</i> = 26.0 Hz), 111.9, 103.1 (d, <i>J</i> = 24.0 Hz), 71.9, 68.1, 57.7, 43.2, 42.2, 39.0, 37.8, 32.5, 22.0. LCMS <i>m</i>/<i>z</i> (M + H) 425. [α]<sup>27</sup><sub>D</sub> −11.0 (<i>c</i> 1.0, CHCl<sub>3</sub>, 99% ee). HRMS <i>m</i>/<i>z</i> 425.2093 (M + H<sup>+</sup>, C<sub>22</sub>H<sub>25</sub>FN<sub>6</sub>O<sub>2</sub>, requires 425.2057).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Modeling Methods</h3><div class="NLM_p last">The figures of crystal structures were created using PyMol: All figures were made using PyMOL Molecular Graphics System, Version 1.8, Schrödinger, LLC. The overlay of crystal structures was carried out with “align” command with default parameters in PyMOL. Hydrophobic mapping used a previously described algorithm.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Expression and Purification of Bromodomain Proteins</h3><div class="NLM_p last">The expression and purification of bromodomain proteins was carried out as previously described.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Expression and Purification of Bromodomain Proteins for Crystallography</h3><div class="NLM_p last">The expression and purification of CRBP and BRD4 bromodomains for crystallography have been previously described.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Thermal Shift Assay Protocol</h3><div class="NLM_p last">His-Flag tagged human CBP bromodomain (K1082-G1197) was expressed in <i>Escherichia coli</i> and purified to >95% purity in-house. In a conical tube CBP (4 μM final) was combined with SYPROOrange (Invitrogen) to a final dye concentration of 10× in 25 mM HEPES, 100 mM NaCl, pH 6.8. The tube was centrifuged briefly to remove precipitate, and 80 μL of the protein:dye solution was then added to each well of a black clear bottom 384-well plate (Greiner), and spun briefly (1 min, 900<i>g</i>). From this stock plate, 23 μL was transferred (three separate transfers per stock plate well) to either DMSO controls or compounds plated from 10 mM DMSO stocks into clear bottom Fluotrac200 plates (Greiner) to a final compound concentration of 50 μM (1.0% v/v DMSO). Subsequently samples (15 μL) were transferred to LightCycler 480 plates (Roche Diagnostics), spun (2 min, 900<i>g</i>), and analyzed on a Roche Lightcycler 480 II using a temperature gradient of 25–65 °C and a scanning rate of 4.2 °C/min. The midpoint of the melting transitions (<i>T</i><sub>m</sub>) were assessed using an application developed in-house measuring the first derivative of the rate of fluorescence change as a function of temperature. Compound induced changes in the melting temperature, Δ<i>T</i><sub>m</sub>, were calculated relative to DMSO controls within the same plate.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Time-Resolved Fluorescence Resonance Energy Transfer Assays</h3><div class="NLM_p last">Compound potencies were evaluated in a panel of biochemical bromodomain binding assays. Binding of biotinylated small-molecule ligands to recombinant His-tagged bromodomains was assessed by time-resolved fluorescence resonance energy transfer (TR-FRET). Test compounds that compete with the biotinylated ligand for bromodomain binding reduce the TR-FRET signal. All biochemical assay protocols were carried out as previously described.<a onclick="showRef(event, 'ref3 ref4 ref24'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref24">(3, 4, 24)</a></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Cellular Assay Protocols</h3><div class="NLM_p last">The CBP BRET assay was carried out as previously described.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> To determine the inhibition of <i>MYC</i> espression, MV-4–11 cells (ATCC) were plated at 10000 cells per well in 96-well plates in RPMI1640 media supplemented with 10% fetal bovine serum and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine. Test compounds diluted in DMSO were transferred to the cell plates, keeping final DMSO concentration consistent at 0.1%, and incubated for 4 h at 37 °C. Lysis and analysis for <i>MYC</i> expression were carried out using QuantiGene 2.0 reagents (Affymetrix/eBioscience, probe set catalogue no. SA-50182) and following the vendor’s instructions. Luminescence was read using an EnVision plate reader (PerkinElmer) and EC<sub>50</sub>s generated in Genedata Screener using a four-parameter nonlinear regression fit.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> In Vitro Metabolic Stability Experiments</h3><div class="NLM_p last">Metabolic stability experiments were performed with 1 μM of compound and were evaluated in pooled liver microsomes from female CD-1 mice (Corning, Tewsbury, MA) and pooled cryopreserved hepatocytes from female CD-1 mice (BioreclamationIVT, Baltimore MD) using methods previously reported.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Liver microsomal incubations consisted of 0.5 mg/mL microsomal protein, 1 mM NADPH in 100 mM Kpi buffer. Reaction was initiated with the addition of compound (1μM), 50 μL aliquots were sampled at 0, 20, 40, and 60 min, and reactions were quenched with 2× volume of acetonitrile containing an in-house internal standard. Cryopreserved hepatocytes were thawed and resuspended in Dulbecco’s Modified Eagle’s Medium (DMEM, pH 7.4). Incubation mixture containing 0.5 × 10<sup>6</sup> cells/mL and 1 μM compound were incubated in a 37 °C incubator with 95% relative humidity and 5% CO<sub>2</sub> environment, 50 μL aliquots were sampled at 0, 60, 120, and 180 min, and reactions were quenched with 2× volume acetonitrile containing an in-house internal standard. Quenched samples from microsomes and hepatocytes were centrifuged for 10 min at 2000<i>g</i>. Supernatant were removed and diluted with water (2×) and analyzed by LC-MS/MS using <i>t</i> = 0 peak area ratio set to 100%. The in vitro intrinsic clearance and scaled hepatic clearance were determined as described by Obach et al.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> MDCK Permeability Experiments</h3><div class="NLM_p last">MDCK cells were plated in 24-well plates at 2.5 × 10<sup>5</sup> cells/mL and allowed to grow for 4 days at 37 °C in 95% humidity and 5% CO<sub>2</sub> environment. Media containing Dulbecco’s Modified Eagle Medium (DMEM) and Earle’s Balanced Salt Solution supplemented with 10% fetal bovine serum was changed 2 days after seeding and the day prior to the experiment. Compound was added to either the apical or the basolateral side of the monolayer at an initial concentration of 10 μM and was incubated at 37 °C for 180 min. Samples were taken from the receiver chambers at 60, 120, and 180 min and analyzed by LC-MS/MS. The apparent permeability (<i>P</i><sub>app</sub>), in the apical-to-basolateral (A–B) and basolateral-to-apical (B–A) directions, was calculated as <i>P</i><sub>app</sub> = (d<i>Q</i>/d<i>t</i>)(1/<i>AC</i><sub>0</sub>), where d<i>Q</i>/d<i>t</i> = rate of compound appearance in the receiver compartment, <i>A</i> = surface area of the inset, and <i>C</i><sub>0</sub> = initial substrate concentration at time = 0. The efflux ratio (ER) was calculated as (<i>P</i><sub>app,B–A</sub>/<i>P</i><sub>app,B–A</sub>).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> In Vitro Protein Binding Experiments</h3><div class="NLM_p last">Mouse plasma (100%) was thawed and was adjusted to pH 7.4 with either sodium hydroxide or phosphoric acid if needed. Plasma (300 μL), spiked with compound (final concentrations 5 μM), was placed into the sample chamber of the single-use RED plate on the donor side, and aliquots (500 μL) of PBS were placed into the adjacent chamber on the receiver side, both in duplicate. The plate was covered with a clear plate cover top and incubated on a Liconic shaker at 37 °C for 4 h. After 4 h, 40 μL aliquots from the receiver and 4 μL from the donor were withdrawn and acetonitrile (150 μL) containing 2.5 nM propranolol (internal standard) was added. To create analytically identical sample matrices to minimize matrix effect, 40 μL of blank plasma was added to receiver wells, whereas 36 μL of blank plasma and 40 μL of PBS were added to donor wells. Samples were centrifuged at 1000<i>g</i> for 10 min, and supernatants (100 μL) were transferred to a 96-well analysis plate. Water (100 μL) was added to the samples prior to LC-MS/MS analysis. The percent of protein binding was calculated from the area ratio of the analyte detected (normalized to internal standard) from the receiver and donor side multiplied by 100.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> CYP Inhibition Assessment</h3><div class="NLM_p last">CYP inhibition was assessed over a concentration range of 0.16–10 uM of <b>59</b> using pooled (n = 150) human liver microsomes (Corning, Tewksbury, MA) using methods previously reported.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Incubation duration and protein concentration was dependent on the CYP isoform and the probe substrate/metabolites assessed. The following substrate/metabolites and incubation times and protein concentrations for each CYP were used: CYP1A2, phenacetin/acetaminophen, 30 min, 0.03 mg/mL protein; CYP2C9, warfarin/7-hydroxywarfarin, 30 min, 0.2 mg/mL protein; CYP2C19, mephenytoin/4-hydroxymephenytoin, 40 min, 0.2 mg/mL protein; CYP2D6, dextromethorphan/dextrorphan, 10 min, 0.03 mg/mL protein; CYP3A4, midazolam/1-hydroxymidazolam, 10 min, 0.03 mg/mL protein; and CYP3A4 testosterone/6β-hydroxytestosterone, 10 min, 0.06 mg/mL protein. These conditions were previously determined to be in the linear rate of formation for the CYP-specific metabolites. All reactions were initiated with 1 mM NADPH and terminated by the addition of 0.1% formic acid in acetonitrile containing appropriate stable labeled internal standard. Samples were analyzed by LC-MS/MS.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> In Vivo PK of <b>59</b></h3><div class="NLM_p">Six nu/nu mice were obtained from Vital River Laboratory Animal Co., Ltd., Beijing, P.R. China. All animals were female, 6–9 weeks old at the time of study, and weighed between 15 and 25 g. Animals (n = 3 per dosing route) were dosed with <b>59</b> 1 mg/kg iv (in propyl ethylene glycol 400 (35% v/v) and water (65% v/v)) or 100 mg/kg po (suspended in 0.5% w/v methylcellulose, 0.2% w/v Tween 80). Food and water were available ad libitum to all animals. Serial blood samples (15 μL) were collected by tail nick at 0.033, 0.083, 0.25, 0.5, 1, 3, 8, and 24 h after the intravenous administration and 0.083, 0.25, 0.5, 1, 3, 8, and 24 h after the oral administration. All blood samples were diluted with 60 μL of water containing 1.7 mg/mL EDTA and kept at −80 °C until analysis. All animal studies were carried out in accordance with the Guide for the Care and Use of Laboratory Animals as adopted and were approved by the Institution’s Animal Care and Use Committee.</div><div class="NLM_p last">Concentrations of <b>59</b> were determined by a nonvalidated LC-MS/MS assay. The diluted blood samples were prepared for analysis by placing a 20 μL aliquot into a 96-well plate followed by the addition of 200 μL of acetonitrile containing an internal standard mixture (0.1 μg/mL diclofenac). The samples were vortexed and centrifuged at 4000 rpm for 20 min at 4 °C; 70 μL of the supernatant was diluted with 140 μL of 0.1% formic acid (FA) in water, and 10 μL of the solution was injected onto an analytical column. An ACQUITY UPLC system (Waters) coupled with an API 4000 mass spectrometer (AB Sciex, Foster City, CA) was used for sample analysis. The mobile phases were 0.3% FA and 2 mM NH<sub>4</sub>OAc in water/ACN (v:v, 95:5) (A) and 0.3% FA and 5 mM NH<sub>4</sub>OAc in ACN/water (v:v, 95:5) (B). The gradient was as follows: starting at 20% B and increased to 90% B for 1.2 min, maintained at 90% B for 0.4 min, then decreased to 20% B within 0.1 min. The total flow rate was 0.55 mL/min, and samples were injected onto an ACQUITY BEH C8 (100 mm × 2.1 mm, 1.7 μm) analytical column with a total run time of 1.7 min. Data were acquired using multiple reactions monitoring (MRM) in positive ion electrospray mode with an operating source temperature of 550 °C. The MRM transition was <i>m</i>/<i>z</i> 425.3 → 313.4 for <b>59</b> and 296.0 → 214.0 for diclofenac. The lower and upper limits of quantitation of the assay for <b>59</b> were 0.005 and 10 μM, respectively.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> In Vitro Evaluation of <b>59</b> in Cells</h3><div class="NLM_p last">Human cancer cell lines were cultured in Dulbecco’s Modified Eagle Media supplemented with 10% fetal bovine serum and 2 mM glutamine. Cultures were maintained at 37 °C and 80% humidity. RNA was isolated from cells using the RNeasy kit according to manufactures instructions (Qiagen). RNA levels of <i>MYC</i>, other oncogenes, and the housekeeping gene ACTB were determined by RT-PCR using iSCRIPT reverse transcriptase (BIO-RAD), TaqMan universal PCR mix (ThermoFisher), and gene specific probes (ABI) according to manufacturer’s instructions. <i>MYC</i> protein levels were determined by Western blot using anti <i>MYC</i> antibodies (Abcam ab32072). Anti α-tubulin (Abcam ab72910) was used as a loading control. Signal was detected using HRP conjugated secondary antibodies. Cell viability was assessed after drug treatment in a 384-well plate format, using CellTiter-Glo reagent (Promega) according to manufacturer’s instructions.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> In Vivo Evaluation of <b>59</b> in MOLM-16 AML PK/PD and Antitumor Efficacy Model</h3><div class="NLM_p">RT-PCR was performed using TaqMan RNA-to-Ct 1-Step kit and Taqman Gene Expression Assays (Applied Biosystems, Carlsbad, CA, USA). The comparative Ct method was used to estimate relative changes in gene expression using MYC Taqman assay (Hs00153408_m1) and ACTB TaqMan assay (Hs01060665_g1) as housekeeping gene.</div><div class="NLM_p">All procedures were approved by and conformed to the guidelines and principles set by the Institutional Animal Care and Use Committee of Genentech and were carried out in an Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC)-accredited facility. Female C.B-17 SCID.bg mice that were 8–9 weeks old and weighed 20–24 g were obtained from Charles River Lab. They were inoculated with five million MOLM-16 leukemia acute myelogenic cells (suspended in a 1:1 mixture of Hank’s Balanced Salt Solution containing Matrigel at a 1:1 ratio) in the right flank subcutaneously. Tumors were monitored until they reached a mean tumor volume of 130–300 mm<sup>3</sup>. The mean tumor volume across all eight groups was 222 ± 6.87 mm<sup>3</sup> (mean ± SD) at the initiation of dosing. Mice were given 0 (vehicle, 0.5% methylcellulose; 0.2% Tween-80), 12.5, 25, and 50 mg/kg of compound <b>59</b> by gavage, twice daily (BID) for 21 days in a volume of 100 μL. Tumor volumes were measured in two dimensions (length and width) using Ultra Cal-IV calipers (model 54-10-111; Fred V. Fowler Co., Newton, MA) and analyzed using Excel, version 11.2 (Microsoft Corporation; Redmond WA). The tumor volume was calculated with the following formula: tumor size (mm<sup>3</sup>) = (longer measurement × shorter measurement<sup>2</sup>) × 0.5. Animal body weights were measured using an Adventura Pro AV812 scale (Ohaus Corporation; Pine Brook, NJ). Percent weight change was calculated using the following formula: group percent weight change = (new weight – initial weight)/initial weight) × 100. Plasma, tumor, and brain samples were collected at 2 h postdose.</div><div class="NLM_p last">Concentrations of <b>59</b> were determined by a nonvalidated LC-MS/MS assay. The plasma samples were prepared for analysis by placing a 25 μL aliquot into a 96-well plate. The tumor samples were collected and weighed. Four volumes of water by tissue weight were added. Using a bead beating homogenizer, the tissue samples were homogenized and 25 μL of each was aliquoted into a 96-well plate. A volume of 200 μL of acetonitrile containing an internal standard (labetalol) was added to the sample. The samples were vortexed and centrifuged at 4000 rpm for 10 min, and 50 μL of the supernatant was diluted with 150 μL of water. A 10 μL injection volume was used for analysis on a SIL-30ACMP autosampler system (Shimadzu, Columbia, MD) was linked to LC-30AD pumps (Shimadzu), coupled with an API 5500 QTrap mass spectrometer (Sciex, Foster City, CA) was used for sample analysis. The mobile phases were 0.1% FA water (A) and 0.1% FA in ACN (B). The gradient was as following: starting at 10% B and increased to 90% B in 0.6 min, maintained at 90% B for 0.2 min, then decreased to 10% B within 0.1 min. The total flow rate was 1.2 mL/min and column for separation was Kinetex XB-C18 column (50 mm × 2.1 mm, 2.6 μm) with a total run time of 1.2 min. Data were acquired using multiple reactions monitoring (MRM) in positive ion electrospray mode with an operating source temperature of 550 °C. The MRM transition was <i>m</i>/<i>z</i> 425.3 → 313.4 for <b>59</b> and 329.076 → 294.1 for labetalol. The lower and upper limits of quantitation of the assay for <b>59</b> were 0.002 and 10 μM, respectively.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01022">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08514" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08514" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01022" class="ext-link">10.1021/acs.jmedchem.6b01022</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Full experimental details and characterization for all reported compounds, metabolite identification data for <b>52</b>, the enantiomer of <b>59</b> experimental details, characterization, biochemical assay data, and cellular assay data, selectivity data for <b>7</b>, crystallography methods, modeling coordinates, ab initio torsion scan data for <b>7</b> and <b>59</b>, BromoScan data for <b>59</b>, CEREP off-target screening data for <b>59</b>, Invitrogen kinase data for <b>59</b>, PK/PD data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01022/suppl_file/jm6b01022_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01022/suppl_file/jm6b01022_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01022/suppl_file/jm6b01022_si_001.pdf">jm6b01022_si_001.pdf (1.48 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01022/suppl_file/jm6b01022_si_002.csv">jm6b01022_si_002.csv (4.37 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes for the structures of the CBP bromodomain in complex with <b>7</b>, <b>44</b>, and <b>59</b> are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTU">5KTU</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTW">5KTW</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTX">5KTX</a>, respectively. PDB code for the structure of the BRD4(1) in complex with <b>59</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KU3">5KU3</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b01022" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61435" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61435" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">F. Anthony Romero</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#02706d6f67706d2c6470636c694265676c672c616d6f"><span class="__cf_email__" data-cfemail="97e5f8faf2e5f8b9f1e5f6f9fcd7f0f2f9f2b9f4f8fa">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Terry D. Crawford</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kwong Wah Lai</span> - <span class="hlFld-Affiliation affiliation">Wuxi
Apptec Co., Ltd., 288
Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s
Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vickie Tsui</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander M. Taylor</span> - <span class="hlFld-Affiliation affiliation">Constellation
Pharmaceuticals, Inc. 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gladys de Leon Boenig</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cameron L. Noland</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeremy Murray</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Justin Ly</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edna F. Choo</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas L. Hunsaker</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emily W. Chan</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Merchant</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samir Kharbanda</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen E. Gascoigne</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan Kaufman</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maureen H. Beresini</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiangpeng Liao</span> - <span class="hlFld-Affiliation affiliation">Wuxi
Apptec Co., Ltd., 288
Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s
Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenfeng Liu</span> - <span class="hlFld-Affiliation affiliation">Wuxi
Apptec Co., Ltd., 288
Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s
Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin X. Chen</span> - <span class="hlFld-Affiliation affiliation">Wuxi
Apptec Co., Ltd., 288
Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s
Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhongguo Chen</span> - <span class="hlFld-Affiliation affiliation">Wuxi
Apptec Co., Ltd., 288
Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s
Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew R. Conery</span> - <span class="hlFld-Affiliation affiliation">Constellation
Pharmaceuticals, Inc. 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexandre Côté</span> - <span class="hlFld-Affiliation affiliation">Constellation
Pharmaceuticals, Inc. 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hariharan Jayaram</span> - <span class="hlFld-Affiliation affiliation">Constellation
Pharmaceuticals, Inc. 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying Jiang</span> - <span class="hlFld-Affiliation affiliation">Wuxi
Apptec Co., Ltd., 288
Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s
Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James R. Kiefer</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tracy Kleinheinz</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yingjie Li</span> - <span class="hlFld-Affiliation affiliation">Wuxi
Apptec Co., Ltd., 288
Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s
Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan Maher</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eneida Pardo</span> - <span class="hlFld-Affiliation affiliation">Constellation
Pharmaceuticals, Inc. 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florence Poy</span> - <span class="hlFld-Affiliation affiliation">Constellation
Pharmaceuticals, Inc. 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kerry L. Spillane</span> - <span class="hlFld-Affiliation affiliation">Constellation
Pharmaceuticals, Inc. 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fei Wang</span> - <span class="hlFld-Affiliation affiliation">Wuxi
Apptec Co., Ltd., 288
Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s
Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Wang</span> - <span class="hlFld-Affiliation affiliation">Wuxi
Apptec Co., Ltd., 288
Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s
Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaocang Wei</span> - <span class="hlFld-Affiliation affiliation">Wuxi
Apptec Co., Ltd., 288
Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s
Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhaowu Xu</span> - <span class="hlFld-Affiliation affiliation">Wuxi
Apptec Co., Ltd., 288
Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s
Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhongya Xu</span> - <span class="hlFld-Affiliation affiliation">Wuxi
Apptec Co., Ltd., 288
Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s
Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ivana Yen</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Zawadzke</span> - <span class="hlFld-Affiliation affiliation">Constellation
Pharmaceuticals, Inc. 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoyu Zhu</span> - <span class="hlFld-Affiliation affiliation">Wuxi
Apptec Co., Ltd., 288
Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s
Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Bellon</span> - <span class="hlFld-Affiliation affiliation">Constellation
Pharmaceuticals, Inc. 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Cummings</span> - <span class="hlFld-Affiliation affiliation">Constellation
Pharmaceuticals, Inc. 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea G. Cochran</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian K. Albrecht</span> - <span class="hlFld-Affiliation affiliation">Constellation
Pharmaceuticals, Inc. 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Magnuson</span> - <span class="hlFld-Affiliation affiliation">Genentech,
Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d194e3185-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10270" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10270" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Mengling Wong, Michael Hayes, and Amber Guillen for compound purification. Baiwei Lin, Deven Wang, and Yutao Jiang are acknowledged for analytical support. Grady Howes, Jan Seerveld, Hao Zheng, Ted Peters, and Gigi Yuen for help with compound management and logistics are also recognized.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i37" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i37"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i38" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i38"> Abbreviations Used</h2><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr><tr><td class="NLM_term">BET</td><td class="NLM_def"><p class="first last">bromodomain and extra C-terminal domain</p></td></tr><tr><td class="NLM_term">BRD4(X)-</td><td class="NLM_def"><p class="first last">bromodomain X (X = 1,2) of the bromodomain-containing protein 4</p></td></tr><tr><td class="NLM_term">BRD9</td><td class="NLM_def"><p class="first last">bromodomain-containing protein 9</p></td></tr><tr><td class="NLM_term">BRET</td><td class="NLM_def"><p class="first last">bioluminescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">CBP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate response element binding protein binding protein</p></td></tr><tr><td class="NLM_term">Cl<sub>hep</sub></td><td class="NLM_def"><p class="first last">predicted hepatic clearance</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last">diisopropylethyl amine</p></td></tr><tr><td class="NLM_term">EP300</td><td class="NLM_def"><p class="first last">adenoviral E1A binding protein</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxid hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HCl</td><td class="NLM_def"><p class="first last">hydrogen chloride</p></td></tr><tr><td class="NLM_term">KAc</td><td class="NLM_def"><p class="first last">acetylated lysine</p></td></tr><tr><td class="NLM_term">MeCN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">MH</td><td class="NLM_def"><p class="first last">mouse hepatocyte</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsome</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub> A to B</td><td class="NLM_def"><p class="first last">apparent permeability apical-to-basolateral</p></td></tr><tr><td class="NLM_term">RT-PCR</td><td class="NLM_def"><p class="first last">reverse transcription polymerase chain reaction</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02650" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02650" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 27 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Romero, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span> </span><span class="NLM_article-title">Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1271</span><span class="NLM_x">–</span> <span class="NLM_lpage">1298</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01514</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01514" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVeqsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1271-1298&author=F.+A.+Romeroauthor=A.+M.+Taylorauthor=T.+D.+Crawfordauthor=V.+Tsuiauthor=A.+C%C3%B4t%C3%A9author=S.+Magnuson&title=Disrupting+Acetyl-Lysine+Recognition%3A+Progress+in+the+Development+of+Bromodomain+Inhibitors&doi=10.1021%2Facs.jmedchem.5b01514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors</span></div><div class="casAuthors">Romero, F. Anthony; Taylor, Alexander M.; Crawford, Terry D.; Tsui, Vickie; Cote, Alexandre; Magnuson, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1271-1298</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains, small protein modules that recognize acetylated lysine on histones, play a significant role in the epigenome, where they function as "readers" that ultimately det. the functional outcome of the post-translational modification.  Because the initial discovery of selective BET inhibitors have helped define the role of that protein family in oncol. and inflammation, BET bromodomains have continued to garner the most attention of any other bromodomain.  More recently, non-BET bromodomain inhibitors that are potent and selective have been disclosed for ATAD2, CBP, BRD7/9, BRPF, BRPF/TRIM24, CECR2, SMARCA4, and BAZ2A/B.  Such novel inhibitors can be used to probe the physiol. function of these non-BET bromodomains and further understanding of their role in certain disease states.  Here, we provide an update to the progress in identifying selective bromodomain inhibitors and their use as biol. tools, as well as our perspective on the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgbRrKGlHaVLVg90H21EOLACvtfcHk0li4cZOsEw-X9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVeqsr%252FO&md5=260352f61301aa88aad48c0b63e6152f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01514%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DCrawford%26aufirst%3DT.%2BD.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DDisrupting%2520Acetyl-Lysine%2520Recognition%253A%2520Progress%2520in%2520the%2520Development%2520of%2520Bromodomain%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1271%26epage%3D1298%26doi%3D10.1021%2Facs.jmedchem.5b01514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Theodoulou, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomkinson, N. C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, P. G.</span><span> </span><span class="NLM_article-title">Progress in the Development of Non-BET Bromodomain Chemical Probes</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">487</span><span class="refDoi"> DOI: 10.1002/cmdc.201500540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1002%2Fcmdc.201500540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=26749027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1ehtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=477-487&author=N.+H.+Theodoulouauthor=N.+C.+O.+Tomkinsonauthor=R.+K.+Prinjhaauthor=P.+G.+Humphreys&title=Progress+in+the+Development+of+Non-BET+Bromodomain+Chemical+Probes&doi=10.1002%2Fcmdc.201500540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the Development of non-BET Bromodomain Chemical Probes</span></div><div class="casAuthors">Theodoulou, Natalie H.; Tomkinson, Nicholas C. O.; Prinjha, Rab K.; Humphreys, Philip G.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">477-487</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The bromodomain and extra terminal (BET) family of bromodomains have been the focus of extensive research, leading to the development of many potent, selective chem. probes and recent clin. assets.  The profound biol. assocd. with BET bromodomain inhibition has provided a convincing rationale for targeting bromodomains for the treatment of disease.  However, the BET family represents just eight of the at least 56 human bromodomains identified to date.  Until recently, there has been significantly less interest in non-BET bromodomains, leaving a vast area of research and the majority of this new target class yet to be thoroughly investigated.  It has been widely reported that several non-BET bromodomain contg. proteins are assocd. with various diseases including cancer and HIV.  Therefore, the development of chem. probes for non-BET bromodomains will facilitate elucidation of their precise biol. roles and potentially lead to the development of new medicines.  This review summarises the progress made towards the development of non-BET bromodomain chem. probes to date.  In addn., we highlight the potential for future work in this new and exciting area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYLj_VyHOS5bVg90H21EOLACvtfcHk0liNLKrHVXeTig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1ehtA%253D%253D&md5=1e1339bf09a10bde8621c18344172fa6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500540%26sid%3Dliteratum%253Aachs%26aulast%3DTheodoulou%26aufirst%3DN.%2BH.%26aulast%3DTomkinson%26aufirst%3DN.%2BC.%2BO.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DHumphreys%26aufirst%3DP.%2BG.%26atitle%3DProgress%2520in%2520the%2520Development%2520of%2520Non-BET%2520Bromodomain%2520Chemical%2520Probes%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D477%26epage%3D487%26doi%3D10.1002%2Fcmdc.201500540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantone, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Leon Boenig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conery, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, O. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawadzke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochran, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637)</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC28Xkt1Cms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=531-536&author=A.+M.+Taylorauthor=A.+C%C3%B4t%C3%A9author=M.+C.+Hewittauthor=R.+Pastorauthor=Y.+Leblancauthor=C.+G.+Nasveschukauthor=F.+A.+Romeroauthor=T.+D.+Crawfordauthor=N.+Cantoneauthor=H.+Jayaramauthor=J.+Setserauthor=J.+Murrayauthor=M.+H.+Beresiniauthor=G.+de+Leon+Boenigauthor=Z.+Chenauthor=A.+R.+Coneryauthor=R.+T.+Cummingsauthor=L.+A.+Dakinauthor=E.+M.+Flynnauthor=O.+W.+Huangauthor=S.+Kaufmanauthor=P.+J.+Kellerauthor=J.+R.+Kieferauthor=T.+Laiauthor=Y.+Liauthor=J.+Liaoauthor=W.+Liuauthor=H.+Luauthor=E.+Pardoauthor=V.+Tsuiauthor=J.+Wangauthor=Y.+Wangauthor=Z.+Xuauthor=F.+Yanauthor=D.+Yuauthor=L.+Zawadzkeauthor=X.+Zhuauthor=X.+Zhuauthor=R.+J.+Simsauthor=A.+G.+Cochranauthor=S.+Bellonauthor=J.+E.+Audiaauthor=S.+Magnusonauthor=B.+K.+Albrecht&title=Fragment-Based+Discovery+of+a+Selective+and+Cell-Active+Benzodiazepinone+CBP%2FEP300+Bromodomain+Inhibitor+%28CPI-637%29&doi=10.1021%2Facsmedchemlett.6b00075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637)</span></div><div class="casAuthors">Taylor, Alexander M.; Cote, Alexandre; Hewitt, Michael C.; Pastor, Richard; Leblanc, Yves; Nasveschuk, Christopher G.; Romero, F. Anthony; Crawford, Terry D.; Cantone, Nico; Jayaram, Hariharan; Setser, Jeremy; Murray, Jeremy; Beresini, Maureen H.; de Leon Boenig, Gladys; Chen, Zhongguo; Conery, Andrew R.; Cummings, Richard T.; Dakin, Leslie A.; Flynn, E. Megan; Huang, Oscar W.; Kaufman, Susan; Keller, Patricia J.; Kiefer, James R.; Lai, Tommy; Li, Yingjie; Liao, Jiangpeng; Liu, Wenfeng; Lu, Henry; Pardo, Eneida; Tsui, Vickie; Wang, Jian; Wang, Yongyun; Xu, Zhaowu; Yan, Fen; Yu, Dong; Zawadzke, Laura; Zhu, Xiaoqin; Zhu, Xiaoyu; Sims, Robert J.; Cochran, Andrea G.; Bellon, Steve; Audia, James E.; Magnuson, Steven; Albrecht, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">531-536</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benzo-fused heterocycles, particularly benzodiazepinones such as I, were prepd. as inhibitors of the bromodomain-contg. proteins CBP (CREB, cAMP response element binding protein) and EP300 (adenoviral E1A-binding protein of 300 kDa) for potential use as antitumor agents; the core benzodiazepinone moiety was identified using fragment-based screening.  The structures of four benzodiazepinones, including I, bound to the bromodomain fragment of human CREB were detd. by X-ray crystallog.  The free energy, enthalpy, and entropy of the binding of I to CREB and its selectivity for CREB and EP300 over other bromodomain-contg. proteins was detd.; I inhibited expression of the transcription factor MYC in human plasmacytoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNm7Blycl0-7Vg90H21EOLACvtfcHk0liNLKrHVXeTig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xkt1Cms7c%253D&md5=8440a9bb3460ff66d43f15041dbbc19d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00075%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DPastor%26aufirst%3DR.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DCrawford%26aufirst%3DT.%2BD.%26aulast%3DCantone%26aufirst%3DN.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DSetser%26aufirst%3DJ.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DBeresini%26aufirst%3DM.%2BH.%26aulast%3Dde%2BLeon%2BBoenig%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DConery%26aufirst%3DA.%2BR.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DFlynn%26aufirst%3DE.%2BM.%26aulast%3DHuang%26aufirst%3DO.%2BW.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DKeller%26aufirst%3DP.%2BJ.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLai%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DZawadzke%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DCochran%26aufirst%3DA.%2BG.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DFragment-Based%2520Discovery%2520of%2520a%2520Selective%2520and%2520Cell-Active%2520Benzodiazepinone%2520CBP%252FEP300%2520Bromodomain%2520Inhibitor%2520%2528CPI-637%2529%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D531%26epage%3D536%26doi%3D10.1021%2Facsmedchemlett.6b00075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Crawford, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplessis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawadzke, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochran, A. G.</span><span> </span><span class="NLM_article-title">Diving Into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5391</span><span class="NLM_x">–</span> <span class="NLM_lpage">5402</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00264</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00264" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC28XosFSnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5391-5402&author=T.+D.+Crawfordauthor=V.+Tsuiauthor=E.+M.+Flynnauthor=S.+Wangauthor=A.+M.+Taylorauthor=A.+C%C3%B4t%C3%A9author=J.+E.+Audiaauthor=M.+H.+Beresiniauthor=D.+J.+Burdickauthor=R.+T.+Cummingsauthor=L.+A.+Dakinauthor=M.+Duplessisauthor=A.+C.+Goodauthor=M.+C.+Hewittauthor=H.-R.+Huangauthor=H.+Jayaramauthor=J.+R.+Kieferauthor=Y.+Jiangauthor=J.+M.+Murrayauthor=C.+G.+Nasveschukauthor=E.+Pardoauthor=F.+Poyauthor=F.+A.+Romeroauthor=Y.+Tangauthor=J.+Wangauthor=Z.+Xuauthor=L.+E.+Zawadzkeauthor=X.+Zhuauthor=B.+K.+Albrechtauthor=S.+R.+Magnusonauthor=S.+F.+Bellonauthor=A.+G.+Cochran&title=Diving+Into+the+Water%3A+Inducible+Binding+Conformations+for+BRD4%2C+TAF1%282%29%2C+BRD9%2C+and+CECR2+Bromodomains&doi=10.1021%2Facs.jmedchem.6b00264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains</span></div><div class="casAuthors">Crawford, Terry D.; Tsui, Vickie; Flynn, E. Megan; Wang, Shumei; Taylor, Alexander M.; Cote, Alexandre; Audia, James E.; Beresini, Maureen H.; Burdick, Daniel J.; Cummings, Richard; Dakin, Les A.; Duplessis, Martin; Good, Andrew C.; Hewitt, Michael C.; Huang, Hon-Ren; Jayaram, Hariharan; Kiefer, James R.; Jiang, Ying; Murray, Jeremy; Nasveschuk, Christopher G.; Pardo, Eneida; Poy, Florence; Romero, F. Anthony; Tang, Yong; Wang, Jian; Xu, Zhaowu; Zawadzke, Laura E.; Zhu, Xiaoyu; Albrecht, Brian K.; Magnuson, Steven R.; Bellon, Steve; Cochran, Andrea G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5391-5402</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The biol. role played by non-BET bromodomains remains poorly understood, and it is therefore imperative to identify potent and highly selective inhibitors to effectively explore the biol. of individual bromodomain proteins.  A ligand-efficient nonselective bromodomain inhibitor was identified from a 6-Me pyrrolopyridone fragment.  Small hydrophobic substituents replacing the N-Me group were designed directing toward the conserved bromodomain water pocket, and two distinct binding conformations were then obsd.  The substituents either directly displaced and rearranged the conserved solvent network, as in BRD4(1) and TAF1(2), or induced a narrow hydrophobic channel adjacent to the lipophilic shelf, as in BRD9 and CECR2.  The preference of distinct substituents for individual bromodomains provided selectivity handles useful for future lead optimization efforts for selective BRD9, CECR2, and TAF1(2) inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTLnuVCIKdHbVg90H21EOLACvtfcHk0lhEIT1qJ8naUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosFSnsbs%253D&md5=bf92e94c5fd3ee36bd8441294ca85185</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00264%26sid%3Dliteratum%253Aachs%26aulast%3DCrawford%26aufirst%3DT.%2BD.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DFlynn%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBeresini%26aufirst%3DM.%2BH.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DDuplessis%26aufirst%3DM.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DHuang%26aufirst%3DH.-R.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZawadzke%26aufirst%3DL.%2BE.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DMagnuson%26aufirst%3DS.%2BR.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DCochran%26aufirst%3DA.%2BG.%26atitle%3DDiving%2520Into%2520the%2520Water%253A%2520Inducible%2520Binding%2520Conformations%2520for%2520BRD4%252C%2520TAF1%25282%2529%252C%2520BRD9%252C%2520and%2520CECR2%2520Bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5391%26epage%3D5402%26doi%3D10.1021%2Facs.jmedchem.6b00264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Delvecchio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaucher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar-Gurrieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panne, D.</span><span> </span><span class="NLM_article-title">Structure of the P300 Catalytic Core and Implications for Chromatin Targeting and HAT Regulation</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1040</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span><span class="refDoi"> DOI: 10.1038/nsmb.2642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1038%2Fnsmb.2642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=23934153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Cgtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1040-1046&author=M.+Delvecchioauthor=J.+Gaucherauthor=C.+Aguilar-Gurrieriauthor=E.+Ortegaauthor=D.+Panne&title=Structure+of+the+P300+Catalytic+Core+and+Implications+for+Chromatin+Targeting+and+HAT+Regulation&doi=10.1038%2Fnsmb.2642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation</span></div><div class="casAuthors">Delvecchio, Manuela; Gaucher, Jonathan; Aguilar-Gurrieri, Carmen; Ortega, Esther; Panne, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1040-1046</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">CBP and p300 are histone acetyltransferases (HATs) that assoc. with and acetylate transcriptional regulators and chromatin.  Mutations in their catalytic 'cores' are linked to genetic disorders, including cancer.  Here we present the 2.8-Å crystal structure of the catalytic core of human p300 contg. its bromodomain, CH2 region and HAT domain.  The structure reveals that the CH2 region contains a discontinuous PHD domain interrupted by a RING domain.  The bromodomain, PHD, RING and HAT domains adopt an assembled configuration with the RING domain positioned over the HAT substrate-binding pocket.  Disease mutations that disrupt RING attachment led to upregulation of HAT activity, thus revealing an inhibitory role for this domain.  The structure provides a starting point for understanding how chromatin-substrate targeting and HAT regulation are coupled and why mutations in the p300 core lead to dysregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlYehjRwdhJ7Vg90H21EOLACvtfcHk0lgP_hD5wYg7YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Cgtr3J&md5=e9352198d513eac6fd93fc2896828d09</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2642%26sid%3Dliteratum%253Aachs%26aulast%3DDelvecchio%26aufirst%3DM.%26aulast%3DGaucher%26aufirst%3DJ.%26aulast%3DAguilar-Gurrieri%26aufirst%3DC.%26aulast%3DOrtega%26aufirst%3DE.%26aulast%3DPanne%26aufirst%3DD.%26atitle%3DStructure%2520of%2520the%2520P300%2520Catalytic%2520Core%2520and%2520Implications%2520for%2520Chromatin%2520Targeting%2520and%2520HAT%2520Regulation%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D1040%26epage%3D1046%26doi%3D10.1038%2Fnsmb.2642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Mujtaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachchidanand</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeleznik-Le, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span> </span><span class="NLM_article-title">Structural Mechanism of the Bromodomain of the Coactivator CBP in P53 Transcriptional Activation</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span><span class="refDoi"> DOI: 10.1016/S1097-2765(03)00528-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1016%2FS1097-2765%2803%2900528-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=14759370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFOhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=251-263&author=S.+Mujtabaauthor=Y.+Heauthor=L.+Zengauthor=S.+Yanauthor=O.+Plotnikovaauthor=+Sachchidanandauthor=R.+Sanchezauthor=N.+J.+Zeleznik-Leauthor=Z.+Ronaiauthor=M.+M.+Zhou&title=Structural+Mechanism+of+the+Bromodomain+of+the+Coactivator+CBP+in+P53+Transcriptional+Activation&doi=10.1016%2FS1097-2765%2803%2900528-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation</span></div><div class="casAuthors">Mujtaba, Shiraz; He, Yan; Zeng, Lei; Yan, Sherry; Plotnikova, Olga; Sachchidanand; Sanchez, Roberto; Zeleznik-Le, Nancy J.; Ronai, Ze'ev; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-263</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Lysine acetylation of the tumor suppressor protein p53 in response to a wide variety of cellular stress signals is required for its activation as a transcription factor that regulates cell cycle arrest, senescence, or apoptosis.  Here, the authors report that the conserved bromodomain of the transcriptional coactivator CBP (CREB binding protein) binds specifically to p53 at the C-terminal acetylated lysine 382.  This bromodomain/acetyllysine binding is responsible for p53 acetylation-dependent coactivator recruitment after DNA damage, a step essential for p53-induced transcriptional activation of the cyclin-dependent kinase inhibitor p21 in G1 cell cycle arrest.  The authors further present the three-dimensional NMR structure of the CBP bromodomain in complex with a lysine 382-acetylated p53 peptide.  Using structural and biochem. analyses, the authors define the mol. determinants for the specificity of this mol. recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3g6bC53YUKbVg90H21EOLACvtfcHk0lgP_hD5wYg7YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFOhsr0%253D&md5=10127e2d2ea5165fd8439bf26a6f9241</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900528-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900528-8%26sid%3Dliteratum%253Aachs%26aulast%3DMujtaba%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DSachchidanand%26aulast%3DSanchez%26aufirst%3DR.%26aulast%3DZeleznik-Le%26aufirst%3DN.%2BJ.%26aulast%3DRonai%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26atitle%3DStructural%2520Mechanism%2520of%2520the%2520Bromodomain%2520of%2520the%2520Coactivator%2520CBP%2520in%2520P53%2520Transcriptional%2520Activation%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D13%26spage%3D251%26epage%3D263%26doi%3D10.1016%2FS1097-2765%2803%2900528-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Ianculescu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegmund, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stallcup, M. R.</span><span> </span><span class="NLM_article-title">Selective Roles for cAMP Response Element-Binding Protein Binding Protein and P300 Protein as Coregulators for Androgen-Regulated Gene Expression in Advanced Prostate Cancer Cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">4000</span><span class="NLM_x">–</span> <span class="NLM_lpage">4013</span><span class="refDoi"> DOI: 10.1074/jbc.M111.300194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1074%2Fjbc.M111.300194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=22174411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=4000-4013&author=I.+Ianculescuauthor=D.+Y.+Wuauthor=K.+D.+Siegmundauthor=M.+R.+Stallcup&title=Selective+Roles+for+cAMP+Response+Element-Binding+Protein+Binding+Protein+and+P300+Protein+as+Coregulators+for+Androgen-Regulated+Gene+Expression+in+Advanced+Prostate+Cancer+Cells&doi=10.1074%2Fjbc.M111.300194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Roles for cAMP Response Element-binding Protein Binding Protein and p300 Protein as Coregulators for Androgen-regulated Gene Expression in Advanced Prostate Cancer Cells</span></div><div class="casAuthors">Ianculescu, Irina; Wu, Dai-Ying; Siegmund, Kimberly D.; Stallcup, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4000-4013</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The protein acetyltransferases p300 and cAMP response element-binding protein binding protein (CBP) are homologous, ubiquitously expressed proteins that interact with hundreds of proteins involved in transcriptional regulation and are involved globally as transcriptional coregulators.  Although these two proteins acetylate and interact with overlapping sets of proteins, we found that p300 and CBP contribute to androgen-induced regulation of distinct sets of genes in C4-2B prostate cancer cells, a model of advanced prostate cancer.  CBP cannot compensate for the loss of p300 to support androgen-induced expression of many genes, such as TMPRSS2 and PSA.  Global gene expression anal. indicated that 47% of androgen-regulated genes are p300-dependent in these cells, whereas, surprisingly, only 0.3% of them are CBP-dependent.  Chromatin immunopptn. anal. after depletion of cellular p300 indicated that p300 is required for androgen-induced acetylation of histones H3 and H4, methylation of histone H3 at Lys-4, and recruitment of TATA box binding protein (TBP) and RNA polymerase II, but not recruitment of the androgen receptor, on the TMPRSS2 gene in response to androgen.  Thus, p300 is the dominant coregulator of the CBP/p300 pair for androgen-regulated gene expression in C4-2B cells. p300 is required at an early stage of chromatin remodeling and transcription complex assembly after binding of androgen receptor to the gene but before many crit. histone modifications occur.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7uJfPL3B4h7Vg90H21EOLACvtfcHk0lioBlXvzmloIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSjtLg%253D&md5=095ab7582da1b7602e2ab898caa5b094</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.300194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.300194%26sid%3Dliteratum%253Aachs%26aulast%3DIanculescu%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DD.%2BY.%26aulast%3DSiegmund%26aufirst%3DK.%2BD.%26aulast%3DStallcup%26aufirst%3DM.%2BR.%26atitle%3DSelective%2520Roles%2520for%2520cAMP%2520Response%2520Element-Binding%2520Protein%2520Binding%2520Protein%2520and%2520P300%2520Protein%2520as%2520Coregulators%2520for%2520Androgen-Regulated%2520Gene%2520Expression%2520in%2520Advanced%2520Prostate%2520Cancer%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D4000%26epage%3D4013%26doi%3D10.1074%2Fjbc.M111.300194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Iyer, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozdag, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldas, C.</span><span> </span><span class="NLM_article-title">P300/CBP and Cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4225</span><span class="NLM_x">–</span> <span class="NLM_lpage">4231</span><span class="refDoi"> DOI: 10.1038/sj.onc.1207118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1038%2Fsj.onc.1207118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=15156177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvVChtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=4225-4231&author=N.+G.+Iyerauthor=H.+Ozdagauthor=C.+Caldas&title=P300%2FCBP+and+Cancer&doi=10.1038%2Fsj.onc.1207118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">p300/CBP and cancer</span></div><div class="casAuthors">Iyer, Narayanan Gopalakrishna; Oezdag, Hilal; Caldas, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4225-4231</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  P300 and cAMP response element-binding protein (CBP) are adenoviral E1A-binding proteins involved in multiple cellular processes, and function as transcriptional co-factors and histone acetyltransferases.  Germline mutation of CBP results in Rubinstein-Taybi syndrome, which is characterized by an increased predisposition to childhood malignancies.  Furthermore, somatic mutations of p300 and CBP occur in a no. of malignancies.  Chromosome translocations target CBP and, less commonly, p300 in acute myeloid leukemia and treatment-related hematol. disorders.  P300 mutations in solid tumors result in truncated p300 protein products or amino-acid substitutions in crit. protein domains, and these are often assocd. with inactivation of the second allele.  A mouse model confirms that p300 and CBP function as suppressors of hematol. tumor formation.  The involvement of these proteins in crit. tumorigenic pathways (including TGF-β, p53 and Rb) provides a mechanistic route as to how their inactivation could result in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKGBLVLWLqkrVg90H21EOLACvtfcHk0lgMK1aAb5K2Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvVChtrc%253D&md5=b68fe6bc258b06515c04a5207410f026</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207118%26sid%3Dliteratum%253Aachs%26aulast%3DIyer%26aufirst%3DN.%2BG.%26aulast%3DOzdag%26aufirst%3DH.%26aulast%3DCaldas%26aufirst%3DC.%26atitle%3DP300%252FCBP%2520and%2520Cancer%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D4225%26epage%3D4231%26doi%3D10.1038%2Fsj.onc.1207118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Faiola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lymar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, E.</span><span> </span><span class="NLM_article-title">Dual Regulation of C-Myc by P300 via Acetylation-Dependent Control of Myc Protein Turnover and Coactivation of Myc-Induced Transcription</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">10220</span><span class="NLM_x">–</span> <span class="NLM_lpage">10234</span><span class="refDoi"> DOI: 10.1128/MCB.25.23.10220-10234.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1128%2FMCB.25.23.10220-10234.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=16287840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Ons7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=10220-10234&author=F.+Faiolaauthor=X.+Liuauthor=S.+Loauthor=S.+Panauthor=K.+Zhangauthor=E.+Lymarauthor=A.+Farinaauthor=E.+Martinez&title=Dual+Regulation+of+C-Myc+by+P300+via+Acetylation-Dependent+Control+of+Myc+Protein+Turnover+and+Coactivation+of+Myc-Induced+Transcription&doi=10.1128%2FMCB.25.23.10220-10234.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription</span></div><div class="casAuthors">Faiola, Francesco; Liu, Xiaohui; Lo, Szuying; Pan, Songqin; Zhang, Kangling; Lymar, Elena; Farina, Anthony; Martinez, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10220-10234</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The c-Myc oncoprotein (Myc) controls cell fate by regulating gene transcription in assocn. with a DNA-binding partner, Max.  While Max lacks a transcription regulatory domain, the N-terminus of Myc contains a transcription activation domain (TAD) that recruits cofactor complexes contg. the histone acetyltransferases (HATs) GCN5 and Tip60.  Here, we report a novel functional interaction between Myc TAD and the p300 coactivator-acetyltransferase.  We show that p300 assocs. with Myc in mammalian cells and in vitro through direct interactions with Myc TAD residues 1 to 110 and acetylates Myc in a TAD-dependent manner in vivo at several lysine residues located between the TAD and DNA-binding domain.  Moreover, the Myc:Max complex is differentially acetylated by p300 and GCN5 and is not acetylated by Tip60 in vitro, suggesting distinct functions for these acetyltransferases.  Whereas p300 and CBP can stabilize Myc independently of acetylation, p300-mediated acetylation results in increased Myc turnover.  In addn., p300 functions as a coactivator that is recruited by Myc to the promoter of the human telomerase reverse transcriptase gene, and p300/CBP stimulates Myc TAD-dependent transcription in a HAT domain-dependent manner.  Our results suggest dual roles for p300/CBP in Myc regulation: as a Myc coactivator that stabilizes Myc and as an inducer of Myc instability via direct Myc acetylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4or2afHXuK7Vg90H21EOLACvtfcHk0lgMK1aAb5K2Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Ons7fL&md5=bbabfb64492444687f048ee59cdc0210</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FMCB.25.23.10220-10234.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.25.23.10220-10234.2005%26sid%3Dliteratum%253Aachs%26aulast%3DFaiola%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLo%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLymar%26aufirst%3DE.%26aulast%3DFarina%26aufirst%3DA.%26aulast%3DMartinez%26aufirst%3DE.%26atitle%3DDual%2520Regulation%2520of%2520C-Myc%2520by%2520P300%2520via%2520Acetylation-Dependent%2520Control%2520of%2520Myc%2520Protein%2520Turnover%2520and%2520Coactivation%2520of%2520Myc-Induced%2520Transcription%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D10220%26epage%3D10234%26doi%3D10.1128%2FMCB.25.23.10220-10234.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Conery, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Centore, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillane, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawadzke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bommi-Reddy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoigne, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibition of the Transcriptional Coactivators CBP/EP300 as a Therapeutic Strategy to Target the IRF4 Network in Multiple Myeloma</span> <span class="citation_source-journal">eLife</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e10483</span><span class="refDoi"> DOI: 10.7554/eLife.10483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.7554%2FeLife.10483" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=e10483&author=A.+R.+Coneryauthor=R.+C.+Centoreauthor=A.+Neissauthor=P.+J.+Kellerauthor=S.+Joshiauthor=K.+L.+Spillaneauthor=P.+Sandyauthor=C.+Hattonauthor=E.+Pardoauthor=L.+Zawadzkeauthor=A.+Bommi-Reddyauthor=K.+E.+Gascoigneauthor=B.+M.+Bryantauthor=J.+A.+Mertzauthor=R.+J.+Sims&title=Bromodomain+Inhibition+of+the+Transcriptional+Coactivators+CBP%2FEP300+as+a+Therapeutic+Strategy+to+Target+the+IRF4+Network+in+Multiple+Myeloma&doi=10.7554%2FeLife.10483"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.7554%2FeLife.10483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.10483%26sid%3Dliteratum%253Aachs%26aulast%3DConery%26aufirst%3DA.%2BR.%26aulast%3DCentore%26aufirst%3DR.%2BC.%26aulast%3DNeiss%26aufirst%3DA.%26aulast%3DKeller%26aufirst%3DP.%2BJ.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DSpillane%26aufirst%3DK.%2BL.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DHatton%26aufirst%3DC.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DZawadzke%26aufirst%3DL.%26aulast%3DBommi-Reddy%26aufirst%3DA.%26aulast%3DGascoigne%26aufirst%3DK.%2BE.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26atitle%3DBromodomain%2520Inhibition%2520of%2520the%2520Transcriptional%2520Coactivators%2520CBP%252FEP300%2520as%2520a%2520Therapeutic%2520Strategy%2520to%2520Target%2520the%2520IRF4%2520Network%2520in%2520Multiple%2520Myeloma%26jtitle%3DeLife%26date%3D2016%26volume%3D5%26spage%3De10483%26doi%3D10.7554%2FeLife.10483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conery, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmeron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakle, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mele, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setser, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatzivassiliou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAlmeida-Nagata, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochran, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawadzke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grogan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lora, J. M.</span><span> </span><span class="NLM_article-title">Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">13014</span><span class="NLM_x">–</span> <span class="NLM_lpage">13027</span><span class="refDoi"> DOI: 10.1074/jbc.M115.708560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1074%2Fjbc.M115.708560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=27056325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSksL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=13014-13027&author=S.+Ghoshauthor=A.+Taylorauthor=M.+Chinauthor=H.-R.+Huangauthor=A.+R.+Coneryauthor=J.+A.+Mertzauthor=A.+Salmeronauthor=P.+J.+Dakleauthor=D.+Meleauthor=A.+C%C3%B4t%C3%A9author=H.+Jayaramauthor=J.+W.+Setserauthor=F.+Poyauthor=G.+Hatzivassiliouauthor=D.+DeAlmeida-Nagataauthor=P.+Sandyauthor=C.+Hattonauthor=F.+A.+Romeroauthor=E.+Chiangauthor=T.+Reimerauthor=T.+Crawfordauthor=E.+Pardoauthor=V.+G.+Watsonauthor=V.+Tsuiauthor=A.+G.+Cochranauthor=L.+Zawadzkeauthor=J.-C.+Harmangeauthor=J.+E.+Audiaauthor=B.+M.+Bryantauthor=R.+T.+Cummingsauthor=S.+R.+Magnusonauthor=J.+L.+Groganauthor=S.+F.+Bellonauthor=B.+K.+Albrechtauthor=R.+J.+Simsauthor=J.+M.+Lora&title=Regulatory+T+Cell+Modulation+by+CBP%2FEP300+Bromodomain+Inhibition&doi=10.1074%2Fjbc.M115.708560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition</span></div><div class="casAuthors">Ghosh, Srimoyee; Taylor, Alexander; Chin, Melissa; Huang, Hon-Ren; Conery, Andrew R.; Mertz, Jennifer A.; Salmeron, Andres; Dakle, Pranal J.; Mele, Deanna; Cote, Alexandre; Jayaram, Hari; Setser, Jeremy W.; Poy, Florence; Hatzivassiliou, Georgia; DeAlmeida-Nagata, Denise; Sandy, Peter; Hatton, Charlie; Romero, F. Anthony; Chiang, Eugene; Reimer, Thornik; Crawford, Terry; Pardo, Eneida; Watson, Venita G.; Tsui, Vickie; Cochran, Andrea G.; Zawadzke, Laura; Harmange, Jean-Christophe; Audia, James E.; Bryant, Barbara M.; Cummings, Richard T.; Magnuson, Steven R.; Grogan, Jane L.; Bellon, Steve F.; Albrecht, Brian K.; Sims, Robert J. III; Lora, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">13014-13027</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Covalent modification of histones is a fundamental mechanism of regulated gene expression in eukaryotes, and interpretation of histone modifications is an essential feature of epigenetic control.  Bromodomains are specialized binding modules that interact with acetylated histones, linking chromatin recognition to gene transcription.  Because of their ability to function in a domain-specific fashion, selective disruption of bromodomain:acetylated histone interactions with chem. probes serves as a powerful means for understanding biol. processes regulated by these chromatin adaptors.  Here the authors describe the discovery and characterization of potent and selective small mol. inhibitors for the bromodomains of CREBBP/EP300 that engage their target in cellular assays.  The authors use these tools to demonstrate a crit. role for CREBBP/EP300 bromodomains in regulatory T cell biol.  Because regulatory T cell recruitment to tumors is a major mechanism of immune evasion by cancer cells, the authors' data highlight the importance of CREBBP/EP300 bromodomain inhibition as a novel, small mol.-based approach for cancer immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9maWuQVImyLVg90H21EOLACvtfcHk0ljKcwpaM-_OrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSksL3F&md5=bc8b4edba81bdbef30b1d8fcfaa19f1e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.708560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.708560%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DChin%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DH.-R.%26aulast%3DConery%26aufirst%3DA.%2BR.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DSalmeron%26aufirst%3DA.%26aulast%3DDakle%26aufirst%3DP.%2BJ.%26aulast%3DMele%26aufirst%3DD.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DSetser%26aufirst%3DJ.%2BW.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DHatzivassiliou%26aufirst%3DG.%26aulast%3DDeAlmeida-Nagata%26aufirst%3DD.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DHatton%26aufirst%3DC.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DChiang%26aufirst%3DE.%26aulast%3DReimer%26aufirst%3DT.%26aulast%3DCrawford%26aufirst%3DT.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DWatson%26aufirst%3DV.%2BG.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DCochran%26aufirst%3DA.%2BG.%26aulast%3DZawadzke%26aufirst%3DL.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DMagnuson%26aufirst%3DS.%2BR.%26aulast%3DGrogan%26aufirst%3DJ.%2BL.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DLora%26aufirst%3DJ.%2BM.%26atitle%3DRegulatory%2520T%2520Cell%2520Modulation%2520by%2520CBP%252FEP300%2520Bromodomain%2520Inhibition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D13014%26epage%3D13027%26doi%3D10.1074%2Fjbc.M115.708560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Chekler, E. L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegrino, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanz, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flick, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langille, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahasrabudhe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonin, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pletcher, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. H.</span><span> </span><span class="NLM_article-title">Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1588</span><span class="NLM_x">–</span> <span class="NLM_lpage">1596</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2015.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1016%2Fj.chembiol.2015.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=26670081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKis7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=1588-1596&author=E.+L.+P.+Cheklerauthor=J.+A.+Pellegrinoauthor=T.+A.+Lanzauthor=R.+A.+Dennyauthor=A.+C.+Flickauthor=J.+Coeauthor=J.+Langilleauthor=A.+Basakauthor=S.+Liuauthor=I.+A.+Stockauthor=P.+Sahasrabudheauthor=P.+D.+Boninauthor=K.+Leeauthor=M.+T.+Pletcherauthor=L.+H.+Jones&title=Transcriptional+Profiling+of+a+Selective+CREB+Binding+Protein+Bromodomain+Inhibitor+Highlights+Therapeutic+Opportunities&doi=10.1016%2Fj.chembiol.2015.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities</span></div><div class="casAuthors">Chekler, Eugene L. Piatnitski; Pellegrino, Jessica A.; Lanz, Thomas A.; Denny, R. Aldrin; Flick, Andrew C.; Coe, Jotham; Langille, Jonathan; Basak, Arindrajit; Liu, Shenping; Stock, Ingrid A.; Sahasrabudhe, Parag; Bonin, Paul D.; Lee, Kevin; Pletcher, Mathew T.; Jones, Lyn H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1588-1596</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Bromodomains are involved in transcriptional regulation through the recognition of acetyl lysine modifications on diverse proteins.  Selective pharmacol. modulators of bromodomains are lacking, although the largely hydrophobic nature of the pocket makes these modules attractive targets for small-mol. inhibitors.  This work describes the structure-based design of a highly selective inhibitor of the CREB binding protein (CBP) bromodomain and its use in cell-based transcriptional profiling expts.  The inhibitor downregulated a no. of inflammatory genes in macrophages that were not affected by a selective BET bromodomain inhibitor.  In addn., the CBP bromodomain inhibitor modulated the mRNA level of the regulator of G-protein signaling 4 (RGS4) gene in neurons, suggesting a potential therapeutic opportunity for CBP inhibitors in the treatment of neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLDeCJH-gX5LVg90H21EOLACvtfcHk0ljF0L7VJG7hdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKis7rE&md5=dc223d58c99b1994f0cdb15b734a5b21</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DChekler%26aufirst%3DE.%2BL.%2BP.%26aulast%3DPellegrino%26aufirst%3DJ.%2BA.%26aulast%3DLanz%26aufirst%3DT.%2BA.%26aulast%3DDenny%26aufirst%3DR.%2BA.%26aulast%3DFlick%26aufirst%3DA.%2BC.%26aulast%3DCoe%26aufirst%3DJ.%26aulast%3DLangille%26aufirst%3DJ.%26aulast%3DBasak%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DStock%26aufirst%3DI.%2BA.%26aulast%3DSahasrabudhe%26aufirst%3DP.%26aulast%3DBonin%26aufirst%3DP.%2BD.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DPletcher%26aufirst%3DM.%2BT.%26aulast%3DJones%26aufirst%3DL.%2BH.%26atitle%3DTranscriptional%2520Profiling%2520of%2520a%2520Selective%2520CREB%2520Binding%2520Protein%2520Bromodomain%2520Inhibitor%2520Highlights%2520Therapeutic%2520Opportunities%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D1588%26epage%3D1596%26doi%3D10.1016%2Fj.chembiol.2015.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Rooney, T. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortopassi, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paton, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-Π Interaction</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6126</span><span class="NLM_x">–</span> <span class="NLM_lpage">6130</span><span class="refDoi"> DOI: 10.1002/anie.201402750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1002%2Fanie.201402750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvFWgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=6126-6130&author=T.+P.+C.+Rooneyauthor=P.+Filippakopoulosauthor=O.+Fedorovauthor=S.+Picaudauthor=W.+A.+Cortopassiauthor=D.+A.+Hayauthor=S.+Martinauthor=A.+Tumberauthor=C.+M.+Rogersauthor=M.+Philpottauthor=M.+Wangauthor=A.+L.+Thompsonauthor=T.+D.+Heightmanauthor=D.+C.+Prydeauthor=A.+Cookauthor=R.+S.+Patonauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=P.+E.+Brennanauthor=S.+J.+Conway&title=A+Series+of+Potent+CREBBP+Bromodomain+Ligands+Reveals+an+Induced-Fit+Pocket+Stabilized+by+a+Cation-%CE%A0+Interaction&doi=10.1002%2Fanie.201402750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-π Interaction</span></div><div class="casAuthors">Rooney, Timothy P. C.; Filippakopoulos, Panagis; Fedorov, Oleg; Picaud, Sarah; Cortopassi, Wilian A.; Hay, Duncan A.; Martin, Sarah; Tumber, Anthony; Rogers, Catherine M.; Philpott, Martin; Wang, Minghua; Thompson, Amber L.; Heightman, Tom D.; Pryde, David C.; Cook, Andrew; Paton, Robert S.; Mueller, Susanne; Knapp, Stefan; Brennan, Paul E.; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6126-6130</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Benzoxazinone and dihydroquinoxalinone fragments were employed as novel acetyl lysine mimics in the development of CREBBP bromodomain ligands.  While the benzoxazinone series showed low affinity for the CREBBP bromodomain, expansion of the dihydroquinoxalinone series resulted in the first potent inhibitors, e.g., I, of a bromodomain outside the BET family.  Structural and computational studies revealed that an internal hydrogen bond stabilized the protein-bound conformation of the dihydroquinoxalinone series.  The side chain of this series binds in an induced-fit pocket forming a cation-π interaction with R1173 of CREBBP.  Compd. I, the most potent compd., inhibited binding of CREBBP to chromatin in U2OS cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHFgTVUKe7lrVg90H21EOLACvtfcHk0ljF0L7VJG7hdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvFWgsb0%253D&md5=42b12e1fe855d2af02c49f8e1031d39e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fanie.201402750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201402750%26sid%3Dliteratum%253Aachs%26aulast%3DRooney%26aufirst%3DT.%2BP.%2BC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DCortopassi%26aufirst%3DW.%2BA.%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DA.%2BL.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DCook%26aufirst%3DA.%26aulast%3DPaton%26aufirst%3DR.%2BS.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DA%2520Series%2520of%2520Potent%2520CREBBP%2520Bromodomain%2520Ligands%2520Reveals%2520an%2520Induced-Fit%2520Pocket%2520Stabilized%2520by%2520a%2520Cation-%25CE%25A0%2520Interaction%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D6126%26epage%3D6130%26doi%3D10.1002%2Fanie.201402750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yapp, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span> </span><span class="NLM_article-title">Discovery and Optimization of Small-Molecule Ligands for the CBP/P300 Bromodomains</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">9308</span><span class="NLM_x">–</span> <span class="NLM_lpage">9319</span><span class="refDoi"> DOI: 10.1021/ja412434f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja412434f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=9308-9319&author=D.+A.+Hayauthor=O.+Fedorovauthor=S.+Martinauthor=D.+C.+Singletonauthor=C.+Tallantauthor=C.+Wellsauthor=S.+Picaudauthor=M.+Philpottauthor=O.+P.+Monteiroauthor=C.+M.+Rogersauthor=S.+J.+Conwayauthor=T.+P.+C.+Rooneyauthor=A.+Tumberauthor=C.+Yappauthor=P.+Filippakopoulosauthor=M.+E.+Bunnageauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=C.+J.+Schofieldauthor=P.+E.+Brennan&title=Discovery+and+Optimization+of+Small-Molecule+Ligands+for+the+CBP%2FP300+Bromodomains&doi=10.1021%2Fja412434f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains</span></div><div class="casAuthors">Hay, Duncan A.; Fedorov, Oleg; Martin, Sarah; Singleton, Dean C.; Tallant, Cynthia; Wells, Christopher; Picaud, Sarah; Philpott, Martin; Monteiro, Octovia P.; Rogers, Catherine M.; Conway, Stuart J.; Rooney, Timothy P. C.; Tumber, Anthony; Yapp, Clarence; Filippakopoulos, Panagis; Bunnage, Mark E.; Muller, Susanne; Knapp, Stefan; Schofield, Christopher J.; Brennan, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9308-9319</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that target bromodomains outside of the bromodomain and extra-terminal (BET) sub-family are lacking.  Here, the authors describe highly potent and selective ligands for the bromodomain module of the human lysine acetyl transferase CBP/p300, developed from a series of 5-isoxazolyl-benzimidazoles.  The starting point was a fragment hit, which was optimized into a more potent and selective lead using parallel synthesis employing Suzuki couplings, benzimidazole-forming reactions, and reductive aminations.  The selectivity of the lead compd. against other bromodomain family members was investigated using a thermal stability assay, which revealed some inhibition of the structurally related BET family members.  To address the BET selectivity issue, x-ray crystal structures of the lead compd. bound to the CREB binding protein (CBP) and the first bromodomain of BRD4 (BRD4(1)) were used to guide the design of more selective compds.  The crystal structures obtained revealed two distinct binding modes.  By varying the aryl substitution pattern and developing conformationally constrained analogs, selectivity for CBP over BRD4(1) was increased.  The optimized compd. is highly potent (Kd = 21 nM) and selective, displaying 40-fold selectivity over BRD4(1).  Cellular activity was demonstrated using fluorescence recovery after photo-bleaching (FRAP) and a p53 reporter assay.  The optimized compds. are cell-active and have nanomolar affinity for CBP/p300; therefore, they should be useful in studies investigating the biol. roles of CBP and p300 and to validate the CBP and p300 bromodomains as therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFzgs1DD4QZLVg90H21EOLACvtfcHk0ljF0L7VJG7hdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsLvP&md5=e5da3e96a4d234453a481c7ee5e788f2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja412434f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja412434f%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DSingleton%26aufirst%3DD.%2BC.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMonteiro%26aufirst%3DO.%2BP.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DRooney%26aufirst%3DT.%2BP.%2BC.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520Small-Molecule%2520Ligands%2520for%2520the%2520CBP%252FP300%2520Bromodomains%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D9308%26epage%3D9319%26doi%3D10.1021%2Fja412434f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span>I-CBP112: A CREBBP/EP300-Selective Chemical Probe; <span class="NLM_publisher-name">SGC</span>: <span class="NLM_publisher-loc">Oxford, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/I-CBP112" class="extLink">http://www.thesgc.org/chemical-probes/I-CBP112</a> (accessed June 16, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=I-CBP112%3A+A+CREBBP%2FEP300-Selective+Chemical+Probe%3B+SGC%3A+Oxford%2C+UK%2C+2015%3B+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FI-CBP112+%28accessed+June+16%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DI-CBP112%253A%2520A%2520CREBBP%252FEP300-Selective%2520Chemical%2520Probe%26pub%3DSGC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Unzue, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiedmer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiliotopoulos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevado, C.</span><span> </span><span class="NLM_article-title">Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1350</span><span class="NLM_x">–</span> <span class="NLM_lpage">1356</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00172</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00172" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsFaktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1350-1356&author=A.+Unzueauthor=M.+Xuauthor=J.+Dongauthor=L.+Wiedmerauthor=D.+Spiliotopoulosauthor=A.+Caflischauthor=C.+Nevado&title=Fragment-Based+Design+of+Selective+Nanomolar+Ligands+of+the+CREBBP+Bromodomain&doi=10.1021%2Facs.jmedchem.5b00172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain</span></div><div class="casAuthors">Unzue, Andrea; Xu, Min; Dong, Jing; Wiedmer, Lars; Spiliotopoulos, Dimitrios; Caflisch, Amedeo; Nevado, Cristina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1350-1356</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel ligands of the CREBBP bromodomain were identified by fragment-based docking.  The in silico discovered hits have been optimized by chem. synthesis into selective nanomolar compds., thereby preserving the ligand efficiency.  The selectivity for the CREBBP bromodomain over other human bromodomain subfamilies has achieved by a benzoate moiety which was predicted by docking to be involved in favorable electrostatic interactions with the Arg1173 side chain, a prediction that could be verified a posteriori by the high-resoln. crystal structure of the CREBBP bromodomain in complex with ligand 6 and also by MD simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy4MHhgfhyu7Vg90H21EOLACvtfcHk0liPLahsIL6MMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsFaktLg%253D&md5=aff73b86b04fc4d7243adcba364ca6a6</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00172%26sid%3Dliteratum%253Aachs%26aulast%3DUnzue%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DWiedmer%26aufirst%3DL.%26aulast%3DSpiliotopoulos%26aufirst%3DD.%26aulast%3DCaflisch%26aufirst%3DA.%26aulast%3DNevado%26aufirst%3DC.%26atitle%3DFragment-Based%2520Design%2520of%2520Selective%2520Nanomolar%2520Ligands%2520of%2520the%2520CREBBP%2520Bromodomain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1350%26epage%3D1356%26doi%3D10.1021%2Facs.jmedchem.5b00172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thanasopoulou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonards, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olzscha, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yapp, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannister, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecellio, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Mahony, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velichko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Thangue, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Generation of a Selective Small Molecule Inhibitor of the CBP/P300 Bromodomain for Leukemia Therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">5106</span><span class="NLM_x">–</span> <span class="NLM_lpage">5119</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-0236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1158%2F0008-5472.CAN-15-0236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=26552700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFensrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=5106-5119&author=S.+Picaudauthor=O.+Fedorovauthor=A.+Thanasopoulouauthor=K.+Leonardsauthor=K.+Jonesauthor=J.+Meierauthor=H.+Olzschaauthor=O.+Monteiroauthor=S.+Martinauthor=M.+Philpottauthor=A.+Tumberauthor=P.+Filippakopoulosauthor=C.+Yappauthor=C.+Wellsauthor=K.+H.+Cheauthor=A.+Bannisterauthor=S.+Robsonauthor=U.+Kumarauthor=N.+Parrauthor=K.+Leeauthor=D.+Lugoauthor=P.+Jeffreyauthor=S.+Taylorauthor=M.+L.+Vecellioauthor=C.+Bountraauthor=P.+E.+Brennanauthor=A.+O%E2%80%99Mahonyauthor=S.+Velichkoauthor=S.+M%C3%BCllerauthor=D.+Hayauthor=D.+L.+Danielsauthor=M.+Urhauthor=N.+B.+La+Thangueauthor=T.+Kouzaridesauthor=R.+Prinjhaauthor=J.+Schwallerauthor=S.+Knapp&title=Generation+of+a+Selective+Small+Molecule+Inhibitor+of+the+CBP%2FP300+Bromodomain+for+Leukemia+Therapy&doi=10.1158%2F0008-5472.CAN-15-0236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy</span></div><div class="casAuthors">Picaud, Sarah; Fedorov, Oleg; Thanasopoulou, Angeliki; Leonards, Katharina; Jones, Katherine; Meier, Julia; Olzscha, Heidi; Monteiro, Octovia; Martin, Sarah; Philpott, Martin; Tumber, Anthony; Filippakopoulos, Panagis; Yapp, Clarence; Wells, Christopher; Che, Ka Hing; Bannister, Andrew; Robson, Samuel; Kumar, Umesh; Parr, Nigel; Lee, Kevin; Lugo, Dave; Jeffrey, Philip; Taylor, Simon; Vecellio, Matteo L.; Bountra, Chas; Brennan, Paul E.; O'Mahony, Alison; Velichko, Sharlene; Mueller, Susanne; Hay, Duncan; Daniels, Danette L.; Urh, Marjeta; La Thangue, Nicholas B.; Kouzarides, Tony; Prinjha, Rab; Schwaller, Juerg; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5106-5119</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The histone acetyltransferases CBP/p300 are involved in recurrent leukemia-assocd. chromosomal translocations and are key regulators of cell growth.  Therefore, efforts to generate inhibitors of CBP/p300 are of clin. value.  We developed a specific and potent acetyl-lysine competitive protein-protein interaction inhibitor, I-CBP112, that targets the CBP/p300 bromodomains.  Exposure of human and mouse leukemic cell lines to I-CBP112 resulted in substantially impaired colony formation and induced cellular differentiation without significant cytotoxicity.  I-CBP112 significantly reduced the leukemia-initiating potential of MLL-AF9+ acute myeloid leukemia cells in a dose-dependent manner in vitro and in vivo.  Interestingly, I-CBP112 increased the cytotoxic activity of BET bromodomain inhibitor JQ1 as well as doxorubicin.  Collectively, we report the development and preclin. evaluation of a novel, potent inhibitor targeting CBP/p300 bromodomains that impairs aberrant self-renewal of leukemic cells.  The synergistic effects of I-CBP112 and current std. therapy (doxorubicin) as well as emerging treatment strategies (BET inhibition) provide new opportunities for combinatorial treatment of leukemia and potentially other cancers.  Cancer Res; 75(23); 5106-19. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWk5dMbmC6K7Vg90H21EOLACvtfcHk0liPLahsIL6MMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFensrzN&md5=da936fa34139ba27abc748db5f78c95e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-0236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-0236%26sid%3Dliteratum%253Aachs%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DThanasopoulou%26aufirst%3DA.%26aulast%3DLeonards%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DMeier%26aufirst%3DJ.%26aulast%3DOlzscha%26aufirst%3DH.%26aulast%3DMonteiro%26aufirst%3DO.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DChe%26aufirst%3DK.%2BH.%26aulast%3DBannister%26aufirst%3DA.%26aulast%3DRobson%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DU.%26aulast%3DParr%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DVecellio%26aufirst%3DM.%2BL.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DA.%26aulast%3DVelichko%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DHay%26aufirst%3DD.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DUrh%26aufirst%3DM.%26aulast%3DLa%2BThangue%26aufirst%3DN.%2BB.%26aulast%3DKouzarides%26aufirst%3DT.%26aulast%3DPrinjha%26aufirst%3DR.%26aulast%3DSchwaller%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DGeneration%2520of%2520a%2520Selective%2520Small%2520Molecule%2520Inhibitor%2520of%2520the%2520CBP%252FP300%2520Bromodomain%2520for%2520Leukemia%2520Therapy%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D5106%26epage%3D5119%26doi%3D10.1158%2F0008-5472.CAN-15-0236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hammitzsch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Mahony, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, F. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Mossawi, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Wit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecellio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wordsworth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowness, P.</span><span> </span><span class="NLM_article-title">CBP30, a Selective CBP/P300 Bromodomain Inhibitor, Suppresses Human Th17 Responses</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">10768</span><span class="NLM_x">–</span> <span class="NLM_lpage">10773</span><span class="refDoi"> DOI: 10.1073/pnas.1501956112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1073%2Fpnas.1501956112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=26261308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSit7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=10768-10773&author=A.+Hammitzschauthor=C.+Tallantauthor=O.+Fedorovauthor=A.+O%E2%80%99Mahonyauthor=P.+E.+Brennanauthor=D.+A.+Hayauthor=F.+O.+Martinezauthor=M.+H.+Al-Mossawiauthor=J.+de+Witauthor=M.+Vecellioauthor=C.+Wellsauthor=P.+Wordsworthauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=P.+Bowness&title=CBP30%2C+a+Selective+CBP%2FP300+Bromodomain+Inhibitor%2C+Suppresses+Human+Th17+Responses&doi=10.1073%2Fpnas.1501956112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses</span></div><div class="casAuthors">Hammitzsch, Ariane; Tallant, Cynthia; Fedorov, Oleg; O'Mahony, Alison; Brennan, Paul E.; Hay, Duncan A.; Martinez, Fernando O.; Al-Mossawi, M. Hussein; de Wit, Jelle; Vecellio, Matteo; Wells, Christopher; Wordsworth, Paul; Muller, Susanne; Knapp, Stefan; Bowness, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">10768-10773</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Th17 responses are crit. to a variety of human autoimmune diseases, and therapeutic targeting with monoclonal antibodies against IL-17 and IL-23 has shown considerable promise.  Here, the authors report data to support selective bromodomain blockade of the transcriptional coactivators CBP (CREB binding protein) and p300 as an alternative approach to inhibit human Th17 responses.  The authors show that CBP30 has marked mol. specificity for the bromodomains of CBP and p300, compared with 43 other bromodomains.  In unbiased cellular testing on a diverse panel of cultured primary human cells, CBP30 reduced immune cell prodn. of IL-17A and other proinflammatory cytokines.  CBP30 also inhibited IL-17A secretion by Th17 cells from healthy donors and patients with ankylosing spondylitis and psoriatic arthritis.  Transcriptional profiling of human T cells after CBP30 treatment showed a much more restricted effect on gene expression than that obsd. with the pan-BET (bromo and extraterminal domain protein family) bromodomain inhibitor JQ1.  This selective targeting of the CBP/p300 bromodomain by CBP30 will potentially lead to fewer side effects than with the broadly acting epigenetic inhibitors currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4fYjOUV2xW7Vg90H21EOLACvtfcHk0liNwGJD_Ewj5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSit7jI&md5=fb9de88ecdd6441628ae1455ac11b65c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1501956112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1501956112%26sid%3Dliteratum%253Aachs%26aulast%3DHammitzsch%26aufirst%3DA.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DA.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DMartinez%26aufirst%3DF.%2BO.%26aulast%3DAl-Mossawi%26aufirst%3DM.%2BH.%26aulast%3Dde%2BWit%26aufirst%3DJ.%26aulast%3DVecellio%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DWordsworth%26aufirst%3DP.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBowness%26aufirst%3DP.%26atitle%3DCBP30%252C%2520a%2520Selective%2520CBP%252FP300%2520Bromodomain%2520Inhibitor%252C%2520Suppresses%2520Human%2520Th17%2520Responses%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D10768%26epage%3D10773%26doi%3D10.1073%2Fpnas.1501956112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Development of Methyl Isoxazoleazepines as Inhibitors of BET</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1842</span><span class="NLM_x">–</span> <span class="NLM_lpage">1848</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.03.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1016%2Fj.bmcl.2015.03.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=25851940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVKrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1842-1848&author=M.+C.+Hewittauthor=Y.+Leblancauthor=V.+S.+Gehlingauthor=R.+G.+Vaswaniauthor=A.+C%C3%B4t%C3%A9author=C.+G.+Nasveschukauthor=A.+M.+Taylorauthor=J.-C.+Harmangeauthor=J.+E.+Audiaauthor=E.+Pardoauthor=R.+Cummingsauthor=S.+Joshiauthor=P.+Sandyauthor=J.+A.+Mertzauthor=R.+J.+Simsauthor=L.+Bergeronauthor=B.+M.+Bryantauthor=S.+Bellonauthor=F.+Poyauthor=H.+Jayaramauthor=Y.+Tangauthor=B.+K.+Albrecht&title=Development+of+Methyl+Isoxazoleazepines+as+Inhibitors+of+BET&doi=10.1016%2Fj.bmcl.2015.03.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Development of methyl isoxazoleazepines as inhibitors of BET</span></div><div class="casAuthors">Hewitt, Michael C.; Leblanc, Yves; Gehling, Victor S.; Vaswani, Rishi G.; Cote, Alexandre; Nasveschuk, Christopher G.; Taylor, Alexander M.; Harmange, Jean-Christophe; Audia, James E.; Pardo, Eneida; Cummings, Rich; Joshi, Shivangi; Sandy, Peter; Mertz, Jennifer A.; Sims, Robert J.; Bergeron, Louise; Bryant, Barbara M.; Bellon, Steve; Poy, Florence; Jayaran, Hariharan; Tang, Yong; Albrecht, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1842-1848</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this report we detail the evolution of our previously reported thiophene isoxazole BET inhibitor chemotype exemplified by CPI-3 to a novel bromodomain selective chemotype (the Me isoxazoleazepine chemotype) exemplified by carboxamide 23.  The Me isoxazoleazepine chemotype provides potent inhibition of the bromodomains of the BET family, excellent in vivo PK across species, low unbound clearance, and target engagement in a MYC PK-PD model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrdQuVhIoU1rVg90H21EOLACvtfcHk0liNwGJD_Ewj5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVKrsL8%253D&md5=fb9a78528287f82ccf004e751e491ee4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.03.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.03.045%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDevelopment%2520of%2520Methyl%2520Isoxazoleazepines%2520as%2520Inhibitors%2520of%2520BET%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1842%26epage%3D1848%26doi%3D10.1016%2Fj.bmcl.2015.03.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lora, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setser, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Discovery of Benzotriazolo[4,3-<i>D</i>][1,4]Diazepines as Orally Active Inhibitors of BET Bromodomains</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span><span class="refDoi"> DOI: 10.1021/ml500411h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500411h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlt1Wls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=145-150&author=A.+M.+Taylorauthor=R.+G.+Vaswaniauthor=V.+S.+Gehlingauthor=M.+C.+Hewittauthor=Y.+Leblancauthor=J.+E.+Audiaauthor=S.+Bellonauthor=R.+T.+Cummingsauthor=A.+C%C3%B4t%C3%A9author=J.-C.+Harmangeauthor=H.+Jayaramauthor=S.+Joshiauthor=J.+M.+Loraauthor=J.+A.+Mertzauthor=A.+Neissauthor=E.+Pardoauthor=C.+G.+Nasveschukauthor=F.+Poyauthor=P.+Sandyauthor=J.+W.+Setserauthor=R.+J.+Simsauthor=Y.+Tangauthor=B.+K.+Albrecht&title=Discovery+of+Benzotriazolo%5B4%2C3-D%5D%5B1%2C4%5DDiazepines+as+Orally+Active+Inhibitors+of+BET+Bromodomains&doi=10.1021%2Fml500411h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Benzotriazolo[4,3-d][1,4]diazepines as Orally Active Inhibitors of BET Bromodomains</span></div><div class="casAuthors">Taylor, Alexander M.; Vaswani, Rishi G.; Gehling, Victor S.; Hewitt, Michael C.; Leblanc, Yves; Audia, James E.; Bellon, Steve; Cummings, Richard T.; Cote, Alexandre; Harmange, Jean-Christophe; Jayaram, Hari; Joshi, Shivangi; Lora, Jose M.; Mertz, Jennifer A.; Neiss, Adrianne; Pardo, Eneida; Nasveschuk, Christopher G.; Poy, Florence; Sandy, Peter; Setser, Jeremy W.; Sims, Robert J.; Tang, Yong; Albrecht, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-150</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of the bromodomains of the BET family, of which BRD4 is a member, has been shown to decrease myc and interleukin (IL) 6 in vivo, markers that are of therapeutic relevance to cancer and inflammatory disease, resp.  Herein the authors report substituted benzo[b]isoxazolo[4,5-d]azepines and benzotriazolo[4,3-d][1,4]diazepines as fragment-derived novel inhibitors of the bromodomain of BRD4.  Compds. from these series were potent and selective in cells, and subsequent optimization of microsomal stability yielded representatives that demonstrated dose- and time-dependent redn. of plasma IL-6 in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDybfuij7kebVg90H21EOLACvtfcHk0liThUQOu_3TeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlt1Wls7k%253D&md5=38759c818814869d6c951a035bad7617</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fml500411h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500411h%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DLora%26aufirst%3DJ.%2BM.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DNeiss%26aufirst%3DA.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DSetser%26aufirst%3DJ.%2BW.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDiscovery%2520of%2520Benzotriazolo%255B4%252C3-D%255D%255B1%252C4%255DDiazepines%2520as%2520Orally%2520Active%2520Inhibitors%2520of%2520BET%2520Bromodomains%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D145%26epage%3D150%26doi%3D10.1021%2Fml500411h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Beresini, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawes, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orren, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turincio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thana, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hascall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, N. J.</span><span> </span><span class="NLM_article-title">Small-Molecule Library Subset Screening as an Aid for Accelerating Lead Identification</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span><span class="refDoi"> DOI: 10.1177/1087057114522515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1177%2F1087057114522515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=24518067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWqu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=758-770&author=M.+H.+Beresiniauthor=Y.+Liuauthor=T.+D.+Dawesauthor=K.+R.+Clarkauthor=L.+Orrenauthor=S.+Schmidtauthor=R.+Turincioauthor=S.+W.+Jonesauthor=R.+A.+Rodriguezauthor=P.+Thanaauthor=D.+Hascallauthor=D.+P.+Grossauthor=N.+J.+Skelton&title=Small-Molecule+Library+Subset+Screening+as+an+Aid+for+Accelerating+Lead+Identification&doi=10.1177%2F1087057114522515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule library subset screening as an aid for accelerating lead identification</span></div><div class="casAuthors">Beresini, Maureen H.; Liu, Yichin; Dawes, Timothy D.; Clark, Kevin R.; Orren, Linda; Schmidt, Stephen; Turincio, Rebecca; Jones, Steven W.; Rodriguez, Richard A.; Thana, Peter; Hascall, Daniel; Gross, Daniel P.; Skelton, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">758-770, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Several small-compd. library subsets (14,000 to 56,000) have been established to complement screening of a larger Genentech corporate library (∼1,300,000).  Two validation sets (∼1% of the total library) contg. compds. representative of the main library were chosen by selection of plates or individual compds.  Use of these subsets guided selection of assay configuration, validated assay reproducibility, and provided ests. of hit rates expected from our full library.  A larger diversity subset representing the scaffold diversity of the full library (3.4% of the total) was designed for screening more challenging targets with limited reagent availability or low-throughput assays.  Retrospective anal. of this subset showed hit rates similar to those of the main library while recovering a higher proportion of hit scaffolds.  Finally, a property-restricted diversity set called the "in-between library" was established to identify ligand-efficient compds. of mol. size between those typically found in fragment and high-throughput screening libraries.  It was screened at fivefold higher concns. than the main library to facilitate identification of less potent yet ligand-efficient compds.  Taken together, this work underscores the value of generating multiple purpose-focused, diversity-based library subsets that are designed using computational approaches coupled with internal screening data analyses to accelerate the lead discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLxwfGU_R_arVg90H21EOLACvtfcHk0liThUQOu_3TeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWqu7jI&md5=a9d79cadab5e3a4bc3a3136d7b548d09</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1177%2F1087057114522515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057114522515%26sid%3Dliteratum%253Aachs%26aulast%3DBeresini%26aufirst%3DM.%2BH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDawes%26aufirst%3DT.%2BD.%26aulast%3DClark%26aufirst%3DK.%2BR.%26aulast%3DOrren%26aufirst%3DL.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DTurincio%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DS.%2BW.%26aulast%3DRodriguez%26aufirst%3DR.%2BA.%26aulast%3DThana%26aufirst%3DP.%26aulast%3DHascall%26aufirst%3DD.%26aulast%3DGross%26aufirst%3DD.%2BP.%26aulast%3DSkelton%26aufirst%3DN.%2BJ.%26atitle%3DSmall-Molecule%2520Library%2520Subset%2520Screening%2520as%2520an%2520Aid%2520for%2520Accelerating%2520Lead%2520Identification%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2014%26volume%3D19%26spage%3D758%26epage%3D770%26doi%3D10.1177%2F1087057114522515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span>MoKa; <span class="NLM_publisher-name">Molecular Discovery</span>: <span class="NLM_publisher-loc">Perugia, Italy</span>; <a href="http://www.moldiscovery.com/software/moka/" class="extLink">www.moldiscovery.com/software/moka/</a> (accessed June 16, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MoKa%3B+Molecular+Discovery%3A+Perugia%2C+Italy%3B+www.moldiscovery.com%2Fsoftware%2Fmoka%2F+%28accessed+June+16%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DMoKa%26pub%3DMolecular%2520Discovery" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Hagemans, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Belzen, I. A. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morán Luengo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüdiger, S. G. D.</span><span> </span><span class="NLM_article-title">A Script to Highlight Hydrophobicity and Charge on Protein Surfaces</span> <span class="citation_source-journal">Front. Mol. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.3389/fmolb.2015.00056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.3389%2Ffmolb.2015.00056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=25988169" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=1-11&author=D.+Hagemansauthor=I.+A.+E.+M.+van+Belzenauthor=T.+Mor%C3%A1n+Luengoauthor=S.+G.+D.+R%C3%BCdiger&title=A+Script+to+Highlight+Hydrophobicity+and+Charge+on+Protein+Surfaces&doi=10.3389%2Ffmolb.2015.00056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3389%2Ffmolb.2015.00056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmolb.2015.00056%26sid%3Dliteratum%253Aachs%26aulast%3DHagemans%26aufirst%3DD.%26aulast%3Dvan%2BBelzen%26aufirst%3DI.%2BA.%2BE.%2BM.%26aulast%3DMor%25C3%25A1n%2BLuengo%26aufirst%3DT.%26aulast%3DR%25C3%25BCdiger%26aufirst%3DS.%2BG.%2BD.%26atitle%3DA%2520Script%2520to%2520Highlight%2520Hydrophobicity%2520and%2520Charge%2520on%2520Protein%2520Surfaces%26jtitle%3DFront.%2520Mol.%2520Biosci.%26date%3D2015%26volume%3D2%26spage%3D1%26epage%3D11%26doi%3D10.3389%2Ffmolb.2015.00056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantone, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Meara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supko, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1330</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01882</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01882" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1330-1339&author=B.+K.+Albrechtauthor=V.+S.+Gehlingauthor=M.+C.+Hewittauthor=R.+G.+Vaswaniauthor=A.+C%C3%B4t%C3%A9author=Y.+Leblancauthor=C.+G.+Nasveschukauthor=S.+Bellonauthor=L.+Bergeronauthor=R.+Campbellauthor=N.+Cantoneauthor=M.+R.+Cooperauthor=R.+T.+Cummingsauthor=H.+Jayaramauthor=S.+Joshiauthor=J.+A.+Mertzauthor=A.+Neissauthor=E.+Normantauthor=M.+O%E2%80%99Mearaauthor=E.+Pardoauthor=F.+Poyauthor=P.+Sandyauthor=J.+Supkoauthor=R.+J.+Simsauthor=J.-C.+Harmangeauthor=A.+M.+Taylorauthor=J.+E.+Audia&title=Identification+of+a+Benzoisoxazoloazepine+Inhibitor+%28CPI-0610%29+of+the+Bromodomain+and+Extra-Terminal+%28BET%29+Family+as+a+Candidate+for+Human+Clinical+Trials&doi=10.1021%2Facs.jmedchem.5b01882"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials</span></div><div class="casAuthors">Albrecht, Brian K.; Gehling, Victor S.; Hewitt, Michael C.; Vaswani, Rishi G.; Cote, Alexandre; Leblanc, Yves; Nasveschuk, Christopher G.; Bellon, Steve; Bergeron, Louise; Campbell, Robert; Cantone, Nico; Cooper, Michael R.; Cummings, Richard T.; Jayaram, Hariharan; Joshi, Shivangi; Mertz, Jennifer A.; Neiss, Adrianne; Normant, Emmanuel; O'Meara, Michael; Pardo, Eneida; Poy, Florence; Sandy, Peter; Supko, Jeffrey; Sims, Robert J.; Harmange, Jean-Christophe; Taylor, Alexander M.; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1330-1339</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, inhibition of the interaction between the bromodomain and extra-terminal domain (BET) family of chromatin adaptors and acetyl-lysine residues on chromatin has emerged as a promising approach to regulate the expression of important disease-relevant genes, including MYC, BCL-2, and NF-κB.  Here we describe the identification and characterization of a potent and selective benzoisoxazoloazepine BET bromodomain inhibitor that attenuates BET-dependent gene expression in vivo, demonstrates antitumor efficacy in an MV-4-11 mouse xenograft model, and is currently undergoing human clin. trials for hematol. malignancies (CPI-0610).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40qjnYl4EZLVg90H21EOLACvtfcHk0lhhDBQszf14Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKjs7g%253D&md5=5e1c5aab26aa58844a9f6670a7bbd78b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01882%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DCantone%26aufirst%3DN.%26aulast%3DCooper%26aufirst%3DM.%2BR.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DNeiss%26aufirst%3DA.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DM.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DSupko%26aufirst%3DJ.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DIdentification%2520of%2520a%2520Benzoisoxazoloazepine%2520Inhibitor%2520%2528CPI-0610%2529%2520of%2520the%2520Bromodomain%2520and%2520Extra-Terminal%2520%2528BET%2529%2520Family%2520as%2520a%2520Candidate%2520for%2520Human%2520Clinical%2520Trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1330%26epage%3D1339%26doi%3D10.1021%2Facs.jmedchem.5b01882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Halladay, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinhababu, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh-Bakht, S. C.</span><span> </span><span class="NLM_article-title">Metabolic Stability Screen for Drug Discovery Using Cassette Analysis and Column Switching</span> <span class="citation_source-journal">Drug Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.2174/187231207779814364</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.2174%2F187231207779814364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=19356021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtleru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2007&pages=67-72&author=J.+S.+Halladayauthor=S.+Wongauthor=S.+M.+Jafferauthor=A.+K.+Sinhababuauthor=S.+C.+Khojasteh-Bakht&title=Metabolic+Stability+Screen+for+Drug+Discovery+Using+Cassette+Analysis+and+Column+Switching&doi=10.2174%2F187231207779814364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic stability screen for drug discovery using cassette analysis and column switching</span></div><div class="casAuthors">Halladay, Jason S.; Wong, Susan; Jaffer, Sharmin M.; Sinhababu, Achintya K.; Khojasteh-Bakht, S. Cyrus</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-72</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">In vitro metabolic stability assays are used to screen compds. for stability in the presence of various drug metabolizing enzymes, usually cytochrome P 450 in liver prepns. (e.g., liver microsomes).  High-throughput metabolic stability assays using pooling methods have been developed to keep pace with screening requirements at the lead ADME optimization stage.  In our lab., we have improved the metabolic stability assay using the cassette anal. method, column switching, and incorporated time saving techniques in method development to yield a robust method which reduces data turnaround time, increases compd. throughput, and maximizes mass spectrometer usage.  This method can det. metabolic stability using microsomes or hepatocytes from any species.  We describe our findings following incubation of 40 different compds. with human liver microsomes and anal. by the cassette and discrete anal. methods.  Similar metabolic stability results were obtained using the cassette anal. and discrete anal. method.  An overall 70% time savings was achieved by pooling four new compds. into one sample for method development/MS optimization, cassetting four samples into one sample to minimize the no. of injections on LC/MS/MS anal., and using a column switching system to analyze the samples, which results in a two-fold decrease in the LC/MS/MS anal. time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKzVSm6sBe1bVg90H21EOLACvtfcHk0lhhDBQszf14Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtleru74%253D&md5=e00c66b3ca6a1eaee107c4eb81e07bf5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F187231207779814364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231207779814364%26sid%3Dliteratum%253Aachs%26aulast%3DHalladay%26aufirst%3DJ.%2BS.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DJaffer%26aufirst%3DS.%2BM.%26aulast%3DSinhababu%26aufirst%3DA.%2BK.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26atitle%3DMetabolic%2520Stability%2520Screen%2520for%2520Drug%2520Discovery%2520Using%2520Cassette%2520Analysis%2520and%2520Column%2520Switching%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2007%26volume%3D1%26spage%3D67%26epage%3D72%26doi%3D10.2174%2F187231207779814364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macintyre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rance, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wastall, P.</span><span> </span><span class="NLM_article-title">The Prediction of Human Pharmacokinetic Parameters From Preclinical and in Vitro Metabolism Data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+Macintyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+Prediction+of+Human+Pharmacokinetic+Parameters+From+Preclinical+and+in+Vitro+Metabolism+Data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0lhhDBQszf14Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacintyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520Prediction%2520of%2520Human%2520Pharmacokinetic%2520Parameters%2520From%2520Preclinical%2520and%2520in%2520Vitro%2520Metabolism%2520Data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Halladay, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delarosa, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh, S. C.</span><span> </span><span class="NLM_article-title">High-Throughput, 384-Well, LC-MS/MS CYP Inhibition Assay Using Automation, Cassette-Analysis Technique and Streamlined Data Analysis</span> <span class="citation_source-journal">Drug Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span><span class="refDoi"> DOI: 10.2174/187231211796905017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.2174%2F187231211796905017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=21867481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Cit7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=220-230&author=J.+S.+Halladayauthor=E.+M.+Delarosaauthor=D.+Tranauthor=L.+Wangauthor=S.+Wongauthor=S.+C.+Khojasteh&title=High-Throughput%2C+384-Well%2C+LC-MS%2FMS+CYP+Inhibition+Assay+Using+Automation%2C+Cassette-Analysis+Technique+and+Streamlined+Data+Analysis&doi=10.2174%2F187231211796905017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput, 384-well, LC-MS/MS CYP inhibition assay using automation, cassette-analysis technique and streamlined data analysis</span></div><div class="casAuthors">Halladay, Jason S.; Delarosa, Erlie Marie; Tran, Daniel; Wang, Leslie; Wong, Susan; Khojasteh, S. Cyrus</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">220-230</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Here we describe a high capacity and high-throughput, automated, 384-well CYP inhibition assay using well-known HLM-based MS probes.  We provide consistently robust IC50 values at the lead optimization stage of the drug discovery process.  Our method uses the Agilent Technologies/Velocity11 BioCel 1200 system, timesaving techniques for sample anal., and streamlined data processing steps.  For each expt., we generate IC50 values for up to 344 compds. and pos. controls for five major CYP isoforms (probe substrate): CYP1A2 (phenacetin), CYP2C9 [(S)-warfarin], CYP2C19 [(S)-mephenytoin], CYP2D6 (dextromethorphan), and CYP3A4/5 (testosterone and midazolam).  Each compd. is incubated sep. at four concns. with each CYP probe substrate under the optimized incubation condition.  Each incubation is quenched with acetonitrile contg. the deuterated internal std. of the resp. metabolite for each probe substrate.  To minimize the no. of samples to be analyzed by LC-MS/MS and reduce the amt. of valuable MS runtime, we utilize timesaving techniques of cassette anal. (pooling the incubation samples at the end of each CYP probe incubation into one) and column switching (reducing the amt. of MS runtime).  Here we also report on the comparison of IC50 results for five major CYP isoforms using our method compared to values reported in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6LFWUX9244rVg90H21EOLACvtfcHk0lgWa4ddutDqGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Cit7bL&md5=87db89d19026e12386ba06d594eeb727</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F187231211796905017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231211796905017%26sid%3Dliteratum%253Aachs%26aulast%3DHalladay%26aufirst%3DJ.%2BS.%26aulast%3DDelarosa%26aufirst%3DE.%2BM.%26aulast%3DTran%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DKhojasteh%26aufirst%3DS.%2BC.%26atitle%3DHigh-Throughput%252C%2520384-Well%252C%2520LC-MS%252FMS%2520CYP%2520Inhibition%2520Assay%2520Using%2520Automation%252C%2520Cassette-Analysis%2520Technique%2520and%2520Streamlined%2520Data%2520Analysis%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2011%26volume%3D5%26spage%3D220%26epage%3D230%26doi%3D10.2174%2F187231211796905017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 46 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">John W. Liebeschuetz</span>. </span><span class="cited-content_cbyCitation_article-title">The Good, the Bad, and the Twisted Revisited: An Analysis of Ligand Geometry in Highly Resolved Protein–Ligand X-ray Structures. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7533-7543. <a href="https://doi.org/10.1021/acs.jmedchem.1c00228" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00228%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BGood%25252C%252Bthe%252BBad%25252C%252Band%252Bthe%252BTwisted%252BRevisited%25253A%252BAn%252BAnalysis%252Bof%252BLigand%252BGeometry%252Bin%252BHighly%252BResolved%252BProtein%2525E2%252580%252593Ligand%252BX-ray%252BStructures%26aulast%3DLiebeschuetz%26aufirst%3DJohn%2BW.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D05022021%26date%3D01062021%26volume%3D64%26issue%3D11%26spage%3D7533%26epage%3D7543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alex Muthengi, Virangika K. Wimalasena, Hailemichael O. Yosief, Melissa J. Bikowitz, Logan H. Sigua, Tingjian Wang, Deyao Li, Zied Gaieb, Gagan Dhawan, Shuai Liu, Jon Erickson, Rommie E. Amaro, Ernst Schönbrunn, Jun Qi, <span class="NLM_string-name hlFld-ContribAuthor">Wei Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Dimethylisoxazole-Attached Imidazo[1,2-a]pyridines as Potent and Selective CBP/P300 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5787-5801. <a href="https://doi.org/10.1021/acs.jmedchem.0c02232" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02232</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02232%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BDimethylisoxazole-Attached%252BImidazo%25255B1%25252C2-a%25255Dpyridines%252Bas%252BPotent%252Band%252BSelective%252BCBP%25252FP300%252BInhibitors%26aulast%3DMuthengi%26aufirst%3DAlex%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D23122020%26date%3D19042021%26volume%3D64%26issue%3D9%26spage%3D5787%26epage%3D5801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Natesh Singh, Ludovic Chaput, <span class="NLM_string-name hlFld-ContribAuthor">Bruno O. Villoutreix</span>. </span><span class="cited-content_cbyCitation_article-title">Fast Rescoring Protocols to Improve the Performance of Structure-Based Virtual Screening Performed on Protein–Protein Interfaces. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (8)
                                     , 3910-3934. <a href="https://doi.org/10.1021/acs.jcim.0c00545" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00545</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00545%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DFast%252BRescoring%252BProtocols%252Bto%252BImprove%252Bthe%252BPerformance%252Bof%252BStructure-Based%252BVirtual%252BScreening%252BPerformed%252Bon%252BProtein%2525E2%252580%252593Protein%252BInterfaces%26aulast%3DSingh%26aufirst%3DNatesh%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16052020%26date%3D11082020%26date%3D03082020%26volume%3D60%26issue%3D8%26spage%3D3910%26epage%3D3934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jian Zhu, Jing Dong, Laurent Batiste, Andrea Unzue, Aymeric Dolbois, Vlad Pascanu, Paweł Śledź, Cristina Nevado, <span class="NLM_string-name hlFld-ContribAuthor">Amedeo Caflisch</span>. </span><span class="cited-content_cbyCitation_article-title">Binding Motifs in the CBP Bromodomain: An Analysis of 20 Crystal Structures of Complexes with Small Molecules. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (9)
                                     , 929-934. <a href="https://doi.org/10.1021/acsmedchemlett.8b00286" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00286</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00286%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBinding%252BMotifs%252Bin%252Bthe%252BCBP%252BBromodomain%25253A%252BAn%252BAnalysis%252Bof%252B20%252BCrystal%252BStructures%252Bof%252BComplexes%252Bwith%252BSmall%252BMolecules%26aulast%3DZhu%26aufirst%3DJian%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D22062018%26date%3D08082018%26date%3D13082018%26date%3D08082018%26volume%3D9%26issue%3D9%26spage%3D929%26epage%3D934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">David J. Edmonds, Daniel W. Kung, Amit S. Kalgutkar, Kevin J. Filipski, David C. Ebner, Shawn Cabral, Aaron C. Smith, Gary E. Aspnes, Samit K. Bhattacharya, Kris A. Borzilleri, Janice A. Brown, Matthew F. Calabrese, Nicole L. Caspers, Emily C. Cokorinos, Edward L. Conn, Matthew S. Dowling, Heather Eng, Bo Feng, Dilinie P. Fernando, Nathan E. Genung, Michael Herr, Ravi G. Kurumbail, Sophie Y. Lavergne, Esther C.-Y. Lee, Qifang Li, Sumathy Mathialagan, Russell A. Miller, Jane Panteleev, Jana Polivkova, Francis Rajamohan, Allan R. Reyes, Christopher T. Salatto, Andre Shavnya, Benjamin A. Thuma, Meihua Tu, Jessica Ward, Jane M. Withka, Jun Xiao, <span class="NLM_string-name hlFld-ContribAuthor">Kimberly O. Cameron</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Metabolic and Renal Clearance in a Series of Indole Acid Direct Activators of 5′-Adenosine Monophosphate-Activated Protein Kinase (AMPK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (6)
                                     , 2372-2383. <a href="https://doi.org/10.1021/acs.jmedchem.7b01641" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01641%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BMetabolic%252Band%252BRenal%252BClearance%252Bin%252Ba%252BSeries%252Bof%252BIndole%252BAcid%252BDirect%252BActivators%252Bof%252B5%2525E2%252580%2525B2-Adenosine%252BMonophosphate-Activated%252BProtein%252BKinase%252B%252528AMPK%252529%26aulast%3DEdmonds%26aufirst%3DDavid%2BJ.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D06112017%26date%3D28022018%26date%3D21022018%26volume%3D61%26issue%3D6%26spage%3D2372%26epage%3D2383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurent  Batiste</span>, <span class="hlFld-ContribAuthor ">Andrea  Unzue</span>, <span class="hlFld-ContribAuthor ">Aymeric  Dolbois</span>, <span class="hlFld-ContribAuthor ">Fabrice  Hassler</span>, <span class="hlFld-ContribAuthor ">Xuan  Wang</span>, <span class="hlFld-ContribAuthor ">Nicholas  Deerain</span>, <span class="hlFld-ContribAuthor ">Jian  Zhu</span>, <span class="hlFld-ContribAuthor ">Dimitrios  Spiliotopoulos</span>, <span class="hlFld-ContribAuthor ">Cristina  Nevado</span>, and <span class="hlFld-ContribAuthor ">Amedeo  Caflisch</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemical Space Expansion of Bromodomain Ligands Guided by in Silico Virtual Couplings (AutoCouple). </span><span class="cited-content_cbyCitation_journal-name">ACS Central Science</span><span> <strong>2018,</strong> <em>4 </em>
                                    (2)
                                     , 180-188. <a href="https://doi.org/10.1021/acscentsci.7b00401" title="DOI URL">https://doi.org/10.1021/acscentsci.7b00401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscentsci.7b00401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscentsci.7b00401%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Central%2520Science%26atitle%3DChemical%252BSpace%252BExpansion%252Bof%252BBromodomain%252BLigands%252BGuided%252Bby%252Bin%252BSilico%252BVirtual%252BCouplings%252B%252528AutoCouple%252529%26aulast%3DBatiste%26aufirst%3DLaurent%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D29082017%26date%3D07022018%26date%3D28022018%26volume%3D4%26issue%3D2%26spage%3D180%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ibraheem  Ali</span>, <span class="hlFld-ContribAuthor ">Ryan J.  Conrad</span>, <span class="hlFld-ContribAuthor ">Eric  Verdin</span>, and <span class="hlFld-ContribAuthor ">Melanie  Ott</span>  . </span><span class="cited-content_cbyCitation_article-title">Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2018,</strong> <em>118 </em>
                                    (3)
                                     , 1216-1252. <a href="https://doi.org/10.1021/acs.chemrev.7b00181" title="DOI URL">https://doi.org/10.1021/acs.chemrev.7b00181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.7b00181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.7b00181%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DLysine%252BAcetylation%252BGoes%252BGlobal%25253A%252BFrom%252BEpigenetics%252Bto%252BMetabolism%252Band%252BTherapeutics%26aulast%3DAli%26aufirst%3DIbraheem%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D31032017%26date%3D06022018%26date%3D14022018%26volume%3D118%26issue%3D3%26spage%3D1216%26epage%3D1252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah M.  Bronner</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">F. Anthony  Romero</span>, <span class="hlFld-ContribAuthor ">Kwong Wah  Lai</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Patrick  Cyr</span>, <span class="hlFld-ContribAuthor ">Maureen H.  Beresini</span>, <span class="hlFld-ContribAuthor ">Gladys  de leon Boenig</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Chen</span>, <span class="hlFld-ContribAuthor ">Edna F.  Choo</span>, <span class="hlFld-ContribAuthor ">Kevin R.  Clark</span>, <span class="hlFld-ContribAuthor ">Terry D.  Crawford</span>, <span class="hlFld-ContribAuthor ">Hariharan  Jayaram</span>, <span class="hlFld-ContribAuthor ">Susan  Kaufman</span>, <span class="hlFld-ContribAuthor ">Ruina  Li</span>, <span class="hlFld-ContribAuthor ">Yingjie  Li</span>, <span class="hlFld-ContribAuthor ">Jiangpeng  Liao</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Wenfeng  Liu</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Jonathan  Maher</span>, <span class="hlFld-ContribAuthor ">John  Wai</span>, <span class="hlFld-ContribAuthor ">Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Aijun  Zheng</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhu</span>, and <span class="hlFld-ContribAuthor ">Steven  Magnuson</span>  . </span><span class="cited-content_cbyCitation_article-title">A Unique Approach to Design Potent and Selective Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (24)
                                     , 10151-10171. <a href="https://doi.org/10.1021/acs.jmedchem.7b01372" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01372</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01372%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BUnique%252BApproach%252Bto%252BDesign%252BPotent%252Band%252BSelective%252BCyclic%252BAdenosine%252BMonophosphate%252BResponse%252BElement%252BBinding%252BProtein%25252C%252BBinding%252BProtein%252B%252528CBP%252529%252BInhibitors%26aulast%3DBronner%26aufirst%3DSarah%2BM.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23092017%26date%3D11122017%26date%3D28122017%26date%3D20112017%26volume%3D60%26issue%3D24%26spage%3D10151%26epage%3D10171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Anthony  Romero</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Kwong Wah  Lai</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Brian K.  Albrecht</span>, <span class="hlFld-ContribAuthor ">Le  An</span>, <span class="hlFld-ContribAuthor ">Maureen H.  Beresini</span>, <span class="hlFld-ContribAuthor ">Gladys  de Leon Boenig</span>, <span class="hlFld-ContribAuthor ">Sarah M.  Bronner</span>, <span class="hlFld-ContribAuthor ">Emily W.  Chan</span>, <span class="hlFld-ContribAuthor ">Kevin X.  Chen</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Chen</span>, <span class="hlFld-ContribAuthor ">Edna F.  Choo</span>, <span class="hlFld-ContribAuthor ">Kyle  Clagg</span>, <span class="hlFld-ContribAuthor ">Kevin  Clark</span>, <span class="hlFld-ContribAuthor ">Terry D.  Crawford</span>, <span class="hlFld-ContribAuthor ">Patrick  Cyr</span>, <span class="hlFld-ContribAuthor ">Denise  de Almeida Nagata</span>, <span class="hlFld-ContribAuthor ">Karen E.  Gascoigne</span>, <span class="hlFld-ContribAuthor ">Jane L.  Grogan</span>, <span class="hlFld-ContribAuthor ">Georgia  Hatzivassiliou</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Thomas L.  Hunsaker</span>, <span class="hlFld-ContribAuthor ">Susan  Kaufman</span>, <span class="hlFld-ContribAuthor ">Stefan G.  Koenig</span>, <span class="hlFld-ContribAuthor ">Ruina  Li</span>, <span class="hlFld-ContribAuthor ">Yingjie  Li</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Jiangpeng  Liao</span>, <span class="hlFld-ContribAuthor ">Wenfeng  Liu</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Jonathan  Maher</span>, <span class="hlFld-ContribAuthor ">Colin  Masui</span>, <span class="hlFld-ContribAuthor ">Mark  Merchant</span>, <span class="hlFld-ContribAuthor ">Yingqing  Ran</span>, <span class="hlFld-ContribAuthor ">Alexander M.  Taylor</span>, <span class="hlFld-ContribAuthor ">John  Wai</span>, <span class="hlFld-ContribAuthor ">Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaocang  Wei</span>, <span class="hlFld-ContribAuthor ">Dong  Yu</span>, <span class="hlFld-ContribAuthor ">Bing-Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhu</span>, and <span class="hlFld-ContribAuthor ">Steven  Magnuson</span>  . </span><span class="cited-content_cbyCitation_article-title">GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (22)
                                     , 9162-9183. <a href="https://doi.org/10.1021/acs.jmedchem.7b00796" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00796</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00796%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGNE-781%25252C%252BA%252BHighly%252BAdvanced%252BPotent%252Band%252BSelective%252BBromodomain%252BInhibitor%252Bof%252BCyclic%252BAdenosine%252BMonophosphate%252BResponse%252BElement%252BBinding%252BProtein%25252C%252BBinding%252BProtein%252B%252528CBP%252529%26aulast%3DRomero%26aufirst%3DF.%2BAnthony%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D05062017%26date%3D21092017%26date%3D22112017%26date%3D11092017%26volume%3D60%26issue%3D22%26spage%3D9162%26epage%3D9183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R. Aldrin  Denny</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Flick</span>, <span class="hlFld-ContribAuthor ">Jotham  Coe</span>, <span class="hlFld-ContribAuthor ">Jonathan  Langille</span>, <span class="hlFld-ContribAuthor ">Arindrajit  Basak</span>, <span class="hlFld-ContribAuthor ">Shenping  Liu</span>, <span class="hlFld-ContribAuthor ">Ingrid  Stock</span>, <span class="hlFld-ContribAuthor ">Parag  Sahasrabudhe</span>, <span class="hlFld-ContribAuthor ">Paul  Bonin</span>, <span class="hlFld-ContribAuthor ">Duncan A.  Hay</span>, <span class="hlFld-ContribAuthor ">Paul E.  Brennan</span>, <span class="hlFld-ContribAuthor ">Mathew  Pletcher</span>, <span class="hlFld-ContribAuthor ">Lyn H.  Jones</span>, and <span class="hlFld-ContribAuthor ">Eugene L. Piatnitski  Chekler</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Highly Selective Inhibitors of the CREB Binding Protein Bromodomain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5349-5363. <a href="https://doi.org/10.1021/acs.jmedchem.6b01839" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01839</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01839%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BHighly%252BSelective%252BInhibitors%252Bof%252Bthe%252BCREB%252BBinding%252BProtein%252BBromodomain%26aulast%3DDenny%26aufirst%3DR.%2BAldrin%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D18122016%26date%3D12052017%26date%3D13072017%26date%3D04042017%26volume%3D60%26issue%3D13%26spage%3D5349%26epage%3D5363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Terry D.  Crawford</span>, <span class="hlFld-ContribAuthor ">James E.  Audia</span>, <span class="hlFld-ContribAuthor ">Steve  Bellon</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Burdick</span>, <span class="hlFld-ContribAuthor ">Archana  Bommi-Reddy</span>, <span class="hlFld-ContribAuthor ">Alexandre  Côté</span>, <span class="hlFld-ContribAuthor ">Richard T.  Cummings</span>, <span class="hlFld-ContribAuthor ">Martin  Duplessis</span>, <span class="hlFld-ContribAuthor ">E. Megan  Flynn</span>, <span class="hlFld-ContribAuthor ">Michael  Hewitt</span>, <span class="hlFld-ContribAuthor ">Hon-Ren  Huang</span>, <span class="hlFld-ContribAuthor ">Hariharan  Jayaram</span>, <span class="hlFld-ContribAuthor ">Ying  Jiang</span>, <span class="hlFld-ContribAuthor ">Shivangi  Joshi</span>, <span class="hlFld-ContribAuthor ">James R.  Kiefer</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Nasveschuk</span>, <span class="hlFld-ContribAuthor ">Arianne  Neiss</span>, <span class="hlFld-ContribAuthor ">Eneida  Pardo</span>, <span class="hlFld-ContribAuthor ">F. Anthony  Romero</span>, <span class="hlFld-ContribAuthor ">Peter  Sandy</span>, <span class="hlFld-ContribAuthor ">Robert J.  Sims, III</span>, <span class="hlFld-ContribAuthor ">Yong  Tang</span>, <span class="hlFld-ContribAuthor ">Alexander M.  Taylor</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Shumei  Wang</span>, <span class="hlFld-ContribAuthor ">Yongyun  Wang</span>, <span class="hlFld-ContribAuthor ">Zhaowu  Xu</span>, <span class="hlFld-ContribAuthor ">Laura  Zawadzke</span>, <span class="hlFld-ContribAuthor ">Xiaoqin  Zhu</span>, <span class="hlFld-ContribAuthor ">Brian K.  Albrecht</span>, <span class="hlFld-ContribAuthor ">Steven R.  Magnuson</span>, and <span class="hlFld-ContribAuthor ">Andrea G.  Cochran</span>  . </span><span class="cited-content_cbyCitation_article-title">GNE-886: A Potent and Selective Inhibitor of the Cat Eye Syndrome Chromosome Region Candidate 2 Bromodomain (CECR2). </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (7)
                                     , 737-741. <a href="https://doi.org/10.1021/acsmedchemlett.7b00132" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00132%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DGNE-886%25253A%252BA%252BPotent%252Band%252BSelective%252BInhibitor%252Bof%252Bthe%252BCat%252BEye%252BSyndrome%252BChromosome%252BRegion%252BCandidate%252B2%252BBromodomain%252B%252528CECR2%252529%26aulast%3DCrawford%26aufirst%3DTerry%2BD.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23032017%26date%3D01062017%26date%3D13062017%26date%3D13072017%26date%3D01062017%26volume%3D8%26issue%3D7%26spage%3D737%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Léa  Bouché</span>, <span class="hlFld-ContribAuthor ">Clara D.  Christ</span>, <span class="hlFld-ContribAuthor ">Stephan  Siegel</span>, <span class="hlFld-ContribAuthor ">Amaury E.  Fernández-Montalván</span>, <span class="hlFld-ContribAuthor ">Simon J.  Holton</span>, <span class="hlFld-ContribAuthor ">Oleg  Fedorov</span>, <span class="hlFld-ContribAuthor ">Antonius  ter Laak</span>, <span class="hlFld-ContribAuthor ">Tatsuo  Sugawara</span>, <span class="hlFld-ContribAuthor ">Detlef  Stöckigt</span>, <span class="hlFld-ContribAuthor ">Cynthia  Tallant</span>, <span class="hlFld-ContribAuthor ">James  Bennett</span>, <span class="hlFld-ContribAuthor ">Octovia  Monteiro</span>, <span class="hlFld-ContribAuthor ">Laura  Díaz-Sáez</span>, <span class="hlFld-ContribAuthor ">Paulina  Siejka</span>, <span class="hlFld-ContribAuthor ">Julia  Meier</span>, <span class="hlFld-ContribAuthor ">Vera  Pütter</span>, <span class="hlFld-ContribAuthor ">Jörg  Weiske</span>, <span class="hlFld-ContribAuthor ">Susanne  Müller</span>, <span class="hlFld-ContribAuthor ">Kilian V. M.  Huber</span>, <span class="hlFld-ContribAuthor ">Ingo V.  Hartung</span>, and <span class="hlFld-ContribAuthor ">Bernard  Haendler</span>  . </span><span class="cited-content_cbyCitation_article-title">Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 4002-4022. <a href="https://doi.org/10.1021/acs.jmedchem.7b00306" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00306%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzoisoquinolinediones%252Bas%252BPotent%252Band%252BSelective%252BInhibitors%252Bof%252BBRPF2%252Band%252BTAF1%25252FTAF1L%252BBromodomains%26aulast%3DBouch%25C3%25A9%26aufirst%3DL%25C3%25A9a%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D24022017%26date%3D01052017%26date%3D11052017%26date%3D12042017%26volume%3D60%26issue%3D9%26spage%3D4002%26epage%3D4022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip G.  Humphreys</span>, <span class="hlFld-ContribAuthor ">Paul  Bamborough</span>, <span class="hlFld-ContribAuthor ">Chun-wa  Chung</span>, <span class="hlFld-ContribAuthor ">Peter D.  Craggs</span>, <span class="hlFld-ContribAuthor ">Laurie  Gordon</span>, <span class="hlFld-ContribAuthor ">Paola  Grandi</span>, <span class="hlFld-ContribAuthor ">Thomas G.  Hayhow</span>, <span class="hlFld-ContribAuthor ">Jameed  Hussain</span>, <span class="hlFld-ContribAuthor ">Katherine L.  Jones</span>, <span class="hlFld-ContribAuthor ">Matthew  Lindon</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Michon</span>, <span class="hlFld-ContribAuthor ">Jessica F.  Renaux</span>, <span class="hlFld-ContribAuthor ">Colin J.  Suckling</span>, <span class="hlFld-ContribAuthor ">David F.  Tough</span>, and <span class="hlFld-ContribAuthor ">Rab K.  Prinjha</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (2)
                                     , 695-709. <a href="https://doi.org/10.1021/acs.jmedchem.6b01566" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01566</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01566%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%25252C%252BCell%252BPenetrant%25252C%252Band%252BSelective%252Bp300%25252FCBP-Associated%252BFactor%252B%252528PCAF%252529%25252FGeneral%252BControl%252BNonderepressible%252B5%252B%252528GCN5%252529%252BBromodomain%252BChemical%252BProbe%26aulast%3DHumphreys%26aufirst%3DPhilip%2BG.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D27102016%26date%3D09012017%26date%3D26012017%26date%3D21122016%26volume%3D60%26issue%3D2%26spage%3D695%26epage%3D709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alvina I.  Khamidullina</span>, <span class="hlFld-ContribAuthor ">Ekaterina A.  Varlamova</span>, <span class="hlFld-ContribAuthor ">Nour Alhuda  Hammoud</span>, <span class="hlFld-ContribAuthor ">Margarita A.  Yastrebova</span>, <span class="hlFld-ContribAuthor ">Alexandra V.  Bruter</span>. </span><span class="cited-content_cbyCitation_article-title">Gene Transcription as a Therapeutic Target in Leukemia. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (14)
                                     , 7340. <a href="https://doi.org/10.3390/ijms22147340" title="DOI URL">https://doi.org/10.3390/ijms22147340</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22147340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22147340%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DGene%252BTranscription%252Bas%252Ba%252BTherapeutic%252BTarget%252Bin%252BLeukemia%26aulast%3DKhamidullina%26aufirst%3DAlvina%2BI.%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D14%26spage%3D7340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raghu  Vannam</span>, <span class="hlFld-ContribAuthor ">Jan  Sayilgan</span>, <span class="hlFld-ContribAuthor ">Samuel  Ojeda</span>, <span class="hlFld-ContribAuthor ">Barbara  Karakyriakou</span>, <span class="hlFld-ContribAuthor ">Eileen  Hu</span>, <span class="hlFld-ContribAuthor ">Johannes  Kreuzer</span>, <span class="hlFld-ContribAuthor ">Robert  Morris</span>, <span class="hlFld-ContribAuthor ">Xcanda Ixchel  Herrera Lopez</span>, <span class="hlFld-ContribAuthor ">Sumit  Rai</span>, <span class="hlFld-ContribAuthor ">Wilhelm  Haas</span>, <span class="hlFld-ContribAuthor ">Michael  Lawrence</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Ott</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted degradation of the enhancer lysine acetyltransferases CBP and p300. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2021,</strong> <em>28 </em>
                                    (4)
                                     , 503-514.e12. <a href="https://doi.org/10.1016/j.chembiol.2020.12.004" title="DOI URL">https://doi.org/10.1016/j.chembiol.2020.12.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2020.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2020.12.004%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DTargeted%252Bdegradation%252Bof%252Bthe%252Benhancer%252Blysine%252Bacetyltransferases%252BCBP%252Band%252Bp300%26aulast%3DVannam%26aufirst%3DRaghu%26date%3D2021%26volume%3D28%26issue%3D4%26spage%3D503%26epage%3D514.e12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.L.  Wu</span>, <span class="hlFld-ContribAuthor ">J.  Zhao</span>, <span class="hlFld-ContribAuthor ">H.B.  Sun</span>, <span class="hlFld-ContribAuthor ">H.Y.  Li</span>, <span class="hlFld-ContribAuthor ">Y.Y.  Yin</span>, <span class="hlFld-ContribAuthor ">L.L.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into interaction mechanism of inhibitors E3T, E3H and E3B with CREB binding protein by using molecular dynamics simulations and MM-GBSA calculations. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2021,</strong> <em>32 </em>
                                    (3)
                                     , 221-246. <a href="https://doi.org/10.1080/1062936X.2021.1887351" title="DOI URL">https://doi.org/10.1080/1062936X.2021.1887351</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2021.1887351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2021.1887351%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DInsights%252Binto%252Binteraction%252Bmechanism%252Bof%252Binhibitors%252BE3T%25252C%252BE3H%252Band%252BE3B%252Bwith%252BCREB%252Bbinding%252Bprotein%252Bby%252Busing%252Bmolecular%252Bdynamics%252Bsimulations%252Band%252BMM-GBSA%252Bcalculations%26aulast%3DWu%26aufirst%3DS.L.%26date%3D2021%26date%3D2021%26volume%3D32%26issue%3D3%26spage%3D221%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Jose  Barrero</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting YY1 in cancer through histone acetylation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 211-223. <a href="https://doi.org/10.1016/B978-0-12-821909-6.00008-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-821909-6.00008-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-821909-6.00008-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-821909-6.00008-0%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BYY1%252Bin%252Bcancer%252Bthrough%252Bhistone%252Bacetylation%26aulast%3DBarrero%26aufirst%3DMaria%2BJose%26date%3D2021%26spage%3D211%26epage%3D223%26pub%3DElsevier%26atitle%3DYY1%252Bin%252Bthe%252BControl%252Bof%252Bthe%252BPathogenesis%252Band%252BDrug%252BResistance%252Bof%252BCancer%26date%3D2021%26volume%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhang-Xu  He</span>, <span class="hlFld-ContribAuthor ">Bing-Fei  Wei</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yun-Peng  Gong</span>, <span class="hlFld-ContribAuthor ">Li-Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Wen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Current development of CBP/p300 inhibitors in the last decade. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112861. <a href="https://doi.org/10.1016/j.ejmech.2020.112861" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112861</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112861%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCurrent%252Bdevelopment%252Bof%252BCBP%25252Fp300%252Binhibitors%252Bin%252Bthe%252Blast%252Bdecade%26aulast%3DHe%26aufirst%3DZhang-Xu%26date%3D2021%26volume%3D209%26spage%3D112861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saamanthi  M</span>, <span class="hlFld-ContribAuthor ">Aruna  S</span>, <span class="hlFld-ContribAuthor ">Girija  R</span>, <span class="hlFld-ContribAuthor ">D.  Vinod</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis novel Pyrazolopyridine derivatives and CREBBP bromodomain inhibitors docking and molecular dynamics. </span><span class="cited-content_cbyCitation_journal-name">Materials Today: Proceedings</span><span> <strong>2021,</strong> <em>45 </em>, 7200-7207. <a href="https://doi.org/10.1016/j.matpr.2021.02.416" title="DOI URL">https://doi.org/10.1016/j.matpr.2021.02.416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.matpr.2021.02.416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.matpr.2021.02.416%26sid%3Dliteratum%253Aachs%26jtitle%3DMaterials%2520Today%253A%2520Proceedings%26atitle%3DDesign%25252C%252Bsynthesis%252Bnovel%252BPyrazolopyridine%252Bderivatives%252Band%252BCREBBP%252Bbromodomain%252Binhibitors%252Bdocking%252Band%252Bmolecular%252Bdynamics%26aulast%3DM%26aufirst%3DSaamanthi%26date%3D2021%26volume%3D45%26spage%3D7200%26epage%3D7207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noortje  van Gils</span>, <span class="hlFld-ContribAuthor ">Tania  Martiañez Canales</span>, <span class="hlFld-ContribAuthor ">Eline  Vermue</span>, <span class="hlFld-ContribAuthor ">Arjo  Rutten</span>, <span class="hlFld-ContribAuthor ">Fedor  Denkers</span>, <span class="hlFld-ContribAuthor ">Tiem  van der Deure</span>, <span class="hlFld-ContribAuthor ">Gert J.  Ossenkoppele</span>, <span class="hlFld-ContribAuthor ">Francis  Giles</span>, <span class="hlFld-ContribAuthor ">Linda  Smit</span>. </span><span class="cited-content_cbyCitation_article-title">The Novel Oral BET-CBP/p300 Dual Inhibitor NEO2734 Is Highly Effective in Eradicating Acute Myeloid Leukemia Blasts and Stem/Progenitor Cells. </span><span class="cited-content_cbyCitation_journal-name">HemaSphere</span><span> <strong>2021,</strong> <em>5 </em>
                                    (8)
                                     , e610. <a href="https://doi.org/10.1097/HS9.0000000000000610" title="DOI URL">https://doi.org/10.1097/HS9.0000000000000610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/HS9.0000000000000610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FHS9.0000000000000610%26sid%3Dliteratum%253Aachs%26jtitle%3DHemaSphere%26atitle%3DThe%252BNovel%252BOral%252BBET-CBP%25252Fp300%252BDual%252BInhibitor%252BNEO2734%252BIs%252BHighly%252BEffective%252Bin%252BEradicating%252BAcute%252BMyeloid%252BLeukemia%252BBlasts%252Band%252BStem%25252FProgenitor%252BCells%26aulast%3Dvan%2BGils%26aufirst%3DNoortje%26date%3D2021%26date%3D2021%26volume%3D5%26issue%3D8%26spage%3De610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyang  Bi</span>, <span class="hlFld-ContribAuthor ">Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Zhongya  Sun</span>, <span class="hlFld-ContribAuthor ">Wenchao  Lu</span>, <span class="hlFld-ContribAuthor ">Pan  Xu</span>, <span class="hlFld-ContribAuthor ">Tian  Lu</span>, <span class="hlFld-ContribAuthor ">Hong  Ding</span>, <span class="hlFld-ContribAuthor ">Naixia  Zhang</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>, <span class="hlFld-ContribAuthor ">Bing  Zhou</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based drug optimization and biological evaluation of tetrahydroquinolin derivatives as selective and potent CBP bromodomain inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (22)
                                     , 127480. <a href="https://doi.org/10.1016/j.bmcl.2020.127480" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127480</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127480%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Bdrug%252Boptimization%252Band%252Bbiological%252Bevaluation%252Bof%252Btetrahydroquinolin%252Bderivatives%252Bas%252Bselective%252Band%252Bpotent%252BCBP%252Bbromodomain%252Binhibitors%26aulast%3DBi%26aufirst%3DXiaoyang%26date%3D2020%26volume%3D30%26issue%3D22%26spage%3D127480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Xiong</span>, <span class="hlFld-ContribAuthor ">Mingming  Zhang</span>, <span class="hlFld-ContribAuthor ">Yingxia  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Development of CBP/p300 Bromodomain Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (33)
                                     , 5583-5598. <a href="https://doi.org/10.2174/0929867326666190731141055" title="DOI URL">https://doi.org/10.2174/0929867326666190731141055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867326666190731141055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867326666190731141055%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BDevelopment%252Bof%252BCBP%25252Fp300%252BBromodomain%252BInhibitors%26aulast%3DXiong%26aufirst%3DYing%26date%3D2020%26volume%3D27%26issue%3D33%26spage%3D5583%26epage%3D5598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Lin</span>, <span class="hlFld-ContribAuthor ">Juan I.  Luengo</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting binding-site arginines in drug design: Recent examples. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (19)
                                     , 127442. <a href="https://doi.org/10.1016/j.bmcl.2020.127442" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127442</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127442%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DExploiting%252Bbinding-site%252Barginines%252Bin%252Bdrug%252Bdesign%25253A%252BRecent%252Bexamples%26aulast%3DLin%26aufirst%3DHong%26date%3D2020%26volume%3D30%26issue%3D19%26spage%3D127442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Filippo  Spriano</span>, <span class="hlFld-ContribAuthor ">Eugenio  Gaudio</span>, <span class="hlFld-ContribAuthor ">Luciano  Cascione</span>, <span class="hlFld-ContribAuthor ">Chiara  Tarantelli</span>, <span class="hlFld-ContribAuthor ">Federica  Melle</span>, <span class="hlFld-ContribAuthor ">Giovanna  Motta</span>, <span class="hlFld-ContribAuthor ">Valdemar  Priebe</span>, <span class="hlFld-ContribAuthor ">Andrea  Rinaldi</span>, <span class="hlFld-ContribAuthor ">Gaetanina  Golino</span>, <span class="hlFld-ContribAuthor ">Afua Adjeiwaa  Mensah</span>, <span class="hlFld-ContribAuthor ">Luca  Aresu</span>, <span class="hlFld-ContribAuthor ">Emanuele  Zucca</span>, <span class="hlFld-ContribAuthor ">Stefano  Pileri</span>, <span class="hlFld-ContribAuthor ">Michael  Witcher</span>, <span class="hlFld-ContribAuthor ">Bill  Brown</span>, <span class="hlFld-ContribAuthor ">Claes  Wahlestedt</span>, <span class="hlFld-ContribAuthor ">Francis  Giles</span>, <span class="hlFld-ContribAuthor ">Anastasios  Stathis</span>, <span class="hlFld-ContribAuthor ">Francesco  Bertoni</span>. </span><span class="cited-content_cbyCitation_article-title">Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734. </span><span class="cited-content_cbyCitation_journal-name">Blood Advances</span><span> <strong>2020,</strong> <em>4 </em>
                                    (17)
                                     , 4124-4135. <a href="https://doi.org/10.1182/bloodadvances.2020001879" title="DOI URL">https://doi.org/10.1182/bloodadvances.2020001879</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/bloodadvances.2020001879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fbloodadvances.2020001879%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%2520Advances%26atitle%3DAntitumor%252Bactivity%252Bof%252Bthe%252Bdual%252BBET%252Band%252BCBP%25252FEP300%252Binhibitor%252BNEO2734%26aulast%3DSpriano%26aufirst%3DFilippo%26date%3D2020%26date%3D2020%26volume%3D4%26issue%3D17%26spage%3D4124%26epage%3D4135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoyang  Bi</span>, <span class="hlFld-ContribAuthor ">Fengcai  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhongya  Sun</span>, <span class="hlFld-ContribAuthor ">Pan  Xu</span>, <span class="hlFld-ContribAuthor ">Hao  Jiang</span>, <span class="hlFld-ContribAuthor ">Wenchao  Lu</span>, <span class="hlFld-ContribAuthor ">Tian  Lu</span>, <span class="hlFld-ContribAuthor ">Hong  Ding</span>, <span class="hlFld-ContribAuthor ">Naixia  Zhang</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>, <span class="hlFld-ContribAuthor ">Bing  Zhou</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of tetrahydroquinolin derivatives as potent inhibitors of CBP bromodomain. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>101 </em>, 103991. <a href="https://doi.org/10.1016/j.bioorg.2020.103991" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103991</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103991%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Btetrahydroquinolin%252Bderivatives%252Bas%252Bpotent%252Binhibitors%252Bof%252BCBP%252Bbromodomain%26aulast%3DChen%26aufirst%3DYu%26date%3D2020%26volume%3D101%26spage%3D103991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandra  Cipriano</span>, <span class="hlFld-ContribAuthor ">Gianluca  Sbardella</span>, <span class="hlFld-ContribAuthor ">Alessio  Ciulli</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting epigenetic reader domains by chemical biology. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2020,</strong> <em>57 </em>, 82-94. <a href="https://doi.org/10.1016/j.cbpa.2020.05.006" title="DOI URL">https://doi.org/10.1016/j.cbpa.2020.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2020.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2020.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DTargeting%252Bepigenetic%252Breader%252Bdomains%252Bby%252Bchemical%252Bbiology%26aulast%3DCipriano%26aufirst%3DAlessandra%26date%3D2020%26volume%3D57%26spage%3D82%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng-cai  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhong-ya  Sun</span>, <span class="hlFld-ContribAuthor ">Li-ping  Liao</span>, <span class="hlFld-ContribAuthor ">Yu  Zuo</span>, <span class="hlFld-ContribAuthor ">Dan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jun  Wang</span>, <span class="hlFld-ContribAuthor ">Yan-tao  Chen</span>, <span class="hlFld-ContribAuthor ">Sen-hao  Xiao</span>, <span class="hlFld-ContribAuthor ">Hao  Jiang</span>, <span class="hlFld-ContribAuthor ">Tian  Lu</span>, <span class="hlFld-ContribAuthor ">Pan  Xu</span>, <span class="hlFld-ContribAuthor ">Li-yan  Yue</span>, <span class="hlFld-ContribAuthor ">Dao-hai  Du</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Chuan-peng  Liu</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2020,</strong> <em>41 </em>
                                    (2)
                                     , 286-292. <a href="https://doi.org/10.1038/s41401-019-0256-2" title="DOI URL">https://doi.org/10.1038/s41401-019-0256-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-019-0256-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-019-0256-2%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DDiscovery%252Bof%252Bnovel%252BCBP%252Bbromodomain%252Binhibitors%252Bthrough%252BTR-FRET-based%252Bhigh-throughput%252Bscreening%26aulast%3DZhang%26aufirst%3DFeng-cai%26date%3D2020%26date%3D2019%26volume%3D41%26issue%3D2%26spage%3D286%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea G.  Cochran</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Conery</span>, <span class="hlFld-ContribAuthor ">Robert J.  Sims</span>. </span><span class="cited-content_cbyCitation_article-title">Bromodomains: a new target class for drug development. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2019,</strong> <em>18 </em>
                                    (8)
                                     , 609-628. <a href="https://doi.org/10.1038/s41573-019-0030-7" title="DOI URL">https://doi.org/10.1038/s41573-019-0030-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-019-0030-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-019-0030-7%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DBromodomains%25253A%252Ba%252Bnew%252Btarget%252Bclass%252Bfor%2525C2%2525A0drug%252Bdevelopment%26aulast%3DCochran%26aufirst%3DAndrea%2BG.%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D8%26spage%3D609%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy R.  Bishop</span>, <span class="hlFld-ContribAuthor ">Yuxiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Michael A.  Erb</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological Modulation of Transcriptional Coregulators in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2019,</strong> <em>40 </em>
                                    (6)
                                     , 388-402. <a href="https://doi.org/10.1016/j.tips.2019.04.004" title="DOI URL">https://doi.org/10.1016/j.tips.2019.04.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2019.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2019.04.004%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DPharmacological%252BModulation%252Bof%252BTranscriptional%252BCoregulators%252Bin%252BCancer%26aulast%3DBishop%26aufirst%3DTimothy%2BR.%26date%3D2019%26volume%3D40%26issue%3D6%26spage%3D388%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iqra  Muneer</span>, <span class="hlFld-ContribAuthor ">Muhammad T.  ul Qamar</span>, <span class="hlFld-ContribAuthor ">Kishver  Tusleem</span>, <span class="hlFld-ContribAuthor ">Sadaf  Abdul Rauf</span>, <span class="hlFld-ContribAuthor ">Hafiz M.J.  Hussain</span>, <span class="hlFld-ContribAuthor ">Abdul R.  Siddiqi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of selective inhibitors for cyclic AMP response element-binding protein. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Drugs</span><span> <strong>2019,</strong> <em>30 </em>
                                    (4)
                                     , 363-373. <a href="https://doi.org/10.1097/CAD.0000000000000727" title="DOI URL">https://doi.org/10.1097/CAD.0000000000000727</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/CAD.0000000000000727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FCAD.0000000000000727%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Drugs%26atitle%3DDiscovery%252Bof%252Bselective%252Binhibitors%252Bfor%252Bcyclic%252BAMP%252Bresponse%252Belement-binding%252Bprotein%26aulast%3DMuneer%26aufirst%3DIqra%26date%3D2019%26volume%3D30%26issue%3D4%26spage%3D363%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veronica  Garcia-Carpizo</span>, <span class="hlFld-ContribAuthor ">Sergio  Ruiz-Llorente</span>, <span class="hlFld-ContribAuthor ">Jacinto  Sarmentero</span>, <span class="hlFld-ContribAuthor ">Ana  González-Corpas</span>, <span class="hlFld-ContribAuthor ">Maria J.  Barrero</span>. </span><span class="cited-content_cbyCitation_article-title">CREBBP/EP300 Bromodomain Inhibition Affects the Proliferation of AR-Positive Breast Cancer Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Research</span><span> <strong>2019,</strong> <em>17 </em>
                                    (3)
                                     , 720-730. <a href="https://doi.org/10.1158/1541-7786.MCR-18-0719" title="DOI URL">https://doi.org/10.1158/1541-7786.MCR-18-0719</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1541-7786.MCR-18-0719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1541-7786.MCR-18-0719%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Research%26atitle%3DCREBBP%25252FEP300%252BBromodomain%252BInhibition%252BAffects%252Bthe%252BProliferation%252Bof%252BAR-Positive%252BBreast%252BCancer%252BCell%252BLines%26aulast%3DGarcia-Carpizo%26aufirst%3DVeronica%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D3%26spage%3D720%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A.  Clegg</span>, <span class="hlFld-ContribAuthor ">Nicholas C. O.  Tomkinson</span>, <span class="hlFld-ContribAuthor ">Rab K.  Prinjha</span>, <span class="hlFld-ContribAuthor ">Philip G.  Humphreys</span>. </span><span class="cited-content_cbyCitation_article-title">Advancements in the Development of non‐BET Bromodomain Chemical Probes. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (4)
                                     , 362-385. <a href="https://doi.org/10.1002/cmdc.201800738" title="DOI URL">https://doi.org/10.1002/cmdc.201800738</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800738%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DAdvancements%252Bin%252Bthe%252BDevelopment%252Bof%252Bnon%2525E2%252580%252590BET%252BBromodomain%252BChemical%252BProbes%26aulast%3DClegg%26aufirst%3DMichael%2BA.%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D4%26spage%3D362%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianluca  Sbardella</span>. </span><span class="cited-content_cbyCitation_article-title">Histone Acetyltransferases: Targets and Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 297-345. <a href="https://doi.org/10.1002/9783527809257.ch12" title="DOI URL">https://doi.org/10.1002/9783527809257.ch12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527809257.ch12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527809257.ch12%26sid%3Dliteratum%253Aachs%26atitle%3DHistone%252BAcetyltransferases%25253A%252BTargets%252Band%252BInhibitors%26aulast%3DSbardella%26aufirst%3DGianluca%26date%3D2019%26date%3D2019%26spage%3D297%26epage%3D345%26pub%3DWiley%26atitle%3DEpigenetic%252BDrug%252BDiscovery%26aulast%3DSippl%26aufirst%3DWolfgang%26date%3D2019%26date%3D2019%26volume%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy  Donner</span>, <span class="hlFld-ContribAuthor ">Heather  King</span>, <span class="hlFld-ContribAuthor ">Paul E.  Brennan</span>, <span class="hlFld-ContribAuthor ">Moses  Moustakim</span>, <span class="hlFld-ContribAuthor ">William J.  Zuercher</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Probes. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 133-152. <a href="https://doi.org/10.1002/9783527809257.ch6" title="DOI URL">https://doi.org/10.1002/9783527809257.ch6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527809257.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527809257.ch6%26sid%3Dliteratum%253Aachs%26atitle%3DChemical%252BProbes%26aulast%3DDonner%26aufirst%3DAmy%26date%3D2019%26date%3D2019%26spage%3D133%26epage%3D152%26pub%3DWiley%26atitle%3DEpigenetic%252BDrug%252BDiscovery%26aulast%3DSippl%26aufirst%3DWolfgang%26date%3D2019%26date%3D2019%26volume%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William C. K.  Pomerantz</span>, <span class="hlFld-ContribAuthor ">Jorden A.  Johnson</span>, <span class="hlFld-ContribAuthor ">Peter D.  Ycas</span>. </span><span class="cited-content_cbyCitation_article-title">Applied Biophysics for Bromodomain Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 287-337. <a href="https://doi.org/10.1007/7355_2019_79" title="DOI URL">https://doi.org/10.1007/7355_2019_79</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2019_79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2019_79%26sid%3Dliteratum%253Aachs%26atitle%3DApplied%252BBiophysics%252Bfor%252BBromodomain%252BDrug%252BDiscovery%26aulast%3DPomerantz%26aufirst%3DWilliam%2BC.%2BK.%26date%3D2019%26date%3D2019%26spage%3D287%26epage%3D337%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DChemical%252BEpigenetics%26aulast%3DMai%26aufirst%3DAntonello%26date%3D2020%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veronica  Garcia-Carpizo</span>, <span class="hlFld-ContribAuthor ">Sergio  Ruiz-Llorente</span>, <span class="hlFld-ContribAuthor ">Jacinto  Sarmentero</span>, <span class="hlFld-ContribAuthor ">Osvaldo  Graña-Castro</span>, <span class="hlFld-ContribAuthor ">David G.  Pisano</span>, <span class="hlFld-ContribAuthor ">Maria J.  Barrero</span>. </span><span class="cited-content_cbyCitation_article-title">CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation. </span><span class="cited-content_cbyCitation_journal-name">Epigenetics & Chromatin</span><span> <strong>2018,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13072-018-0197-x" title="DOI URL">https://doi.org/10.1186/s13072-018-0197-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13072-018-0197-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13072-018-0197-x%26sid%3Dliteratum%253Aachs%26jtitle%3DEpigenetics%2520%2526%2520Chromatin%26atitle%3DCREBBP%25252FEP300%252Bbromodomains%252Bare%252Bcritical%252Bto%252Bsustain%252Bthe%252BGATA1%25252FMYC%252Bregulatory%252Baxis%252Bin%252Bproliferation%26aulast%3DGarcia-Carpizo%26aufirst%3DVeronica%26date%3D2018%26date%3D2018%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meghan E  Breen</span>, <span class="hlFld-ContribAuthor ">Anna K  Mapp</span>. </span><span class="cited-content_cbyCitation_article-title">Modulating the masters: chemical tools to dissect CBP and p300 function. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2018,</strong> <em>45 </em>, 195-203. <a href="https://doi.org/10.1016/j.cbpa.2018.06.005" title="DOI URL">https://doi.org/10.1016/j.cbpa.2018.06.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2018.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2018.06.005%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DModulating%252Bthe%252Bmasters%25253A%252Bchemical%252Btools%252Bto%252Bdissect%252BCBP%252Band%252Bp300%252Bfunction%26aulast%3DBreen%26aufirst%3DMeghan%2BE%26date%3D2018%26volume%3D45%26spage%3D195%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Zhu</span>, <span class="hlFld-ContribAuthor ">Chunxian  Zhou</span>, <span class="hlFld-ContribAuthor ">Amedeo  Caflisch</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based discovery of selective BRPF1 bromodomain inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>155 </em>, 337-352. <a href="https://doi.org/10.1016/j.ejmech.2018.05.037" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.05.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.05.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.05.037%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdiscovery%252Bof%252Bselective%252BBRPF1%252Bbromodomain%252Binhibitors%26aulast%3DZhu%26aufirst%3DJian%26date%3D2018%26volume%3D155%26spage%3D337%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiuping  Xiang</span>, <span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoqian  Xue</span>, <span class="hlFld-ContribAuthor ">Ming  Song</span>, <span class="hlFld-ContribAuthor ">Cheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Chenchang  Li</span>, <span class="hlFld-ContribAuthor ">Chun  Wu</span>, <span class="hlFld-ContribAuthor ">Kuai  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Hui</span>, <span class="hlFld-ContribAuthor ">Yulai  Zhou</span>, <span class="hlFld-ContribAuthor ">Jeff B.  Smaill</span>, <span class="hlFld-ContribAuthor ">Adam V.  Patterson</span>, <span class="hlFld-ContribAuthor ">Donghai  Wu</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>, <span class="hlFld-ContribAuthor ">Yong  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of 1-(1 H -indol-1-yl)ethanone derivatives as CBP/EP300 bromodomain inhibitors for the treatment of castration-resistant prostate cancer. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>147 </em>, 238-252. <a href="https://doi.org/10.1016/j.ejmech.2018.01.087" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.01.087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.01.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.01.087%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252B1-%2525281%252BH%252B-indol-1-yl%252529ethanone%252Bderivatives%252Bas%252BCBP%25252FEP300%252Bbromodomain%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bcastration-resistant%252Bprostate%252Bcancer%26aulast%3DXiang%26aufirst%3DQiuping%26date%3D2018%26volume%3D147%26spage%3D238%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue-Song  Wang</span>, <span class="hlFld-ContribAuthor ">Qing-Chuan  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Theoretical research in structure characteristics of different inhibitors and differences of binding modes with CBP bromodomain. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (3)
                                     , 712-720. <a href="https://doi.org/10.1016/j.bmc.2017.12.040" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.12.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.12.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.12.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DTheoretical%252Bresearch%252Bin%252Bstructure%252Bcharacteristics%252Bof%252Bdifferent%252Binhibitors%252Band%252Bdifferences%252Bof%252Bbinding%252Bmodes%252Bwith%252BCBP%252Bbromodomain%26aulast%3DWang%26aufirst%3DXue-Song%26date%3D2018%26volume%3D26%26issue%3D3%26spage%3D712%26epage%3D720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kwong Wah  Lai</span>, <span class="hlFld-ContribAuthor ">F. Anthony  Romero</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Maureen H.  Beresini</span>, <span class="hlFld-ContribAuthor ">Gladys  de Leon Boenig</span>, <span class="hlFld-ContribAuthor ">Sarah M.  Bronner</span>, <span class="hlFld-ContribAuthor ">Kevin  Chen</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Chen</span>, <span class="hlFld-ContribAuthor ">Edna F.  Choo</span>, <span class="hlFld-ContribAuthor ">Terry D.  Crawford</span>, <span class="hlFld-ContribAuthor ">Patrick  Cyr</span>, <span class="hlFld-ContribAuthor ">Susan  Kaufman</span>, <span class="hlFld-ContribAuthor ">Yingjie  Li</span>, <span class="hlFld-ContribAuthor ">Jiangpeng  Liao</span>, <span class="hlFld-ContribAuthor ">Wenfeng  Liu</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Weichao  Shen</span>, <span class="hlFld-ContribAuthor ">John  Wai</span>, <span class="hlFld-ContribAuthor ">Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Caicai  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Steven  Magnuson</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of a biaryl series as inhibitors for the bromodomains of CBP/P300. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (1)
                                     , 15-23. <a href="https://doi.org/10.1016/j.bmcl.2017.11.025" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.11.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.11.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.11.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Ba%252Bbiaryl%252Bseries%252Bas%252Binhibitors%252Bfor%252Bthe%252Bbromodomains%252Bof%252BCBP%25252FP300%26aulast%3DLai%26aufirst%3DKwong%2BWah%26date%3D2018%26volume%3D28%26issue%3D1%26spage%3D15%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bianca  Wiedemann</span>, <span class="hlFld-ContribAuthor ">Jörn  Weisner</span>, <span class="hlFld-ContribAuthor ">Daniel  Rauh</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical modulation of transcription factors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (8)
                                     , 1249-1272. <a href="https://doi.org/10.1039/C8MD00273H" title="DOI URL">https://doi.org/10.1039/C8MD00273H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8MD00273H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8MD00273H%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DChemical%252Bmodulation%252Bof%252Btranscription%252Bfactors%26aulast%3DWiedemann%26aufirst%3DBianca%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D8%26spage%3D1249%26epage%3D1272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qianqian  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoli  An</span>, <span class="hlFld-ContribAuthor ">Jiahui  Xu</span>, <span class="hlFld-ContribAuthor ">Yuwei  Wang</span>, <span class="hlFld-ContribAuthor ">Liang  Liu</span>, <span class="hlFld-ContribAuthor ">Elaine Lai-Han  Leung</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Classical molecular dynamics and metadynamics simulations decipher the mechanism of CBP30 selectively inhibiting CBP/p300 bromodomains. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (35)
                                     , 6521-6530. <a href="https://doi.org/10.1039/C8OB01526K" title="DOI URL">https://doi.org/10.1039/C8OB01526K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB01526K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB01526K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DClassical%252Bmolecular%252Bdynamics%252Band%252Bmetadynamics%252Bsimulations%252Bdecipher%252Bthe%252Bmechanism%252Bof%252BCBP30%252Bselectively%252Binhibiting%252BCBP%25252Fp300%252Bbromodomains%26aulast%3DWang%26aufirst%3DQianqian%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D35%26spage%3D6521%26epage%3D6530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingyan  Jin</span>, <span class="hlFld-ContribAuthor ">Jesse  Garcia</span>, <span class="hlFld-ContribAuthor ">Emily  Chan</span>, <span class="hlFld-ContribAuthor ">Cecile  de la Cruz</span>, <span class="hlFld-ContribAuthor ">Ehud  Segal</span>, <span class="hlFld-ContribAuthor ">Mark  Merchant</span>, <span class="hlFld-ContribAuthor ">Samir  Kharbanda</span>, <span class="hlFld-ContribAuthor ">Ryan  Raisner</span>, <span class="hlFld-ContribAuthor ">Peter M.  Haverty</span>, <span class="hlFld-ContribAuthor ">Zora  Modrusan</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Edna  Choo</span>, <span class="hlFld-ContribAuthor ">Susan  Kaufman</span>, <span class="hlFld-ContribAuthor ">Maureen H.  Beresini</span>, <span class="hlFld-ContribAuthor ">F. Anthony  Romero</span>, <span class="hlFld-ContribAuthor ">Steven  Magnuson</span>, <span class="hlFld-ContribAuthor ">Karen E.  Gascoigne</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2017,</strong> <em>77 </em>
                                    (20)
                                     , 5564-5575. <a href="https://doi.org/10.1158/0008-5472.CAN-17-0314" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-17-0314</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-17-0314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-17-0314%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DTherapeutic%252BTargeting%252Bof%252Bthe%252BCBP%25252Fp300%252BBromodomain%252BBlocks%252Bthe%252BGrowth%252Bof%252BCastration-Resistant%252BProstate%252BCancer%26aulast%3DJin%26aufirst%3DLingyan%26date%3D2017%26date%3D2017%26volume%3D77%26issue%3D20%26spage%3D5564%26epage%3D5575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Barrero</span>. </span><span class="cited-content_cbyCitation_article-title">Epigenetic Strategies to Boost Cancer Immunotherapies. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2017,</strong> <em>18 </em>
                                    (6)
                                     , 1108. <a href="https://doi.org/10.3390/ijms18061108" title="DOI URL">https://doi.org/10.3390/ijms18061108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms18061108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms18061108%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DEpigenetic%252BStrategies%252Bto%252BBoost%252BCancer%252BImmunotherapies%26aulast%3DBarrero%26aufirst%3DMaria%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D6%26spage%3D1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dimitrios  Spiliotopoulos</span>, <span class="hlFld-ContribAuthor ">Jian  Zhu</span>, <span class="hlFld-ContribAuthor ">Eike-Christian  Wamhoff</span>, <span class="hlFld-ContribAuthor ">Nicholas  Deerain</span>, <span class="hlFld-ContribAuthor ">Jean-Rémy  Marchand</span>, <span class="hlFld-ContribAuthor ">Jonas  Aretz</span>, <span class="hlFld-ContribAuthor ">Christoph  Rademacher</span>, <span class="hlFld-ContribAuthor ">Amedeo  Caflisch</span>. </span><span class="cited-content_cbyCitation_article-title">Virtual screen to NMR (VS2NMR): Discovery of fragment hits for the CBP bromodomain. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (11)
                                     , 2472-2478. <a href="https://doi.org/10.1016/j.bmcl.2017.04.001" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.04.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.04.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DVirtual%252Bscreen%252Bto%252BNMR%252B%252528VS2NMR%252529%25253A%252BDiscovery%252Bof%252Bfragment%252Bhits%252Bfor%252Bthe%252BCBP%252Bbromodomain%26aulast%3DSpiliotopoulos%26aufirst%3DDimitrios%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D2472%26epage%3D2478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0027.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. CBP and the first bromodomain of the bromodomain-containing protein 4 [BRD4(1)] time-resolved fluorescence resonance energy transfer (TR-FRET) biochemical IC<sub>50</sub>s, CBP bioluminescence resonance energy transfer (BRET), cellular IC<sub>50</sub>s, and MYC cellular EC<sub>50</sub>s for selected CBP bromodomain inhibitors reported in the literature. Data shown in this figure were determined using assay protocols reported in this paper. All values are reported as means of values from at least two determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) CBP-selective screening hit <b>7</b>. (B) Co-crystal structure of <b>7</b> and the CBP bromodomain (1.38 Å resolution; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTU">5KTU</a>). Residues engaging in important contacts between the ligand and receptor are shown in stick representation. Water molecules are shown as small red spheres. (C) Compound <b>7</b> placed into the BRD4(1) binding site by overlay of the BRD4(1) complex structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MXF">3MXF</a>) and the complex structure shown in B. Only ligand <b>7</b> and the BRD4(1) protein are shown. BRD4 Trp81 is shown in stick representation (bottom right). (D) The solvent accessible surface of the CBP bromodomain colored to highlight hydrophobicity and charge where hydrocarbon groups without polar substitutions are yellow, negatively charged oxygens of glutamate and aspartate are red, nitrogens of positively charged functional groups of lysine and arginine are blue, and all remaining atoms including the polar backbone is white. Bound ligand <b>7</b> is shown in stick representation (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. A co-crystal structure of <b>44</b> and the CBP bromodomain (1.09 Å resolution, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTW">5KTW</a>) displaying important contacts between the ligand and receptor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Properties of <b>59</b>. <sup><i>a</i></sup>All IC<sub>50</sub> values are reported as means of values from at least two determinations. <sup><i>b</i></sup>MDCK cell line; apical-to-basolateral; units = × 10<sup>–6</sup> cm s<sup>–1</sup>. <sup><i>c</i></sup>Mouse plasma protein binding. <sup><i>d</i></sup>Mouse liver microsome-predicted hepatic clearance. <sup><i>e</i></sup>Mouse hepatocyte-predicted hepatic clearance. <sup><i>f</i></sup>Compounds were dosed iv (1 mg kg<sup>–1</sup>) as PEG400/H<sub>2</sub>O (35/65) solution and po (100 mg kg<sup>–1</sup>) as an aqueous suspension with 0.5% methylcellulose and 0.2% Tween 80.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0006.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) A co-crystal structure of <b>59</b> in the CBP bromodomain (1.23 Å resolution, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTX">5KTX</a>) displaying important contacts between the ligand and receptor. (B) A co-crystal structure of <b>59</b> in the BRD4(1) (1.14 Å resolution, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KU3">5KU3</a>) displaying important contacts between the ligand and receptor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0007.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vitro evaluation of <b>59</b>. (A) The indicated cell lines were treated for 4 h with 5 μM <b>59</b> or DMSO control. <i>MYC</i> expression was then determined by RT-PCR. Data represents mean ± standard deviation (SD). <i>N</i> = 4. (B) MOLM-16 AML cells were treated for 4 h with the indicated concentrations of <b>59</b> or DMSO control. <i>MYC</i> expression was then determined by RT-PCR and Western blot. (C) MOLM-16 AML cells were treated for 4 h with 5 μM <b>59</b> or DMSO control. Expression of the indicated oncogenes was then determined by RT-PCR. Data represent mean ± SD <i>N</i> = 4. (D) The indicated cell lines were treated with a dose range of <b>59</b>. After 6 days, cell viability was measured by CellTiter-Glo. Plot shows absolute IC<sub>50</sub> in μM. Data represent mean ± SD <i>N</i> = 3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0008.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In vivo evaluation of <b>59</b>. (A) Effect on <i>MYC</i> transcript levels with single doses of <b>59</b> in MOLM-16 tumor-bearing animals (<i>n</i> = 3/group; mean ± SEM plotted). Plasma and tumor levels were adjusted for PPB, and mean plasma and tumor unbound drug levels (±SD) are displayed. Displayed are the <i>MYC</i> EC<sub>90</sub> (green) and BRD4 IC<sub>50</sub> (red) for <b>59</b>. (B) Antitumor efficacy of <b>59</b> in a MOLM-16 AML xenograft study and effect on body weight (<i>n</i> = 8/group; mean ± SEM plotted).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Substituted Aryl Analogues <b>8</b>–<b>20</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KO<i>t</i>Bu, THF, rt; (b) CH<sub>3</sub>I, 40 °C; (c) hydrazine monohydrate, EtOH, 85 °C, 5–44% from <b>60</b>.</p></p></figure><figure data-id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Analogues <b>21</b>–<b>25</b> Exploring the KAc Binding Site</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-isothiocyanato-3-methylbenzene, KOtBu, THF, rt; (b) CH<sub>3</sub>I, 40 °C, 100%; (c) hydrazine monohydrate, EtOH, 80 °C, 91%; (d) HCl/EtOAc, rt, 83%; (e) propionic acid or butyric acid or cyclopropanecarboxylic acid, HATU, TEA, DMF, rt, 37–43%; (f) CH<sub>3</sub>SO<sub>2</sub>Cl or trifluoroacetic anhydride, TEA, DCM, rt, 38%.</p></p></figure><figure data-id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Analogues <b>26</b>–<b>38</b> Exploring the ZA Loop Region</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) alkyl halide, CsCO<sub>3</sub> or K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 11–37%; (b) acrylonitrile, DBU, MeCN, rt, 16%; (c) cyclopropylhydrazine, TEA, EtOH, 80 °C; (d) HCl/EtOAc, rt; (e) acetic anhydride, TEA, DMF, rt, 5% from <b>66</b>.</p></p></figure><figure data-id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Analogues Amides <b>39</b>–<b>44</b> That Explore the LPF Shelf</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (bromomethyl)cyclopropane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C; (b) KOH, MeOH/H<sub>2</sub>O, rt; (c) Amine, DIEA, HATU, DMF, 35 °C, 11–35% from <b>16</b>.</p></p></figure><figure data-id="sch5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0013.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Aryl Analogues <b>45</b>–<b>54</b> Exploring the LPF Shelf</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (bromomethyl)cyclopropane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 47–49%; (b) Ar-B(OH)<sub>2</sub>, dioxane/water, Na<sub>2</sub>CO<sub>3</sub>, Pd(dppf)Cl<sub>2</sub>, 110 °C, 17–48%; (c) 2-(tributylstannyl)pyridine, Pd(PPh<sub>3</sub>)<sub>4</sub>, toluene, 120 °C, 31%.</p></p></figure><figure data-id="sch6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0014.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Analogues <b>55</b>–<b>58</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole, dioxane/water, Na<sub>2</sub>CO<sub>3</sub>, Pd(dppf)Cl<sub>2</sub>, 110 °C, 65%; (b) MeI, 3-iodooxetane, (<i>R</i>)-tetrahydrofuran-3-yl methanesulfonate or (<i>S</i>)-tetrahydrofuran-3-yl methanesulfonate CsCO<sub>3</sub>, DMF, 80 °C, 4–26%.</p></p></figure><figure data-id="sch7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/medium/jm-2016-010224_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0015.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of in Vivo Probe <b>59</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-23/acs.jmedchem.6b01022/20161202/images/large/jm-2016-010224_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01022&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-bromo-2-fluoro-1-isothiocyanato-benzene, KOtBu, THF, rt; (b) CH<sub>3</sub>I, 40 °C, 51%; (c) hydrazine monohydrate, EtOH, 85 °C, 96%; (d) 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole, dioxane/water, Na<sub>2</sub>CO<sub>3</sub>, Pd(dppf)Cl<sub>2</sub>, 100 °C, 63%; (e) (<i>R</i>)-tetrahydrofuran-3-yl methanesulfonate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 °C, 42%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60251" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 27 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Romero, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span> </span><span class="NLM_article-title">Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1271</span><span class="NLM_x">–</span> <span class="NLM_lpage">1298</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01514</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01514" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVeqsr%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1271-1298&author=F.+A.+Romeroauthor=A.+M.+Taylorauthor=T.+D.+Crawfordauthor=V.+Tsuiauthor=A.+C%C3%B4t%C3%A9author=S.+Magnuson&title=Disrupting+Acetyl-Lysine+Recognition%3A+Progress+in+the+Development+of+Bromodomain+Inhibitors&doi=10.1021%2Facs.jmedchem.5b01514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors</span></div><div class="casAuthors">Romero, F. Anthony; Taylor, Alexander M.; Crawford, Terry D.; Tsui, Vickie; Cote, Alexandre; Magnuson, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1271-1298</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains, small protein modules that recognize acetylated lysine on histones, play a significant role in the epigenome, where they function as "readers" that ultimately det. the functional outcome of the post-translational modification.  Because the initial discovery of selective BET inhibitors have helped define the role of that protein family in oncol. and inflammation, BET bromodomains have continued to garner the most attention of any other bromodomain.  More recently, non-BET bromodomain inhibitors that are potent and selective have been disclosed for ATAD2, CBP, BRD7/9, BRPF, BRPF/TRIM24, CECR2, SMARCA4, and BAZ2A/B.  Such novel inhibitors can be used to probe the physiol. function of these non-BET bromodomains and further understanding of their role in certain disease states.  Here, we provide an update to the progress in identifying selective bromodomain inhibitors and their use as biol. tools, as well as our perspective on the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgbRrKGlHaVLVg90H21EOLACvtfcHk0lhuyeujJTJGUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVeqsr%252FO&md5=260352f61301aa88aad48c0b63e6152f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01514%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DCrawford%26aufirst%3DT.%2BD.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DDisrupting%2520Acetyl-Lysine%2520Recognition%253A%2520Progress%2520in%2520the%2520Development%2520of%2520Bromodomain%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1271%26epage%3D1298%26doi%3D10.1021%2Facs.jmedchem.5b01514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Theodoulou, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomkinson, N. C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, P. G.</span><span> </span><span class="NLM_article-title">Progress in the Development of Non-BET Bromodomain Chemical Probes</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">487</span><span class="refDoi"> DOI: 10.1002/cmdc.201500540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1002%2Fcmdc.201500540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=26749027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1ehtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=477-487&author=N.+H.+Theodoulouauthor=N.+C.+O.+Tomkinsonauthor=R.+K.+Prinjhaauthor=P.+G.+Humphreys&title=Progress+in+the+Development+of+Non-BET+Bromodomain+Chemical+Probes&doi=10.1002%2Fcmdc.201500540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the Development of non-BET Bromodomain Chemical Probes</span></div><div class="casAuthors">Theodoulou, Natalie H.; Tomkinson, Nicholas C. O.; Prinjha, Rab K.; Humphreys, Philip G.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">477-487</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The bromodomain and extra terminal (BET) family of bromodomains have been the focus of extensive research, leading to the development of many potent, selective chem. probes and recent clin. assets.  The profound biol. assocd. with BET bromodomain inhibition has provided a convincing rationale for targeting bromodomains for the treatment of disease.  However, the BET family represents just eight of the at least 56 human bromodomains identified to date.  Until recently, there has been significantly less interest in non-BET bromodomains, leaving a vast area of research and the majority of this new target class yet to be thoroughly investigated.  It has been widely reported that several non-BET bromodomain contg. proteins are assocd. with various diseases including cancer and HIV.  Therefore, the development of chem. probes for non-BET bromodomains will facilitate elucidation of their precise biol. roles and potentially lead to the development of new medicines.  This review summarises the progress made towards the development of non-BET bromodomain chem. probes to date.  In addn., we highlight the potential for future work in this new and exciting area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYLj_VyHOS5bVg90H21EOLACvtfcHk0lhJIjikXDg7pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1ehtA%253D%253D&md5=1e1339bf09a10bde8621c18344172fa6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500540%26sid%3Dliteratum%253Aachs%26aulast%3DTheodoulou%26aufirst%3DN.%2BH.%26aulast%3DTomkinson%26aufirst%3DN.%2BC.%2BO.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DHumphreys%26aufirst%3DP.%2BG.%26atitle%3DProgress%2520in%2520the%2520Development%2520of%2520Non-BET%2520Bromodomain%2520Chemical%2520Probes%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D477%26epage%3D487%26doi%3D10.1002%2Fcmdc.201500540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantone, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Leon Boenig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conery, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, O. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawadzke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochran, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637)</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC28Xkt1Cms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=531-536&author=A.+M.+Taylorauthor=A.+C%C3%B4t%C3%A9author=M.+C.+Hewittauthor=R.+Pastorauthor=Y.+Leblancauthor=C.+G.+Nasveschukauthor=F.+A.+Romeroauthor=T.+D.+Crawfordauthor=N.+Cantoneauthor=H.+Jayaramauthor=J.+Setserauthor=J.+Murrayauthor=M.+H.+Beresiniauthor=G.+de+Leon+Boenigauthor=Z.+Chenauthor=A.+R.+Coneryauthor=R.+T.+Cummingsauthor=L.+A.+Dakinauthor=E.+M.+Flynnauthor=O.+W.+Huangauthor=S.+Kaufmanauthor=P.+J.+Kellerauthor=J.+R.+Kieferauthor=T.+Laiauthor=Y.+Liauthor=J.+Liaoauthor=W.+Liuauthor=H.+Luauthor=E.+Pardoauthor=V.+Tsuiauthor=J.+Wangauthor=Y.+Wangauthor=Z.+Xuauthor=F.+Yanauthor=D.+Yuauthor=L.+Zawadzkeauthor=X.+Zhuauthor=X.+Zhuauthor=R.+J.+Simsauthor=A.+G.+Cochranauthor=S.+Bellonauthor=J.+E.+Audiaauthor=S.+Magnusonauthor=B.+K.+Albrecht&title=Fragment-Based+Discovery+of+a+Selective+and+Cell-Active+Benzodiazepinone+CBP%2FEP300+Bromodomain+Inhibitor+%28CPI-637%29&doi=10.1021%2Facsmedchemlett.6b00075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637)</span></div><div class="casAuthors">Taylor, Alexander M.; Cote, Alexandre; Hewitt, Michael C.; Pastor, Richard; Leblanc, Yves; Nasveschuk, Christopher G.; Romero, F. Anthony; Crawford, Terry D.; Cantone, Nico; Jayaram, Hariharan; Setser, Jeremy; Murray, Jeremy; Beresini, Maureen H.; de Leon Boenig, Gladys; Chen, Zhongguo; Conery, Andrew R.; Cummings, Richard T.; Dakin, Leslie A.; Flynn, E. Megan; Huang, Oscar W.; Kaufman, Susan; Keller, Patricia J.; Kiefer, James R.; Lai, Tommy; Li, Yingjie; Liao, Jiangpeng; Liu, Wenfeng; Lu, Henry; Pardo, Eneida; Tsui, Vickie; Wang, Jian; Wang, Yongyun; Xu, Zhaowu; Yan, Fen; Yu, Dong; Zawadzke, Laura; Zhu, Xiaoqin; Zhu, Xiaoyu; Sims, Robert J.; Cochran, Andrea G.; Bellon, Steve; Audia, James E.; Magnuson, Steven; Albrecht, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">531-536</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benzo-fused heterocycles, particularly benzodiazepinones such as I, were prepd. as inhibitors of the bromodomain-contg. proteins CBP (CREB, cAMP response element binding protein) and EP300 (adenoviral E1A-binding protein of 300 kDa) for potential use as antitumor agents; the core benzodiazepinone moiety was identified using fragment-based screening.  The structures of four benzodiazepinones, including I, bound to the bromodomain fragment of human CREB were detd. by X-ray crystallog.  The free energy, enthalpy, and entropy of the binding of I to CREB and its selectivity for CREB and EP300 over other bromodomain-contg. proteins was detd.; I inhibited expression of the transcription factor MYC in human plasmacytoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNm7Blycl0-7Vg90H21EOLACvtfcHk0lhJIjikXDg7pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xkt1Cms7c%253D&md5=8440a9bb3460ff66d43f15041dbbc19d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00075%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DPastor%26aufirst%3DR.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DCrawford%26aufirst%3DT.%2BD.%26aulast%3DCantone%26aufirst%3DN.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DSetser%26aufirst%3DJ.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DBeresini%26aufirst%3DM.%2BH.%26aulast%3Dde%2BLeon%2BBoenig%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DConery%26aufirst%3DA.%2BR.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DFlynn%26aufirst%3DE.%2BM.%26aulast%3DHuang%26aufirst%3DO.%2BW.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DKeller%26aufirst%3DP.%2BJ.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLai%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DZawadzke%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DCochran%26aufirst%3DA.%2BG.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DFragment-Based%2520Discovery%2520of%2520a%2520Selective%2520and%2520Cell-Active%2520Benzodiazepinone%2520CBP%252FEP300%2520Bromodomain%2520Inhibitor%2520%2528CPI-637%2529%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D531%26epage%3D536%26doi%3D10.1021%2Facsmedchemlett.6b00075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Crawford, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresini, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakin, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplessis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Good, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawadzke, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochran, A. G.</span><span> </span><span class="NLM_article-title">Diving Into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">5391</span><span class="NLM_x">–</span> <span class="NLM_lpage">5402</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00264</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00264" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC28XosFSnsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5391-5402&author=T.+D.+Crawfordauthor=V.+Tsuiauthor=E.+M.+Flynnauthor=S.+Wangauthor=A.+M.+Taylorauthor=A.+C%C3%B4t%C3%A9author=J.+E.+Audiaauthor=M.+H.+Beresiniauthor=D.+J.+Burdickauthor=R.+T.+Cummingsauthor=L.+A.+Dakinauthor=M.+Duplessisauthor=A.+C.+Goodauthor=M.+C.+Hewittauthor=H.-R.+Huangauthor=H.+Jayaramauthor=J.+R.+Kieferauthor=Y.+Jiangauthor=J.+M.+Murrayauthor=C.+G.+Nasveschukauthor=E.+Pardoauthor=F.+Poyauthor=F.+A.+Romeroauthor=Y.+Tangauthor=J.+Wangauthor=Z.+Xuauthor=L.+E.+Zawadzkeauthor=X.+Zhuauthor=B.+K.+Albrechtauthor=S.+R.+Magnusonauthor=S.+F.+Bellonauthor=A.+G.+Cochran&title=Diving+Into+the+Water%3A+Inducible+Binding+Conformations+for+BRD4%2C+TAF1%282%29%2C+BRD9%2C+and+CECR2+Bromodomains&doi=10.1021%2Facs.jmedchem.6b00264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains</span></div><div class="casAuthors">Crawford, Terry D.; Tsui, Vickie; Flynn, E. Megan; Wang, Shumei; Taylor, Alexander M.; Cote, Alexandre; Audia, James E.; Beresini, Maureen H.; Burdick, Daniel J.; Cummings, Richard; Dakin, Les A.; Duplessis, Martin; Good, Andrew C.; Hewitt, Michael C.; Huang, Hon-Ren; Jayaram, Hariharan; Kiefer, James R.; Jiang, Ying; Murray, Jeremy; Nasveschuk, Christopher G.; Pardo, Eneida; Poy, Florence; Romero, F. Anthony; Tang, Yong; Wang, Jian; Xu, Zhaowu; Zawadzke, Laura E.; Zhu, Xiaoyu; Albrecht, Brian K.; Magnuson, Steven R.; Bellon, Steve; Cochran, Andrea G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5391-5402</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The biol. role played by non-BET bromodomains remains poorly understood, and it is therefore imperative to identify potent and highly selective inhibitors to effectively explore the biol. of individual bromodomain proteins.  A ligand-efficient nonselective bromodomain inhibitor was identified from a 6-Me pyrrolopyridone fragment.  Small hydrophobic substituents replacing the N-Me group were designed directing toward the conserved bromodomain water pocket, and two distinct binding conformations were then obsd.  The substituents either directly displaced and rearranged the conserved solvent network, as in BRD4(1) and TAF1(2), or induced a narrow hydrophobic channel adjacent to the lipophilic shelf, as in BRD9 and CECR2.  The preference of distinct substituents for individual bromodomains provided selectivity handles useful for future lead optimization efforts for selective BRD9, CECR2, and TAF1(2) inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTLnuVCIKdHbVg90H21EOLACvtfcHk0lgyGg0zspuZgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosFSnsbs%253D&md5=bf92e94c5fd3ee36bd8441294ca85185</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00264%26sid%3Dliteratum%253Aachs%26aulast%3DCrawford%26aufirst%3DT.%2BD.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DFlynn%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBeresini%26aufirst%3DM.%2BH.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DDuplessis%26aufirst%3DM.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DHuang%26aufirst%3DH.-R.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZawadzke%26aufirst%3DL.%2BE.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DMagnuson%26aufirst%3DS.%2BR.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DCochran%26aufirst%3DA.%2BG.%26atitle%3DDiving%2520Into%2520the%2520Water%253A%2520Inducible%2520Binding%2520Conformations%2520for%2520BRD4%252C%2520TAF1%25282%2529%252C%2520BRD9%252C%2520and%2520CECR2%2520Bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5391%26epage%3D5402%26doi%3D10.1021%2Facs.jmedchem.6b00264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Delvecchio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaucher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar-Gurrieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panne, D.</span><span> </span><span class="NLM_article-title">Structure of the P300 Catalytic Core and Implications for Chromatin Targeting and HAT Regulation</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1040</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span><span class="refDoi"> DOI: 10.1038/nsmb.2642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1038%2Fnsmb.2642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=23934153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Cgtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1040-1046&author=M.+Delvecchioauthor=J.+Gaucherauthor=C.+Aguilar-Gurrieriauthor=E.+Ortegaauthor=D.+Panne&title=Structure+of+the+P300+Catalytic+Core+and+Implications+for+Chromatin+Targeting+and+HAT+Regulation&doi=10.1038%2Fnsmb.2642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation</span></div><div class="casAuthors">Delvecchio, Manuela; Gaucher, Jonathan; Aguilar-Gurrieri, Carmen; Ortega, Esther; Panne, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1040-1046</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">CBP and p300 are histone acetyltransferases (HATs) that assoc. with and acetylate transcriptional regulators and chromatin.  Mutations in their catalytic 'cores' are linked to genetic disorders, including cancer.  Here we present the 2.8-Å crystal structure of the catalytic core of human p300 contg. its bromodomain, CH2 region and HAT domain.  The structure reveals that the CH2 region contains a discontinuous PHD domain interrupted by a RING domain.  The bromodomain, PHD, RING and HAT domains adopt an assembled configuration with the RING domain positioned over the HAT substrate-binding pocket.  Disease mutations that disrupt RING attachment led to upregulation of HAT activity, thus revealing an inhibitory role for this domain.  The structure provides a starting point for understanding how chromatin-substrate targeting and HAT regulation are coupled and why mutations in the p300 core lead to dysregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlYehjRwdhJ7Vg90H21EOLACvtfcHk0lgyGg0zspuZgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Cgtr3J&md5=e9352198d513eac6fd93fc2896828d09</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2642%26sid%3Dliteratum%253Aachs%26aulast%3DDelvecchio%26aufirst%3DM.%26aulast%3DGaucher%26aufirst%3DJ.%26aulast%3DAguilar-Gurrieri%26aufirst%3DC.%26aulast%3DOrtega%26aufirst%3DE.%26aulast%3DPanne%26aufirst%3DD.%26atitle%3DStructure%2520of%2520the%2520P300%2520Catalytic%2520Core%2520and%2520Implications%2520for%2520Chromatin%2520Targeting%2520and%2520HAT%2520Regulation%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D1040%26epage%3D1046%26doi%3D10.1038%2Fnsmb.2642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Mujtaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachchidanand</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeleznik-Le, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span> </span><span class="NLM_article-title">Structural Mechanism of the Bromodomain of the Coactivator CBP in P53 Transcriptional Activation</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span><span class="refDoi"> DOI: 10.1016/S1097-2765(03)00528-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1016%2FS1097-2765%2803%2900528-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=14759370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFOhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=251-263&author=S.+Mujtabaauthor=Y.+Heauthor=L.+Zengauthor=S.+Yanauthor=O.+Plotnikovaauthor=+Sachchidanandauthor=R.+Sanchezauthor=N.+J.+Zeleznik-Leauthor=Z.+Ronaiauthor=M.+M.+Zhou&title=Structural+Mechanism+of+the+Bromodomain+of+the+Coactivator+CBP+in+P53+Transcriptional+Activation&doi=10.1016%2FS1097-2765%2803%2900528-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation</span></div><div class="casAuthors">Mujtaba, Shiraz; He, Yan; Zeng, Lei; Yan, Sherry; Plotnikova, Olga; Sachchidanand; Sanchez, Roberto; Zeleznik-Le, Nancy J.; Ronai, Ze'ev; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-263</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Lysine acetylation of the tumor suppressor protein p53 in response to a wide variety of cellular stress signals is required for its activation as a transcription factor that regulates cell cycle arrest, senescence, or apoptosis.  Here, the authors report that the conserved bromodomain of the transcriptional coactivator CBP (CREB binding protein) binds specifically to p53 at the C-terminal acetylated lysine 382.  This bromodomain/acetyllysine binding is responsible for p53 acetylation-dependent coactivator recruitment after DNA damage, a step essential for p53-induced transcriptional activation of the cyclin-dependent kinase inhibitor p21 in G1 cell cycle arrest.  The authors further present the three-dimensional NMR structure of the CBP bromodomain in complex with a lysine 382-acetylated p53 peptide.  Using structural and biochem. analyses, the authors define the mol. determinants for the specificity of this mol. recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3g6bC53YUKbVg90H21EOLACvtfcHk0lgyGg0zspuZgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFOhsr0%253D&md5=10127e2d2ea5165fd8439bf26a6f9241</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900528-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900528-8%26sid%3Dliteratum%253Aachs%26aulast%3DMujtaba%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DSachchidanand%26aulast%3DSanchez%26aufirst%3DR.%26aulast%3DZeleznik-Le%26aufirst%3DN.%2BJ.%26aulast%3DRonai%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26atitle%3DStructural%2520Mechanism%2520of%2520the%2520Bromodomain%2520of%2520the%2520Coactivator%2520CBP%2520in%2520P53%2520Transcriptional%2520Activation%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D13%26spage%3D251%26epage%3D263%26doi%3D10.1016%2FS1097-2765%2803%2900528-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Ianculescu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegmund, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stallcup, M. R.</span><span> </span><span class="NLM_article-title">Selective Roles for cAMP Response Element-Binding Protein Binding Protein and P300 Protein as Coregulators for Androgen-Regulated Gene Expression in Advanced Prostate Cancer Cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">4000</span><span class="NLM_x">–</span> <span class="NLM_lpage">4013</span><span class="refDoi"> DOI: 10.1074/jbc.M111.300194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1074%2Fjbc.M111.300194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=22174411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=4000-4013&author=I.+Ianculescuauthor=D.+Y.+Wuauthor=K.+D.+Siegmundauthor=M.+R.+Stallcup&title=Selective+Roles+for+cAMP+Response+Element-Binding+Protein+Binding+Protein+and+P300+Protein+as+Coregulators+for+Androgen-Regulated+Gene+Expression+in+Advanced+Prostate+Cancer+Cells&doi=10.1074%2Fjbc.M111.300194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Roles for cAMP Response Element-binding Protein Binding Protein and p300 Protein as Coregulators for Androgen-regulated Gene Expression in Advanced Prostate Cancer Cells</span></div><div class="casAuthors">Ianculescu, Irina; Wu, Dai-Ying; Siegmund, Kimberly D.; Stallcup, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4000-4013</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The protein acetyltransferases p300 and cAMP response element-binding protein binding protein (CBP) are homologous, ubiquitously expressed proteins that interact with hundreds of proteins involved in transcriptional regulation and are involved globally as transcriptional coregulators.  Although these two proteins acetylate and interact with overlapping sets of proteins, we found that p300 and CBP contribute to androgen-induced regulation of distinct sets of genes in C4-2B prostate cancer cells, a model of advanced prostate cancer.  CBP cannot compensate for the loss of p300 to support androgen-induced expression of many genes, such as TMPRSS2 and PSA.  Global gene expression anal. indicated that 47% of androgen-regulated genes are p300-dependent in these cells, whereas, surprisingly, only 0.3% of them are CBP-dependent.  Chromatin immunopptn. anal. after depletion of cellular p300 indicated that p300 is required for androgen-induced acetylation of histones H3 and H4, methylation of histone H3 at Lys-4, and recruitment of TATA box binding protein (TBP) and RNA polymerase II, but not recruitment of the androgen receptor, on the TMPRSS2 gene in response to androgen.  Thus, p300 is the dominant coregulator of the CBP/p300 pair for androgen-regulated gene expression in C4-2B cells. p300 is required at an early stage of chromatin remodeling and transcription complex assembly after binding of androgen receptor to the gene but before many crit. histone modifications occur.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7uJfPL3B4h7Vg90H21EOLACvtfcHk0li8bdnzQWLPTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSjtLg%253D&md5=095ab7582da1b7602e2ab898caa5b094</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.300194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.300194%26sid%3Dliteratum%253Aachs%26aulast%3DIanculescu%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DD.%2BY.%26aulast%3DSiegmund%26aufirst%3DK.%2BD.%26aulast%3DStallcup%26aufirst%3DM.%2BR.%26atitle%3DSelective%2520Roles%2520for%2520cAMP%2520Response%2520Element-Binding%2520Protein%2520Binding%2520Protein%2520and%2520P300%2520Protein%2520as%2520Coregulators%2520for%2520Androgen-Regulated%2520Gene%2520Expression%2520in%2520Advanced%2520Prostate%2520Cancer%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D4000%26epage%3D4013%26doi%3D10.1074%2Fjbc.M111.300194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Iyer, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozdag, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldas, C.</span><span> </span><span class="NLM_article-title">P300/CBP and Cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4225</span><span class="NLM_x">–</span> <span class="NLM_lpage">4231</span><span class="refDoi"> DOI: 10.1038/sj.onc.1207118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1038%2Fsj.onc.1207118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=15156177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvVChtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=4225-4231&author=N.+G.+Iyerauthor=H.+Ozdagauthor=C.+Caldas&title=P300%2FCBP+and+Cancer&doi=10.1038%2Fsj.onc.1207118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">p300/CBP and cancer</span></div><div class="casAuthors">Iyer, Narayanan Gopalakrishna; Oezdag, Hilal; Caldas, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4225-4231</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  P300 and cAMP response element-binding protein (CBP) are adenoviral E1A-binding proteins involved in multiple cellular processes, and function as transcriptional co-factors and histone acetyltransferases.  Germline mutation of CBP results in Rubinstein-Taybi syndrome, which is characterized by an increased predisposition to childhood malignancies.  Furthermore, somatic mutations of p300 and CBP occur in a no. of malignancies.  Chromosome translocations target CBP and, less commonly, p300 in acute myeloid leukemia and treatment-related hematol. disorders.  P300 mutations in solid tumors result in truncated p300 protein products or amino-acid substitutions in crit. protein domains, and these are often assocd. with inactivation of the second allele.  A mouse model confirms that p300 and CBP function as suppressors of hematol. tumor formation.  The involvement of these proteins in crit. tumorigenic pathways (including TGF-β, p53 and Rb) provides a mechanistic route as to how their inactivation could result in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKGBLVLWLqkrVg90H21EOLACvtfcHk0li8bdnzQWLPTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvVChtrc%253D&md5=b68fe6bc258b06515c04a5207410f026</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207118%26sid%3Dliteratum%253Aachs%26aulast%3DIyer%26aufirst%3DN.%2BG.%26aulast%3DOzdag%26aufirst%3DH.%26aulast%3DCaldas%26aufirst%3DC.%26atitle%3DP300%252FCBP%2520and%2520Cancer%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D4225%26epage%3D4231%26doi%3D10.1038%2Fsj.onc.1207118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Faiola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lymar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, E.</span><span> </span><span class="NLM_article-title">Dual Regulation of C-Myc by P300 via Acetylation-Dependent Control of Myc Protein Turnover and Coactivation of Myc-Induced Transcription</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">10220</span><span class="NLM_x">–</span> <span class="NLM_lpage">10234</span><span class="refDoi"> DOI: 10.1128/MCB.25.23.10220-10234.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1128%2FMCB.25.23.10220-10234.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=16287840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Ons7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=10220-10234&author=F.+Faiolaauthor=X.+Liuauthor=S.+Loauthor=S.+Panauthor=K.+Zhangauthor=E.+Lymarauthor=A.+Farinaauthor=E.+Martinez&title=Dual+Regulation+of+C-Myc+by+P300+via+Acetylation-Dependent+Control+of+Myc+Protein+Turnover+and+Coactivation+of+Myc-Induced+Transcription&doi=10.1128%2FMCB.25.23.10220-10234.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription</span></div><div class="casAuthors">Faiola, Francesco; Liu, Xiaohui; Lo, Szuying; Pan, Songqin; Zhang, Kangling; Lymar, Elena; Farina, Anthony; Martinez, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10220-10234</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The c-Myc oncoprotein (Myc) controls cell fate by regulating gene transcription in assocn. with a DNA-binding partner, Max.  While Max lacks a transcription regulatory domain, the N-terminus of Myc contains a transcription activation domain (TAD) that recruits cofactor complexes contg. the histone acetyltransferases (HATs) GCN5 and Tip60.  Here, we report a novel functional interaction between Myc TAD and the p300 coactivator-acetyltransferase.  We show that p300 assocs. with Myc in mammalian cells and in vitro through direct interactions with Myc TAD residues 1 to 110 and acetylates Myc in a TAD-dependent manner in vivo at several lysine residues located between the TAD and DNA-binding domain.  Moreover, the Myc:Max complex is differentially acetylated by p300 and GCN5 and is not acetylated by Tip60 in vitro, suggesting distinct functions for these acetyltransferases.  Whereas p300 and CBP can stabilize Myc independently of acetylation, p300-mediated acetylation results in increased Myc turnover.  In addn., p300 functions as a coactivator that is recruited by Myc to the promoter of the human telomerase reverse transcriptase gene, and p300/CBP stimulates Myc TAD-dependent transcription in a HAT domain-dependent manner.  Our results suggest dual roles for p300/CBP in Myc regulation: as a Myc coactivator that stabilizes Myc and as an inducer of Myc instability via direct Myc acetylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4or2afHXuK7Vg90H21EOLACvtfcHk0ljCTaysGq3ebw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Ons7fL&md5=bbabfb64492444687f048ee59cdc0210</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1128%2FMCB.25.23.10220-10234.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.25.23.10220-10234.2005%26sid%3Dliteratum%253Aachs%26aulast%3DFaiola%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLo%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLymar%26aufirst%3DE.%26aulast%3DFarina%26aufirst%3DA.%26aulast%3DMartinez%26aufirst%3DE.%26atitle%3DDual%2520Regulation%2520of%2520C-Myc%2520by%2520P300%2520via%2520Acetylation-Dependent%2520Control%2520of%2520Myc%2520Protein%2520Turnover%2520and%2520Coactivation%2520of%2520Myc-Induced%2520Transcription%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D10220%26epage%3D10234%26doi%3D10.1128%2FMCB.25.23.10220-10234.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Conery, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Centore, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillane, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawadzke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bommi-Reddy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gascoigne, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibition of the Transcriptional Coactivators CBP/EP300 as a Therapeutic Strategy to Target the IRF4 Network in Multiple Myeloma</span> <span class="citation_source-journal">eLife</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e10483</span><span class="refDoi"> DOI: 10.7554/eLife.10483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.7554%2FeLife.10483" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=e10483&author=A.+R.+Coneryauthor=R.+C.+Centoreauthor=A.+Neissauthor=P.+J.+Kellerauthor=S.+Joshiauthor=K.+L.+Spillaneauthor=P.+Sandyauthor=C.+Hattonauthor=E.+Pardoauthor=L.+Zawadzkeauthor=A.+Bommi-Reddyauthor=K.+E.+Gascoigneauthor=B.+M.+Bryantauthor=J.+A.+Mertzauthor=R.+J.+Sims&title=Bromodomain+Inhibition+of+the+Transcriptional+Coactivators+CBP%2FEP300+as+a+Therapeutic+Strategy+to+Target+the+IRF4+Network+in+Multiple+Myeloma&doi=10.7554%2FeLife.10483"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.7554%2FeLife.10483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.10483%26sid%3Dliteratum%253Aachs%26aulast%3DConery%26aufirst%3DA.%2BR.%26aulast%3DCentore%26aufirst%3DR.%2BC.%26aulast%3DNeiss%26aufirst%3DA.%26aulast%3DKeller%26aufirst%3DP.%2BJ.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DSpillane%26aufirst%3DK.%2BL.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DHatton%26aufirst%3DC.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DZawadzke%26aufirst%3DL.%26aulast%3DBommi-Reddy%26aufirst%3DA.%26aulast%3DGascoigne%26aufirst%3DK.%2BE.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26atitle%3DBromodomain%2520Inhibition%2520of%2520the%2520Transcriptional%2520Coactivators%2520CBP%252FEP300%2520as%2520a%2520Therapeutic%2520Strategy%2520to%2520Target%2520the%2520IRF4%2520Network%2520in%2520Multiple%2520Myeloma%26jtitle%3DeLife%26date%3D2016%26volume%3D5%26spage%3De10483%26doi%3D10.7554%2FeLife.10483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conery, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmeron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakle, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mele, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setser, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatzivassiliou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAlmeida-Nagata, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochran, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawadzke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grogan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lora, J. M.</span><span> </span><span class="NLM_article-title">Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">291</span><span class="NLM_x">, </span> <span class="NLM_fpage">13014</span><span class="NLM_x">–</span> <span class="NLM_lpage">13027</span><span class="refDoi"> DOI: 10.1074/jbc.M115.708560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1074%2Fjbc.M115.708560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=27056325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSksL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=13014-13027&author=S.+Ghoshauthor=A.+Taylorauthor=M.+Chinauthor=H.-R.+Huangauthor=A.+R.+Coneryauthor=J.+A.+Mertzauthor=A.+Salmeronauthor=P.+J.+Dakleauthor=D.+Meleauthor=A.+C%C3%B4t%C3%A9author=H.+Jayaramauthor=J.+W.+Setserauthor=F.+Poyauthor=G.+Hatzivassiliouauthor=D.+DeAlmeida-Nagataauthor=P.+Sandyauthor=C.+Hattonauthor=F.+A.+Romeroauthor=E.+Chiangauthor=T.+Reimerauthor=T.+Crawfordauthor=E.+Pardoauthor=V.+G.+Watsonauthor=V.+Tsuiauthor=A.+G.+Cochranauthor=L.+Zawadzkeauthor=J.-C.+Harmangeauthor=J.+E.+Audiaauthor=B.+M.+Bryantauthor=R.+T.+Cummingsauthor=S.+R.+Magnusonauthor=J.+L.+Groganauthor=S.+F.+Bellonauthor=B.+K.+Albrechtauthor=R.+J.+Simsauthor=J.+M.+Lora&title=Regulatory+T+Cell+Modulation+by+CBP%2FEP300+Bromodomain+Inhibition&doi=10.1074%2Fjbc.M115.708560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition</span></div><div class="casAuthors">Ghosh, Srimoyee; Taylor, Alexander; Chin, Melissa; Huang, Hon-Ren; Conery, Andrew R.; Mertz, Jennifer A.; Salmeron, Andres; Dakle, Pranal J.; Mele, Deanna; Cote, Alexandre; Jayaram, Hari; Setser, Jeremy W.; Poy, Florence; Hatzivassiliou, Georgia; DeAlmeida-Nagata, Denise; Sandy, Peter; Hatton, Charlie; Romero, F. Anthony; Chiang, Eugene; Reimer, Thornik; Crawford, Terry; Pardo, Eneida; Watson, Venita G.; Tsui, Vickie; Cochran, Andrea G.; Zawadzke, Laura; Harmange, Jean-Christophe; Audia, James E.; Bryant, Barbara M.; Cummings, Richard T.; Magnuson, Steven R.; Grogan, Jane L.; Bellon, Steve F.; Albrecht, Brian K.; Sims, Robert J. III; Lora, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">13014-13027</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Covalent modification of histones is a fundamental mechanism of regulated gene expression in eukaryotes, and interpretation of histone modifications is an essential feature of epigenetic control.  Bromodomains are specialized binding modules that interact with acetylated histones, linking chromatin recognition to gene transcription.  Because of their ability to function in a domain-specific fashion, selective disruption of bromodomain:acetylated histone interactions with chem. probes serves as a powerful means for understanding biol. processes regulated by these chromatin adaptors.  Here the authors describe the discovery and characterization of potent and selective small mol. inhibitors for the bromodomains of CREBBP/EP300 that engage their target in cellular assays.  The authors use these tools to demonstrate a crit. role for CREBBP/EP300 bromodomains in regulatory T cell biol.  Because regulatory T cell recruitment to tumors is a major mechanism of immune evasion by cancer cells, the authors' data highlight the importance of CREBBP/EP300 bromodomain inhibition as a novel, small mol.-based approach for cancer immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9maWuQVImyLVg90H21EOLACvtfcHk0ljCTaysGq3ebw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSksL3F&md5=bc8b4edba81bdbef30b1d8fcfaa19f1e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.708560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.708560%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DA.%26aulast%3DChin%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DH.-R.%26aulast%3DConery%26aufirst%3DA.%2BR.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DSalmeron%26aufirst%3DA.%26aulast%3DDakle%26aufirst%3DP.%2BJ.%26aulast%3DMele%26aufirst%3DD.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DSetser%26aufirst%3DJ.%2BW.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DHatzivassiliou%26aufirst%3DG.%26aulast%3DDeAlmeida-Nagata%26aufirst%3DD.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DHatton%26aufirst%3DC.%26aulast%3DRomero%26aufirst%3DF.%2BA.%26aulast%3DChiang%26aufirst%3DE.%26aulast%3DReimer%26aufirst%3DT.%26aulast%3DCrawford%26aufirst%3DT.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DWatson%26aufirst%3DV.%2BG.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DCochran%26aufirst%3DA.%2BG.%26aulast%3DZawadzke%26aufirst%3DL.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DMagnuson%26aufirst%3DS.%2BR.%26aulast%3DGrogan%26aufirst%3DJ.%2BL.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DLora%26aufirst%3DJ.%2BM.%26atitle%3DRegulatory%2520T%2520Cell%2520Modulation%2520by%2520CBP%252FEP300%2520Bromodomain%2520Inhibition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D13014%26epage%3D13027%26doi%3D10.1074%2Fjbc.M115.708560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Chekler, E. L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegrino, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanz, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flick, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langille, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahasrabudhe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonin, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pletcher, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. H.</span><span> </span><span class="NLM_article-title">Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1588</span><span class="NLM_x">–</span> <span class="NLM_lpage">1596</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2015.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1016%2Fj.chembiol.2015.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=26670081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKis7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=1588-1596&author=E.+L.+P.+Cheklerauthor=J.+A.+Pellegrinoauthor=T.+A.+Lanzauthor=R.+A.+Dennyauthor=A.+C.+Flickauthor=J.+Coeauthor=J.+Langilleauthor=A.+Basakauthor=S.+Liuauthor=I.+A.+Stockauthor=P.+Sahasrabudheauthor=P.+D.+Boninauthor=K.+Leeauthor=M.+T.+Pletcherauthor=L.+H.+Jones&title=Transcriptional+Profiling+of+a+Selective+CREB+Binding+Protein+Bromodomain+Inhibitor+Highlights+Therapeutic+Opportunities&doi=10.1016%2Fj.chembiol.2015.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities</span></div><div class="casAuthors">Chekler, Eugene L. Piatnitski; Pellegrino, Jessica A.; Lanz, Thomas A.; Denny, R. Aldrin; Flick, Andrew C.; Coe, Jotham; Langille, Jonathan; Basak, Arindrajit; Liu, Shenping; Stock, Ingrid A.; Sahasrabudhe, Parag; Bonin, Paul D.; Lee, Kevin; Pletcher, Mathew T.; Jones, Lyn H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1588-1596</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Bromodomains are involved in transcriptional regulation through the recognition of acetyl lysine modifications on diverse proteins.  Selective pharmacol. modulators of bromodomains are lacking, although the largely hydrophobic nature of the pocket makes these modules attractive targets for small-mol. inhibitors.  This work describes the structure-based design of a highly selective inhibitor of the CREB binding protein (CBP) bromodomain and its use in cell-based transcriptional profiling expts.  The inhibitor downregulated a no. of inflammatory genes in macrophages that were not affected by a selective BET bromodomain inhibitor.  In addn., the CBP bromodomain inhibitor modulated the mRNA level of the regulator of G-protein signaling 4 (RGS4) gene in neurons, suggesting a potential therapeutic opportunity for CBP inhibitors in the treatment of neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLDeCJH-gX5LVg90H21EOLACvtfcHk0li3QEpWZ3kuaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKis7rE&md5=dc223d58c99b1994f0cdb15b734a5b21</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DChekler%26aufirst%3DE.%2BL.%2BP.%26aulast%3DPellegrino%26aufirst%3DJ.%2BA.%26aulast%3DLanz%26aufirst%3DT.%2BA.%26aulast%3DDenny%26aufirst%3DR.%2BA.%26aulast%3DFlick%26aufirst%3DA.%2BC.%26aulast%3DCoe%26aufirst%3DJ.%26aulast%3DLangille%26aufirst%3DJ.%26aulast%3DBasak%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DStock%26aufirst%3DI.%2BA.%26aulast%3DSahasrabudhe%26aufirst%3DP.%26aulast%3DBonin%26aufirst%3DP.%2BD.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DPletcher%26aufirst%3DM.%2BT.%26aulast%3DJones%26aufirst%3DL.%2BH.%26atitle%3DTranscriptional%2520Profiling%2520of%2520a%2520Selective%2520CREB%2520Binding%2520Protein%2520Bromodomain%2520Inhibitor%2520Highlights%2520Therapeutic%2520Opportunities%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D1588%26epage%3D1596%26doi%3D10.1016%2Fj.chembiol.2015.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Rooney, T. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortopassi, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paton, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-Π Interaction</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6126</span><span class="NLM_x">–</span> <span class="NLM_lpage">6130</span><span class="refDoi"> DOI: 10.1002/anie.201402750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1002%2Fanie.201402750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvFWgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=6126-6130&author=T.+P.+C.+Rooneyauthor=P.+Filippakopoulosauthor=O.+Fedorovauthor=S.+Picaudauthor=W.+A.+Cortopassiauthor=D.+A.+Hayauthor=S.+Martinauthor=A.+Tumberauthor=C.+M.+Rogersauthor=M.+Philpottauthor=M.+Wangauthor=A.+L.+Thompsonauthor=T.+D.+Heightmanauthor=D.+C.+Prydeauthor=A.+Cookauthor=R.+S.+Patonauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=P.+E.+Brennanauthor=S.+J.+Conway&title=A+Series+of+Potent+CREBBP+Bromodomain+Ligands+Reveals+an+Induced-Fit+Pocket+Stabilized+by+a+Cation-%CE%A0+Interaction&doi=10.1002%2Fanie.201402750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-π Interaction</span></div><div class="casAuthors">Rooney, Timothy P. C.; Filippakopoulos, Panagis; Fedorov, Oleg; Picaud, Sarah; Cortopassi, Wilian A.; Hay, Duncan A.; Martin, Sarah; Tumber, Anthony; Rogers, Catherine M.; Philpott, Martin; Wang, Minghua; Thompson, Amber L.; Heightman, Tom D.; Pryde, David C.; Cook, Andrew; Paton, Robert S.; Mueller, Susanne; Knapp, Stefan; Brennan, Paul E.; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6126-6130</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Benzoxazinone and dihydroquinoxalinone fragments were employed as novel acetyl lysine mimics in the development of CREBBP bromodomain ligands.  While the benzoxazinone series showed low affinity for the CREBBP bromodomain, expansion of the dihydroquinoxalinone series resulted in the first potent inhibitors, e.g., I, of a bromodomain outside the BET family.  Structural and computational studies revealed that an internal hydrogen bond stabilized the protein-bound conformation of the dihydroquinoxalinone series.  The side chain of this series binds in an induced-fit pocket forming a cation-π interaction with R1173 of CREBBP.  Compd. I, the most potent compd., inhibited binding of CREBBP to chromatin in U2OS cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHFgTVUKe7lrVg90H21EOLACvtfcHk0li3QEpWZ3kuaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvFWgsb0%253D&md5=42b12e1fe855d2af02c49f8e1031d39e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fanie.201402750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201402750%26sid%3Dliteratum%253Aachs%26aulast%3DRooney%26aufirst%3DT.%2BP.%2BC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DCortopassi%26aufirst%3DW.%2BA.%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DA.%2BL.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DCook%26aufirst%3DA.%26aulast%3DPaton%26aufirst%3DR.%2BS.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DA%2520Series%2520of%2520Potent%2520CREBBP%2520Bromodomain%2520Ligands%2520Reveals%2520an%2520Induced-Fit%2520Pocket%2520Stabilized%2520by%2520a%2520Cation-%25CE%25A0%2520Interaction%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D6126%26epage%3D6130%26doi%3D10.1002%2Fanie.201402750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yapp, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span> </span><span class="NLM_article-title">Discovery and Optimization of Small-Molecule Ligands for the CBP/P300 Bromodomains</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">9308</span><span class="NLM_x">–</span> <span class="NLM_lpage">9319</span><span class="refDoi"> DOI: 10.1021/ja412434f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja412434f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=9308-9319&author=D.+A.+Hayauthor=O.+Fedorovauthor=S.+Martinauthor=D.+C.+Singletonauthor=C.+Tallantauthor=C.+Wellsauthor=S.+Picaudauthor=M.+Philpottauthor=O.+P.+Monteiroauthor=C.+M.+Rogersauthor=S.+J.+Conwayauthor=T.+P.+C.+Rooneyauthor=A.+Tumberauthor=C.+Yappauthor=P.+Filippakopoulosauthor=M.+E.+Bunnageauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=C.+J.+Schofieldauthor=P.+E.+Brennan&title=Discovery+and+Optimization+of+Small-Molecule+Ligands+for+the+CBP%2FP300+Bromodomains&doi=10.1021%2Fja412434f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains</span></div><div class="casAuthors">Hay, Duncan A.; Fedorov, Oleg; Martin, Sarah; Singleton, Dean C.; Tallant, Cynthia; Wells, Christopher; Picaud, Sarah; Philpott, Martin; Monteiro, Octovia P.; Rogers, Catherine M.; Conway, Stuart J.; Rooney, Timothy P. C.; Tumber, Anthony; Yapp, Clarence; Filippakopoulos, Panagis; Bunnage, Mark E.; Muller, Susanne; Knapp, Stefan; Schofield, Christopher J.; Brennan, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9308-9319</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that target bromodomains outside of the bromodomain and extra-terminal (BET) sub-family are lacking.  Here, the authors describe highly potent and selective ligands for the bromodomain module of the human lysine acetyl transferase CBP/p300, developed from a series of 5-isoxazolyl-benzimidazoles.  The starting point was a fragment hit, which was optimized into a more potent and selective lead using parallel synthesis employing Suzuki couplings, benzimidazole-forming reactions, and reductive aminations.  The selectivity of the lead compd. against other bromodomain family members was investigated using a thermal stability assay, which revealed some inhibition of the structurally related BET family members.  To address the BET selectivity issue, x-ray crystal structures of the lead compd. bound to the CREB binding protein (CBP) and the first bromodomain of BRD4 (BRD4(1)) were used to guide the design of more selective compds.  The crystal structures obtained revealed two distinct binding modes.  By varying the aryl substitution pattern and developing conformationally constrained analogs, selectivity for CBP over BRD4(1) was increased.  The optimized compd. is highly potent (Kd = 21 nM) and selective, displaying 40-fold selectivity over BRD4(1).  Cellular activity was demonstrated using fluorescence recovery after photo-bleaching (FRAP) and a p53 reporter assay.  The optimized compds. are cell-active and have nanomolar affinity for CBP/p300; therefore, they should be useful in studies investigating the biol. roles of CBP and p300 and to validate the CBP and p300 bromodomains as therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFzgs1DD4QZLVg90H21EOLACvtfcHk0li3QEpWZ3kuaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsLvP&md5=e5da3e96a4d234453a481c7ee5e788f2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja412434f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja412434f%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DSingleton%26aufirst%3DD.%2BC.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMonteiro%26aufirst%3DO.%2BP.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DRooney%26aufirst%3DT.%2BP.%2BC.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520Small-Molecule%2520Ligands%2520for%2520the%2520CBP%252FP300%2520Bromodomains%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D9308%26epage%3D9319%26doi%3D10.1021%2Fja412434f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span>I-CBP112: A CREBBP/EP300-Selective Chemical Probe; <span class="NLM_publisher-name">SGC</span>: <span class="NLM_publisher-loc">Oxford, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/I-CBP112" class="extLink">http://www.thesgc.org/chemical-probes/I-CBP112</a> (accessed June 16, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=I-CBP112%3A+A+CREBBP%2FEP300-Selective+Chemical+Probe%3B+SGC%3A+Oxford%2C+UK%2C+2015%3B+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FI-CBP112+%28accessed+June+16%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DI-CBP112%253A%2520A%2520CREBBP%252FEP300-Selective%2520Chemical%2520Probe%26pub%3DSGC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Unzue, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiedmer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiliotopoulos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevado, C.</span><span> </span><span class="NLM_article-title">Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1350</span><span class="NLM_x">–</span> <span class="NLM_lpage">1356</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00172</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00172" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsFaktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1350-1356&author=A.+Unzueauthor=M.+Xuauthor=J.+Dongauthor=L.+Wiedmerauthor=D.+Spiliotopoulosauthor=A.+Caflischauthor=C.+Nevado&title=Fragment-Based+Design+of+Selective+Nanomolar+Ligands+of+the+CREBBP+Bromodomain&doi=10.1021%2Facs.jmedchem.5b00172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain</span></div><div class="casAuthors">Unzue, Andrea; Xu, Min; Dong, Jing; Wiedmer, Lars; Spiliotopoulos, Dimitrios; Caflisch, Amedeo; Nevado, Cristina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1350-1356</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel ligands of the CREBBP bromodomain were identified by fragment-based docking.  The in silico discovered hits have been optimized by chem. synthesis into selective nanomolar compds., thereby preserving the ligand efficiency.  The selectivity for the CREBBP bromodomain over other human bromodomain subfamilies has achieved by a benzoate moiety which was predicted by docking to be involved in favorable electrostatic interactions with the Arg1173 side chain, a prediction that could be verified a posteriori by the high-resoln. crystal structure of the CREBBP bromodomain in complex with ligand 6 and also by MD simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy4MHhgfhyu7Vg90H21EOLACvtfcHk0li46dBEm_9t-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsFaktLg%253D&md5=aff73b86b04fc4d7243adcba364ca6a6</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00172%26sid%3Dliteratum%253Aachs%26aulast%3DUnzue%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DWiedmer%26aufirst%3DL.%26aulast%3DSpiliotopoulos%26aufirst%3DD.%26aulast%3DCaflisch%26aufirst%3DA.%26aulast%3DNevado%26aufirst%3DC.%26atitle%3DFragment-Based%2520Design%2520of%2520Selective%2520Nanomolar%2520Ligands%2520of%2520the%2520CREBBP%2520Bromodomain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1350%26epage%3D1356%26doi%3D10.1021%2Facs.jmedchem.5b00172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thanasopoulou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonards, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olzscha, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yapp, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannister, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecellio, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Mahony, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velichko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Thangue, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Generation of a Selective Small Molecule Inhibitor of the CBP/P300 Bromodomain for Leukemia Therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">5106</span><span class="NLM_x">–</span> <span class="NLM_lpage">5119</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-15-0236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1158%2F0008-5472.CAN-15-0236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=26552700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFensrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=5106-5119&author=S.+Picaudauthor=O.+Fedorovauthor=A.+Thanasopoulouauthor=K.+Leonardsauthor=K.+Jonesauthor=J.+Meierauthor=H.+Olzschaauthor=O.+Monteiroauthor=S.+Martinauthor=M.+Philpottauthor=A.+Tumberauthor=P.+Filippakopoulosauthor=C.+Yappauthor=C.+Wellsauthor=K.+H.+Cheauthor=A.+Bannisterauthor=S.+Robsonauthor=U.+Kumarauthor=N.+Parrauthor=K.+Leeauthor=D.+Lugoauthor=P.+Jeffreyauthor=S.+Taylorauthor=M.+L.+Vecellioauthor=C.+Bountraauthor=P.+E.+Brennanauthor=A.+O%E2%80%99Mahonyauthor=S.+Velichkoauthor=S.+M%C3%BCllerauthor=D.+Hayauthor=D.+L.+Danielsauthor=M.+Urhauthor=N.+B.+La+Thangueauthor=T.+Kouzaridesauthor=R.+Prinjhaauthor=J.+Schwallerauthor=S.+Knapp&title=Generation+of+a+Selective+Small+Molecule+Inhibitor+of+the+CBP%2FP300+Bromodomain+for+Leukemia+Therapy&doi=10.1158%2F0008-5472.CAN-15-0236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy</span></div><div class="casAuthors">Picaud, Sarah; Fedorov, Oleg; Thanasopoulou, Angeliki; Leonards, Katharina; Jones, Katherine; Meier, Julia; Olzscha, Heidi; Monteiro, Octovia; Martin, Sarah; Philpott, Martin; Tumber, Anthony; Filippakopoulos, Panagis; Yapp, Clarence; Wells, Christopher; Che, Ka Hing; Bannister, Andrew; Robson, Samuel; Kumar, Umesh; Parr, Nigel; Lee, Kevin; Lugo, Dave; Jeffrey, Philip; Taylor, Simon; Vecellio, Matteo L.; Bountra, Chas; Brennan, Paul E.; O'Mahony, Alison; Velichko, Sharlene; Mueller, Susanne; Hay, Duncan; Daniels, Danette L.; Urh, Marjeta; La Thangue, Nicholas B.; Kouzarides, Tony; Prinjha, Rab; Schwaller, Juerg; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5106-5119</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The histone acetyltransferases CBP/p300 are involved in recurrent leukemia-assocd. chromosomal translocations and are key regulators of cell growth.  Therefore, efforts to generate inhibitors of CBP/p300 are of clin. value.  We developed a specific and potent acetyl-lysine competitive protein-protein interaction inhibitor, I-CBP112, that targets the CBP/p300 bromodomains.  Exposure of human and mouse leukemic cell lines to I-CBP112 resulted in substantially impaired colony formation and induced cellular differentiation without significant cytotoxicity.  I-CBP112 significantly reduced the leukemia-initiating potential of MLL-AF9+ acute myeloid leukemia cells in a dose-dependent manner in vitro and in vivo.  Interestingly, I-CBP112 increased the cytotoxic activity of BET bromodomain inhibitor JQ1 as well as doxorubicin.  Collectively, we report the development and preclin. evaluation of a novel, potent inhibitor targeting CBP/p300 bromodomains that impairs aberrant self-renewal of leukemic cells.  The synergistic effects of I-CBP112 and current std. therapy (doxorubicin) as well as emerging treatment strategies (BET inhibition) provide new opportunities for combinatorial treatment of leukemia and potentially other cancers.  Cancer Res; 75(23); 5106-19. ©2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWk5dMbmC6K7Vg90H21EOLACvtfcHk0li46dBEm_9t-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFensrzN&md5=da936fa34139ba27abc748db5f78c95e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-15-0236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-15-0236%26sid%3Dliteratum%253Aachs%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DThanasopoulou%26aufirst%3DA.%26aulast%3DLeonards%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DMeier%26aufirst%3DJ.%26aulast%3DOlzscha%26aufirst%3DH.%26aulast%3DMonteiro%26aufirst%3DO.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DChe%26aufirst%3DK.%2BH.%26aulast%3DBannister%26aufirst%3DA.%26aulast%3DRobson%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DU.%26aulast%3DParr%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DVecellio%26aufirst%3DM.%2BL.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DA.%26aulast%3DVelichko%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DHay%26aufirst%3DD.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DUrh%26aufirst%3DM.%26aulast%3DLa%2BThangue%26aufirst%3DN.%2BB.%26aulast%3DKouzarides%26aufirst%3DT.%26aulast%3DPrinjha%26aufirst%3DR.%26aulast%3DSchwaller%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DGeneration%2520of%2520a%2520Selective%2520Small%2520Molecule%2520Inhibitor%2520of%2520the%2520CBP%252FP300%2520Bromodomain%2520for%2520Leukemia%2520Therapy%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D5106%26epage%3D5119%26doi%3D10.1158%2F0008-5472.CAN-15-0236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hammitzsch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Mahony, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, F. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Mossawi, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Wit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecellio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wordsworth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowness, P.</span><span> </span><span class="NLM_article-title">CBP30, a Selective CBP/P300 Bromodomain Inhibitor, Suppresses Human Th17 Responses</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">10768</span><span class="NLM_x">–</span> <span class="NLM_lpage">10773</span><span class="refDoi"> DOI: 10.1073/pnas.1501956112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1073%2Fpnas.1501956112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=26261308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSit7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=10768-10773&author=A.+Hammitzschauthor=C.+Tallantauthor=O.+Fedorovauthor=A.+O%E2%80%99Mahonyauthor=P.+E.+Brennanauthor=D.+A.+Hayauthor=F.+O.+Martinezauthor=M.+H.+Al-Mossawiauthor=J.+de+Witauthor=M.+Vecellioauthor=C.+Wellsauthor=P.+Wordsworthauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=P.+Bowness&title=CBP30%2C+a+Selective+CBP%2FP300+Bromodomain+Inhibitor%2C+Suppresses+Human+Th17+Responses&doi=10.1073%2Fpnas.1501956112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses</span></div><div class="casAuthors">Hammitzsch, Ariane; Tallant, Cynthia; Fedorov, Oleg; O'Mahony, Alison; Brennan, Paul E.; Hay, Duncan A.; Martinez, Fernando O.; Al-Mossawi, M. Hussein; de Wit, Jelle; Vecellio, Matteo; Wells, Christopher; Wordsworth, Paul; Muller, Susanne; Knapp, Stefan; Bowness, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">10768-10773</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Th17 responses are crit. to a variety of human autoimmune diseases, and therapeutic targeting with monoclonal antibodies against IL-17 and IL-23 has shown considerable promise.  Here, the authors report data to support selective bromodomain blockade of the transcriptional coactivators CBP (CREB binding protein) and p300 as an alternative approach to inhibit human Th17 responses.  The authors show that CBP30 has marked mol. specificity for the bromodomains of CBP and p300, compared with 43 other bromodomains.  In unbiased cellular testing on a diverse panel of cultured primary human cells, CBP30 reduced immune cell prodn. of IL-17A and other proinflammatory cytokines.  CBP30 also inhibited IL-17A secretion by Th17 cells from healthy donors and patients with ankylosing spondylitis and psoriatic arthritis.  Transcriptional profiling of human T cells after CBP30 treatment showed a much more restricted effect on gene expression than that obsd. with the pan-BET (bromo and extraterminal domain protein family) bromodomain inhibitor JQ1.  This selective targeting of the CBP/p300 bromodomain by CBP30 will potentially lead to fewer side effects than with the broadly acting epigenetic inhibitors currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4fYjOUV2xW7Vg90H21EOLACvtfcHk0lgbsbYUvZUWYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSit7jI&md5=fb9de88ecdd6441628ae1455ac11b65c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1501956112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1501956112%26sid%3Dliteratum%253Aachs%26aulast%3DHammitzsch%26aufirst%3DA.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DA.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DMartinez%26aufirst%3DF.%2BO.%26aulast%3DAl-Mossawi%26aufirst%3DM.%2BH.%26aulast%3Dde%2BWit%26aufirst%3DJ.%26aulast%3DVecellio%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DWordsworth%26aufirst%3DP.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBowness%26aufirst%3DP.%26atitle%3DCBP30%252C%2520a%2520Selective%2520CBP%252FP300%2520Bromodomain%2520Inhibitor%252C%2520Suppresses%2520Human%2520Th17%2520Responses%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D10768%26epage%3D10773%26doi%3D10.1073%2Fpnas.1501956112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Development of Methyl Isoxazoleazepines as Inhibitors of BET</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1842</span><span class="NLM_x">–</span> <span class="NLM_lpage">1848</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.03.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1016%2Fj.bmcl.2015.03.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=25851940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVKrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1842-1848&author=M.+C.+Hewittauthor=Y.+Leblancauthor=V.+S.+Gehlingauthor=R.+G.+Vaswaniauthor=A.+C%C3%B4t%C3%A9author=C.+G.+Nasveschukauthor=A.+M.+Taylorauthor=J.-C.+Harmangeauthor=J.+E.+Audiaauthor=E.+Pardoauthor=R.+Cummingsauthor=S.+Joshiauthor=P.+Sandyauthor=J.+A.+Mertzauthor=R.+J.+Simsauthor=L.+Bergeronauthor=B.+M.+Bryantauthor=S.+Bellonauthor=F.+Poyauthor=H.+Jayaramauthor=Y.+Tangauthor=B.+K.+Albrecht&title=Development+of+Methyl+Isoxazoleazepines+as+Inhibitors+of+BET&doi=10.1016%2Fj.bmcl.2015.03.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Development of methyl isoxazoleazepines as inhibitors of BET</span></div><div class="casAuthors">Hewitt, Michael C.; Leblanc, Yves; Gehling, Victor S.; Vaswani, Rishi G.; Cote, Alexandre; Nasveschuk, Christopher G.; Taylor, Alexander M.; Harmange, Jean-Christophe; Audia, James E.; Pardo, Eneida; Cummings, Rich; Joshi, Shivangi; Sandy, Peter; Mertz, Jennifer A.; Sims, Robert J.; Bergeron, Louise; Bryant, Barbara M.; Bellon, Steve; Poy, Florence; Jayaran, Hariharan; Tang, Yong; Albrecht, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1842-1848</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this report we detail the evolution of our previously reported thiophene isoxazole BET inhibitor chemotype exemplified by CPI-3 to a novel bromodomain selective chemotype (the Me isoxazoleazepine chemotype) exemplified by carboxamide 23.  The Me isoxazoleazepine chemotype provides potent inhibition of the bromodomains of the BET family, excellent in vivo PK across species, low unbound clearance, and target engagement in a MYC PK-PD model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrdQuVhIoU1rVg90H21EOLACvtfcHk0lgbsbYUvZUWYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVKrsL8%253D&md5=fb9a78528287f82ccf004e751e491ee4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.03.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.03.045%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDevelopment%2520of%2520Methyl%2520Isoxazoleazepines%2520as%2520Inhibitors%2520of%2520BET%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1842%26epage%3D1848%26doi%3D10.1016%2Fj.bmcl.2015.03.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lora, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setser, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Discovery of Benzotriazolo[4,3-<i>D</i>][1,4]Diazepines as Orally Active Inhibitors of BET Bromodomains</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span><span class="refDoi"> DOI: 10.1021/ml500411h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500411h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlt1Wls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=145-150&author=A.+M.+Taylorauthor=R.+G.+Vaswaniauthor=V.+S.+Gehlingauthor=M.+C.+Hewittauthor=Y.+Leblancauthor=J.+E.+Audiaauthor=S.+Bellonauthor=R.+T.+Cummingsauthor=A.+C%C3%B4t%C3%A9author=J.-C.+Harmangeauthor=H.+Jayaramauthor=S.+Joshiauthor=J.+M.+Loraauthor=J.+A.+Mertzauthor=A.+Neissauthor=E.+Pardoauthor=C.+G.+Nasveschukauthor=F.+Poyauthor=P.+Sandyauthor=J.+W.+Setserauthor=R.+J.+Simsauthor=Y.+Tangauthor=B.+K.+Albrecht&title=Discovery+of+Benzotriazolo%5B4%2C3-D%5D%5B1%2C4%5DDiazepines+as+Orally+Active+Inhibitors+of+BET+Bromodomains&doi=10.1021%2Fml500411h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Benzotriazolo[4,3-d][1,4]diazepines as Orally Active Inhibitors of BET Bromodomains</span></div><div class="casAuthors">Taylor, Alexander M.; Vaswani, Rishi G.; Gehling, Victor S.; Hewitt, Michael C.; Leblanc, Yves; Audia, James E.; Bellon, Steve; Cummings, Richard T.; Cote, Alexandre; Harmange, Jean-Christophe; Jayaram, Hari; Joshi, Shivangi; Lora, Jose M.; Mertz, Jennifer A.; Neiss, Adrianne; Pardo, Eneida; Nasveschuk, Christopher G.; Poy, Florence; Sandy, Peter; Setser, Jeremy W.; Sims, Robert J.; Tang, Yong; Albrecht, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-150</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of the bromodomains of the BET family, of which BRD4 is a member, has been shown to decrease myc and interleukin (IL) 6 in vivo, markers that are of therapeutic relevance to cancer and inflammatory disease, resp.  Herein the authors report substituted benzo[b]isoxazolo[4,5-d]azepines and benzotriazolo[4,3-d][1,4]diazepines as fragment-derived novel inhibitors of the bromodomain of BRD4.  Compds. from these series were potent and selective in cells, and subsequent optimization of microsomal stability yielded representatives that demonstrated dose- and time-dependent redn. of plasma IL-6 in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDybfuij7kebVg90H21EOLACvtfcHk0lhX8lLl9A-krA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlt1Wls7k%253D&md5=38759c818814869d6c951a035bad7617</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fml500411h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500411h%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DLora%26aufirst%3DJ.%2BM.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DNeiss%26aufirst%3DA.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DSetser%26aufirst%3DJ.%2BW.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDiscovery%2520of%2520Benzotriazolo%255B4%252C3-D%255D%255B1%252C4%255DDiazepines%2520as%2520Orally%2520Active%2520Inhibitors%2520of%2520BET%2520Bromodomains%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D145%26epage%3D150%26doi%3D10.1021%2Fml500411h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Beresini, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawes, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orren, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turincio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thana, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hascall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, N. J.</span><span> </span><span class="NLM_article-title">Small-Molecule Library Subset Screening as an Aid for Accelerating Lead Identification</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span><span class="refDoi"> DOI: 10.1177/1087057114522515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.1177%2F1087057114522515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=24518067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWqu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=758-770&author=M.+H.+Beresiniauthor=Y.+Liuauthor=T.+D.+Dawesauthor=K.+R.+Clarkauthor=L.+Orrenauthor=S.+Schmidtauthor=R.+Turincioauthor=S.+W.+Jonesauthor=R.+A.+Rodriguezauthor=P.+Thanaauthor=D.+Hascallauthor=D.+P.+Grossauthor=N.+J.+Skelton&title=Small-Molecule+Library+Subset+Screening+as+an+Aid+for+Accelerating+Lead+Identification&doi=10.1177%2F1087057114522515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule library subset screening as an aid for accelerating lead identification</span></div><div class="casAuthors">Beresini, Maureen H.; Liu, Yichin; Dawes, Timothy D.; Clark, Kevin R.; Orren, Linda; Schmidt, Stephen; Turincio, Rebecca; Jones, Steven W.; Rodriguez, Richard A.; Thana, Peter; Hascall, Daniel; Gross, Daniel P.; Skelton, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">758-770, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Several small-compd. library subsets (14,000 to 56,000) have been established to complement screening of a larger Genentech corporate library (∼1,300,000).  Two validation sets (∼1% of the total library) contg. compds. representative of the main library were chosen by selection of plates or individual compds.  Use of these subsets guided selection of assay configuration, validated assay reproducibility, and provided ests. of hit rates expected from our full library.  A larger diversity subset representing the scaffold diversity of the full library (3.4% of the total) was designed for screening more challenging targets with limited reagent availability or low-throughput assays.  Retrospective anal. of this subset showed hit rates similar to those of the main library while recovering a higher proportion of hit scaffolds.  Finally, a property-restricted diversity set called the "in-between library" was established to identify ligand-efficient compds. of mol. size between those typically found in fragment and high-throughput screening libraries.  It was screened at fivefold higher concns. than the main library to facilitate identification of less potent yet ligand-efficient compds.  Taken together, this work underscores the value of generating multiple purpose-focused, diversity-based library subsets that are designed using computational approaches coupled with internal screening data analyses to accelerate the lead discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLxwfGU_R_arVg90H21EOLACvtfcHk0lg98GEJj0cZLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWqu7jI&md5=a9d79cadab5e3a4bc3a3136d7b548d09</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1177%2F1087057114522515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057114522515%26sid%3Dliteratum%253Aachs%26aulast%3DBeresini%26aufirst%3DM.%2BH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDawes%26aufirst%3DT.%2BD.%26aulast%3DClark%26aufirst%3DK.%2BR.%26aulast%3DOrren%26aufirst%3DL.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DTurincio%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DS.%2BW.%26aulast%3DRodriguez%26aufirst%3DR.%2BA.%26aulast%3DThana%26aufirst%3DP.%26aulast%3DHascall%26aufirst%3DD.%26aulast%3DGross%26aufirst%3DD.%2BP.%26aulast%3DSkelton%26aufirst%3DN.%2BJ.%26atitle%3DSmall-Molecule%2520Library%2520Subset%2520Screening%2520as%2520an%2520Aid%2520for%2520Accelerating%2520Lead%2520Identification%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2014%26volume%3D19%26spage%3D758%26epage%3D770%26doi%3D10.1177%2F1087057114522515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span>MoKa; <span class="NLM_publisher-name">Molecular Discovery</span>: <span class="NLM_publisher-loc">Perugia, Italy</span>; <a href="http://www.moldiscovery.com/software/moka/" class="extLink">www.moldiscovery.com/software/moka/</a> (accessed June 16, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MoKa%3B+Molecular+Discovery%3A+Perugia%2C+Italy%3B+www.moldiscovery.com%2Fsoftware%2Fmoka%2F+%28accessed+June+16%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DMoKa%26pub%3DMolecular%2520Discovery" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Hagemans, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Belzen, I. A. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morán Luengo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüdiger, S. G. D.</span><span> </span><span class="NLM_article-title">A Script to Highlight Hydrophobicity and Charge on Protein Surfaces</span> <span class="citation_source-journal">Front. Mol. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.3389/fmolb.2015.00056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.3389%2Ffmolb.2015.00056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=25988169" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=1-11&author=D.+Hagemansauthor=I.+A.+E.+M.+van+Belzenauthor=T.+Mor%C3%A1n+Luengoauthor=S.+G.+D.+R%C3%BCdiger&title=A+Script+to+Highlight+Hydrophobicity+and+Charge+on+Protein+Surfaces&doi=10.3389%2Ffmolb.2015.00056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3389%2Ffmolb.2015.00056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmolb.2015.00056%26sid%3Dliteratum%253Aachs%26aulast%3DHagemans%26aufirst%3DD.%26aulast%3Dvan%2BBelzen%26aufirst%3DI.%2BA.%2BE.%2BM.%26aulast%3DMor%25C3%25A1n%2BLuengo%26aufirst%3DT.%26aulast%3DR%25C3%25BCdiger%26aufirst%3DS.%2BG.%2BD.%26atitle%3DA%2520Script%2520to%2520Highlight%2520Hydrophobicity%2520and%2520Charge%2520on%2520Protein%2520Surfaces%26jtitle%3DFront.%2520Mol.%2520Biosci.%26date%3D2015%26volume%3D2%26spage%3D1%26epage%3D11%26doi%3D10.3389%2Ffmolb.2015.00056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Albrecht, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantone, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Meara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supko, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1330</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01882</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01882" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1330-1339&author=B.+K.+Albrechtauthor=V.+S.+Gehlingauthor=M.+C.+Hewittauthor=R.+G.+Vaswaniauthor=A.+C%C3%B4t%C3%A9author=Y.+Leblancauthor=C.+G.+Nasveschukauthor=S.+Bellonauthor=L.+Bergeronauthor=R.+Campbellauthor=N.+Cantoneauthor=M.+R.+Cooperauthor=R.+T.+Cummingsauthor=H.+Jayaramauthor=S.+Joshiauthor=J.+A.+Mertzauthor=A.+Neissauthor=E.+Normantauthor=M.+O%E2%80%99Mearaauthor=E.+Pardoauthor=F.+Poyauthor=P.+Sandyauthor=J.+Supkoauthor=R.+J.+Simsauthor=J.-C.+Harmangeauthor=A.+M.+Taylorauthor=J.+E.+Audia&title=Identification+of+a+Benzoisoxazoloazepine+Inhibitor+%28CPI-0610%29+of+the+Bromodomain+and+Extra-Terminal+%28BET%29+Family+as+a+Candidate+for+Human+Clinical+Trials&doi=10.1021%2Facs.jmedchem.5b01882"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials</span></div><div class="casAuthors">Albrecht, Brian K.; Gehling, Victor S.; Hewitt, Michael C.; Vaswani, Rishi G.; Cote, Alexandre; Leblanc, Yves; Nasveschuk, Christopher G.; Bellon, Steve; Bergeron, Louise; Campbell, Robert; Cantone, Nico; Cooper, Michael R.; Cummings, Richard T.; Jayaram, Hariharan; Joshi, Shivangi; Mertz, Jennifer A.; Neiss, Adrianne; Normant, Emmanuel; O'Meara, Michael; Pardo, Eneida; Poy, Florence; Sandy, Peter; Supko, Jeffrey; Sims, Robert J.; Harmange, Jean-Christophe; Taylor, Alexander M.; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1330-1339</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, inhibition of the interaction between the bromodomain and extra-terminal domain (BET) family of chromatin adaptors and acetyl-lysine residues on chromatin has emerged as a promising approach to regulate the expression of important disease-relevant genes, including MYC, BCL-2, and NF-κB.  Here we describe the identification and characterization of a potent and selective benzoisoxazoloazepine BET bromodomain inhibitor that attenuates BET-dependent gene expression in vivo, demonstrates antitumor efficacy in an MV-4-11 mouse xenograft model, and is currently undergoing human clin. trials for hematol. malignancies (CPI-0610).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40qjnYl4EZLVg90H21EOLACvtfcHk0lg98GEJj0cZLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKjs7g%253D&md5=5e1c5aab26aa58844a9f6670a7bbd78b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01882%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DCantone%26aufirst%3DN.%26aulast%3DCooper%26aufirst%3DM.%2BR.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DNeiss%26aufirst%3DA.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DM.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DSupko%26aufirst%3DJ.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DIdentification%2520of%2520a%2520Benzoisoxazoloazepine%2520Inhibitor%2520%2528CPI-0610%2529%2520of%2520the%2520Bromodomain%2520and%2520Extra-Terminal%2520%2528BET%2529%2520Family%2520as%2520a%2520Candidate%2520for%2520Human%2520Clinical%2520Trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1330%26epage%3D1339%26doi%3D10.1021%2Facs.jmedchem.5b01882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Halladay, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinhababu, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh-Bakht, S. C.</span><span> </span><span class="NLM_article-title">Metabolic Stability Screen for Drug Discovery Using Cassette Analysis and Column Switching</span> <span class="citation_source-journal">Drug Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.2174/187231207779814364</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.2174%2F187231207779814364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=19356021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtleru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2007&pages=67-72&author=J.+S.+Halladayauthor=S.+Wongauthor=S.+M.+Jafferauthor=A.+K.+Sinhababuauthor=S.+C.+Khojasteh-Bakht&title=Metabolic+Stability+Screen+for+Drug+Discovery+Using+Cassette+Analysis+and+Column+Switching&doi=10.2174%2F187231207779814364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic stability screen for drug discovery using cassette analysis and column switching</span></div><div class="casAuthors">Halladay, Jason S.; Wong, Susan; Jaffer, Sharmin M.; Sinhababu, Achintya K.; Khojasteh-Bakht, S. Cyrus</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-72</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">In vitro metabolic stability assays are used to screen compds. for stability in the presence of various drug metabolizing enzymes, usually cytochrome P 450 in liver prepns. (e.g., liver microsomes).  High-throughput metabolic stability assays using pooling methods have been developed to keep pace with screening requirements at the lead ADME optimization stage.  In our lab., we have improved the metabolic stability assay using the cassette anal. method, column switching, and incorporated time saving techniques in method development to yield a robust method which reduces data turnaround time, increases compd. throughput, and maximizes mass spectrometer usage.  This method can det. metabolic stability using microsomes or hepatocytes from any species.  We describe our findings following incubation of 40 different compds. with human liver microsomes and anal. by the cassette and discrete anal. methods.  Similar metabolic stability results were obtained using the cassette anal. and discrete anal. method.  An overall 70% time savings was achieved by pooling four new compds. into one sample for method development/MS optimization, cassetting four samples into one sample to minimize the no. of injections on LC/MS/MS anal., and using a column switching system to analyze the samples, which results in a two-fold decrease in the LC/MS/MS anal. time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKzVSm6sBe1bVg90H21EOLACvtfcHk0ljpvM-8t1Ezrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtleru74%253D&md5=e00c66b3ca6a1eaee107c4eb81e07bf5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F187231207779814364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231207779814364%26sid%3Dliteratum%253Aachs%26aulast%3DHalladay%26aufirst%3DJ.%2BS.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DJaffer%26aufirst%3DS.%2BM.%26aulast%3DSinhababu%26aufirst%3DA.%2BK.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26atitle%3DMetabolic%2520Stability%2520Screen%2520for%2520Drug%2520Discovery%2520Using%2520Cassette%2520Analysis%2520and%2520Column%2520Switching%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2007%26volume%3D1%26spage%3D67%26epage%3D72%26doi%3D10.2174%2F187231207779814364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macintyre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rance, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wastall, P.</span><span> </span><span class="NLM_article-title">The Prediction of Human Pharmacokinetic Parameters From Preclinical and in Vitro Metabolism Data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+Macintyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+Prediction+of+Human+Pharmacokinetic+Parameters+From+Preclinical+and+in+Vitro+Metabolism+Data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0ljpvM-8t1Ezrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacintyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520Prediction%2520of%2520Human%2520Pharmacokinetic%2520Parameters%2520From%2520Preclinical%2520and%2520in%2520Vitro%2520Metabolism%2520Data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Halladay, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delarosa, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh, S. C.</span><span> </span><span class="NLM_article-title">High-Throughput, 384-Well, LC-MS/MS CYP Inhibition Assay Using Automation, Cassette-Analysis Technique and Streamlined Data Analysis</span> <span class="citation_source-journal">Drug Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span><span class="refDoi"> DOI: 10.2174/187231211796905017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=10.2174%2F187231211796905017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=21867481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Cit7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=220-230&author=J.+S.+Halladayauthor=E.+M.+Delarosaauthor=D.+Tranauthor=L.+Wangauthor=S.+Wongauthor=S.+C.+Khojasteh&title=High-Throughput%2C+384-Well%2C+LC-MS%2FMS+CYP+Inhibition+Assay+Using+Automation%2C+Cassette-Analysis+Technique+and+Streamlined+Data+Analysis&doi=10.2174%2F187231211796905017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput, 384-well, LC-MS/MS CYP inhibition assay using automation, cassette-analysis technique and streamlined data analysis</span></div><div class="casAuthors">Halladay, Jason S.; Delarosa, Erlie Marie; Tran, Daniel; Wang, Leslie; Wong, Susan; Khojasteh, S. Cyrus</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">220-230</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Here we describe a high capacity and high-throughput, automated, 384-well CYP inhibition assay using well-known HLM-based MS probes.  We provide consistently robust IC50 values at the lead optimization stage of the drug discovery process.  Our method uses the Agilent Technologies/Velocity11 BioCel 1200 system, timesaving techniques for sample anal., and streamlined data processing steps.  For each expt., we generate IC50 values for up to 344 compds. and pos. controls for five major CYP isoforms (probe substrate): CYP1A2 (phenacetin), CYP2C9 [(S)-warfarin], CYP2C19 [(S)-mephenytoin], CYP2D6 (dextromethorphan), and CYP3A4/5 (testosterone and midazolam).  Each compd. is incubated sep. at four concns. with each CYP probe substrate under the optimized incubation condition.  Each incubation is quenched with acetonitrile contg. the deuterated internal std. of the resp. metabolite for each probe substrate.  To minimize the no. of samples to be analyzed by LC-MS/MS and reduce the amt. of valuable MS runtime, we utilize timesaving techniques of cassette anal. (pooling the incubation samples at the end of each CYP probe incubation into one) and column switching (reducing the amt. of MS runtime).  Here we also report on the comparison of IC50 results for five major CYP isoforms using our method compared to values reported in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6LFWUX9244rVg90H21EOLACvtfcHk0ljpvM-8t1Ezrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Cit7bL&md5=87db89d19026e12386ba06d594eeb727</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F187231211796905017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231211796905017%26sid%3Dliteratum%253Aachs%26aulast%3DHalladay%26aufirst%3DJ.%2BS.%26aulast%3DDelarosa%26aufirst%3DE.%2BM.%26aulast%3DTran%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DKhojasteh%26aufirst%3DS.%2BC.%26atitle%3DHigh-Throughput%252C%2520384-Well%252C%2520LC-MS%252FMS%2520CYP%2520Inhibition%2520Assay%2520Using%2520Automation%252C%2520Cassette-Analysis%2520Technique%2520and%2520Streamlined%2520Data%2520Analysis%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2011%26volume%3D5%26spage%3D220%26epage%3D230%26doi%3D10.2174%2F187231211796905017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MXF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MXF','PDB','3MXF'); return false;">PDB: 3MXF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTU','PDB','5KTU'); return false;">PDB: 5KTU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTW','PDB','5KTW'); return false;">PDB: 5KTW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTX','PDB','5KTX'); return false;">PDB: 5KTX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KU3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KU3','PDB','5KU3'); return false;">PDB: 5KU3</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i34"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01022">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_52776"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01022">10.1021/acs.jmedchem.6b01022</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Full experimental details and characterization for all reported compounds, metabolite identification data for <b>52</b>, the enantiomer of <b>59</b> experimental details, characterization, biochemical assay data, and cellular assay data, selectivity data for <b>7</b>, crystallography methods, modeling coordinates, ab initio torsion scan data for <b>7</b> and <b>59</b>, BromoScan data for <b>59</b>, CEREP off-target screening data for <b>59</b>, Invitrogen kinase data for <b>59</b>, PK/PD data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01022/suppl_file/jm6b01022_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01022/suppl_file/jm6b01022_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01022/suppl_file/jm6b01022_si_001.pdf">jm6b01022_si_001.pdf (1.48 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01022/suppl_file/jm6b01022_si_002.csv">jm6b01022_si_002.csv (4.37 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB codes for the structures of the CBP bromodomain in complex with <b>7</b>, <b>44</b>, and <b>59</b> are <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTU">5KTU</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTW">5KTW</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KTX">5KTX</a>, respectively. PDB code for the structure of the BRD4(1) in complex with <b>59</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KU3">5KU3</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01022&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-23%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01022" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01022" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799877468712390","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
